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ABSTRACT 
The mammalian small intestine is a major site (second in total activity only to the liver) 
for the synthesis and secretion of plasma apolipoproteins, and contributes significantly to 
overall whole-body lipid dynamics. 
A prominent feature of the small intestine is its exposure to periodic loads of meals often 
containing dramatically varying amounts or types of food components, including lipids 
such as tri-acylglycerols, cholesterol and cholesteryl esters. Since the trans-epithelial 
transport of most of these latter materials requires the elaboration of particles partially 
covered by apolipoproteins, the regulation of the biosynthesis or, more correctly, the 
availability of these proteins is an important and as yet little-understood problem. 
Previous studies have been conducted on systems which, for one or the other reason, 
have not permitted the following questions to be satisfactorily or coherently answered: 
Does the ingestion of fat-containing meals, either acutely or chronically, increase the rate 
of biosynthesis of intestinal apolipoproteins such as apo B-48, and is this the principal 
method of matching the "demand" with the supply of this "packaging material" needed 
for fat transport across the intestinal epithelial cells? Alternatively, does the maintenance 
of a large steady-state intracellular pool in the face of variations in intracellular 
apolipoprotein degradation, controlled by acute or chronic lipid ingestion, produce the 
required "match" between supply and demand for these proteins (as has recently been 
suggested in studies on liver cells)? 
An in vitro system was therefore devised whereby sheets of intestinal epithelial cells 
(enterocytes) were freshly isolated from the jejuna of adult male Syrian golden hamsters 
and incubated for several hours in a medium supporting steady-state protein synthesis, in 
a manner which was assumed to be similar to the activity just before the killing of the 
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donor animals. (Hamsters appear on various grounds to be a better small-animal model 
of human lipoprotein metabolism than the more commonly studied rats). The isolated 
epithelial cell sheets produced primary apolipoprotein products that could be extracted 
from the cells or detected in the incubation media, free from the subsequent 
modifications that they are known to undergo in vivo. 
Hamsters maintained on a low-fat chow were either studied as such or subjected to a 
variety of dietary treatments designed to maximize (over short or long time periods) 
intracellular apolipoprotein requirements for the "packaging" of tri-acylglycerol-rich 
lipoproteins, especially chylomicrons: acute bolus administration of lipid into the gut; 
overnight feeding of fat-enriched food; and chronic (six week) fat feeding. 
Using specific antisera and immuno-precipitation techniques, apo B-48 and two other 
principal intestinal apolipoproteins were shown to be synthesized in the steady state by 
intestinal cell sheets derived from control animals and from those subjected to acute or 
chronic fat-containing diets. Secretion took place, however, only when prior fat 
exposure of the donor intestines had occurred. 
Pulse-chase labelling was used to compare the rates of apolipoprotein synthesis, 
degradation and secretion in the same cell sheet preparations. The rates of 
apolipoprotein B-48 synthesis did not vary significantly under conditions of low or high 
trans-epithelial lipid flux, supporting findings derived from in vivo experimental systems. 
In contrast with data from other systems, however, the biosynthesis of apolipoprotein A-
IV was not reproducibly increased on fat challenge. The rates of apo B-48 degradation 
varied significantly and were markedly reduced under conditions of fat feeding. The 
experiments permit a choice between the two alternatives mentioned above: 
Ingestion of fatty foods, either acutely or over long periods of time, does not increase the 
rates of biosynthesis of apolipoproteins such as apo B-48; but variations in the rate of 
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intracellular degradation of this and probably other apolipoproteins allows the intestinal 
cells to match their requirements for lipid-transporting molecules to the demands of any 
given situation, relying in each case on a large steady-state intracellular pool maintained 
by "constitutive" biosynthesis. Importantly, there seems also to be a specific, possibly 
related effect of fat feeding on the secretion of lipoproteins into the intestinal 
extracellular fluid. 
These conclusions coincide with those obtained by other workers from studies of 
apolipoprotein B dynamics in isolated hepatocytes and in the hepatoma-derived liver cell 
line, Hep G2. The mechanisms underlying these phenomena are as yet unresolved. 
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1.1 INTRODUCTION: LIPIDS AND LIPOPROTEINS IN HEALTH AND 
DISEASE 
2 
Lipids are a heterogeneous group of organic compounds usually defined in terms of their 
common property of being insoluble or poorly soluble in aqueous solutions but soluble in 
non-polar, organic solvents. Lipids such as long-chain fatty acids, tri-acylglycerols and 
waxes (in some animals) serve as important energy sources, being ultimately oxidised to 
provide adenosine triphosphate. Tri-acylglycerols, which consist of various long-chain 
fatty acids esterified with the hydroxyl groups on the three carbon atoms of glycerol, are 
both a direct source of energy and a potential source when stored as fat in adipose tissue. 
A second major function of lipids is as structural components of cell membranes. These 
contain phospholipids and compound glycerophospholipids, sphingophospholipids and 
glycosphingolipids. Cholesterol, a sterol compound, is also a major structural component 
of cell membranes, and serves as a substrate in the liver for the synthesis of bile acids 
which, in tum, assist in the processes of digestion and absorption of other lipids in the 
bowel. Cholesterol is also the precursor molecule from which steroid hormones are 
synthesized in certain tissues. Vitamin D is another sterol derivative with functions in 
regulating calcium and phosphorus metabolism and bone calcification. 
Finally, the terpenes constitute another important class of lipid compounds. They 
include the dolichols and the lipid-soluble vitamins A, E and K with functions in 
glycoprotein synthesis, as well as vision and epithelial integrity, anti-oxidant activity and 
blood coagulation, respectively (Montgomery et al. 1977, Mayes 1988). 
In order to perform their functions, however, lipids as relatively water-insoluble 
compounds have to be transported in an aqueous environment - the blood plasma - from 
one tissue to another. This problem of lipid transport is generally overcome by the 
formation of a group of water-soluble lipid-transport macromolecules called lipoproteins. 
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Lipoproteins are particles consisting of non-polar lipids (tri-acylglycerols and cholesteryl 
esters) in a hydrophobic core, surrounded by a surface layer of amphipathic lipids (free 
cholesterol and phospholipids) and proteins, with the polar aspects of these molecules 
orientated towards the aqueous environment. The protein moieties of lipoproteins are 
known as apolipoproteins or apoproteins. The phospholipids are mainly 
phosphatidylcholine (lecithin) and sphingomyelin. The larger lipoproteins serve 
principally to transport exogenous dietary lipid (especially tri-acylglycerols) from the 
intestine to various body tissues and to export endogenously synthesized tri-acylglycerols 
from the liver to various tissues including adipose tissue. The smaller lipoproteins have 
more complex and diverse functions. (The transport of free fatty acids mobilized from 
tri-acylglycerol stores in adipose tissue during periods of fasting is facilitated by 
albumin, a soluble protein which binds free fatty acids with high affinity, while ketone 
bodies, which arise from the partial oxidation of free fatty acids in the liver, are readily 
soluble in plasma). 
Circulating plasma lipoproteins have been separated and classified into four main classes, 
depending on their density (a function of the lipid/protein ratio) or their electrophoretic 
mobility (dependent on the apoprotein composition) (Fig. 1.1). These lipoprotein classes 
are respectively called chylomicrons, very low density lipoproteins (VLDL), low density 
lipoproteins (LDL) and high density lipoproteins (HDL). A further group of 
intermediate density lipoproteins (IDL) has also been defined (Table 1.1). Of the major 
groups, the chylomicrons and very low density lipoproteins (VLDL) are quantitatively 
the most important in the transport of tri-acylglycerols. Chylomicrons transport dietary 
fat from the intestine while VLDLs transport tri-acylglycerols from the liver to extra-
hepatic tissues. IDL's are formed in the plasma by the action of the enzyme, 
Lipoprotein Lipase, on tri-acylglycerol-rich lipoproteins. High density lipoproteins 
-
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Fig. 1.1. Separation of plasma lipoproteins by electrophoresis. 
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Table 1.1. Physical properties of human plasma lipoprotein classes. 
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(HDL) are involved inter alia in the catabolism of VLDL and chylomicrons and the 
transport of cholesterol from peripheral tissues to the liver. 
The medical interest in lipid transport and metabolism is derived from epidemiological 
and experimental evidence linking atherosclerotic cardiovascular disease to abnormalities 
of plasma lipids. There is evidence that the prevalence and incidence of atherosclerosis 
and its clinical manifestations (coronary heart disease, peripheral vascular disease and 
cerebro-vascular disease) are increased in societies with a high dietary intake of total fat, 
saturated fat and cholesterol. The serum cholesterol concentrations in these populations 
are also generally higher than those of people whose diet is low in these constituents and 
who also have less atherosclerotic cardiovascular disease. 
Experiments in non-human primates and other mammals have shown that chronic, diet-
induced hypercholesterolaemia is associated with the development of atherosclerosis 
(Faggiotto & Ross 1984). The association between premature atherosclerosis and the 
genetic condition of Familial Hypercholesterolaemia (Type Ila Hyperlipidaemia) in 
which a deficiency, defect or absence of low density lipoprotein receptors (LDL 
receptors) results in a failure of normal LDL catabolism and a consequent accumulation 
of (cholesterol-rich) LDL particles in the plasma, provides further support to the 
argument linking lipids (especially LDL-cholesterol) to atherogenesis (Steinberg 1983, 
Goldstein & Brown 1989). 
Cholesterol and other plasma lipid or lipoprotein components characteristically 
accumulate in atheromatous plaques. In the general population, however, who do not 
have Familial Hypercholesterolaemia and where the majority of cases of atherosclerosis-
related disease occurs, atherosclerosis and its clinical manifestations appear to be 
multifactorial in origin, with cigarette smoking, diet, obesity, hypertension, heredity, 
diabetes, lack of exercise and stress all playing potential roles in the aetiology of the 
disease. In addition to the positive correlation between LDL-cholesterol levels and the 
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risk of coronary heart disease, a negative correlation exists between HDL cholesterol 
levels and atherosclerotic disease, i.e. low HDL cholesterol levels are associated with an 
increased risk of disease. Furthermore, it is the reduced cholesterol level of a 
subfraction of HDL, HD:Li (as opposed to HD~), which correlates even better with the 
increased risk (Gordon et al. 1977, Eder & Gidez 1982). 
Post-prandial lipaemia has been postulated to be a factor in atherogenesis (Patsch 1987). 
Some researchers have demonstrated a strong inverse association between the magnitude 
of post-prandial lipaemia (fat tolerance) and HD:Li cholesterol levels. Post-prandial 
lipaemia could affect the atherosclerotic process directly through the appearance of post-
prandially occurring lipoproteins (e.g. chylomicron remnants that may, because of their 
prolonged circulation in the plasma, interact with endothelial arterial walls), or 
indirectly, via effects on other lipoproteins such as LDL or HDL. 
The serum levels of the apolipoproteins have also been studied in relation to heart 
disease. Elevated levels of apolipoprotein B (an apolipoprotein found on the LDL 
particle) and reduced levels of Apolipoprotein A-I (found on HDL) have been found in 
subjects with coronary heart disease (Kreisberg 1983). More recent epidemiological 
evidence has suggested that high plasma levels of another lipoprotein, Lipoprotein (a) or 
Lp(a) correlate with an increased risk of coronary artery disease. Lp(a) consists of an 
LDL-like particle containing the apolipoprotein B-100 (see later), linked by disulphide 
bonding to a high molecular weight glycoprotein, apolipoprotein (a), which is a 
translation product of a gene closely related to the plasminogen structural gene (Lawn 
1992) (see Fig. 1.2). While the links between abnormal serum lipids and atherosclerotic 
disease have been emphasized, abnormalities of lipoproteins are also found in other 
disease states, the commonest of which is diabetes mellitus. Hypothyroidism and renal 
disease are also associated with lipoprotein abnormalities and there are a number of less 
common conditions of inherited defects in lipoprotein metabolism or 
8 
dyslipoproteinaemias resulting in either hypolipoproteinaemia (e.g. 
Abetalipoproteinaemia, Tangiers disease and Familial Hypobetalipoproteinaemia) or 
hyperlipoproteinaemia/hyperlipidaemia, such as the various types of Familial 






Fig. 1.2. A schematic representation of lipoprotein (a). The apolipoprotein (a) molecule is 
linked by disulphide bridging to the apolipoprotein B-100 moiety of the LDL particle. 
(Ref. Lawn 1992). 
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1.2 DIGESTION AND ABSORPTION OF LIPIDS 
The intestinally produced chylomicrons, which consist largely of exogenous diet-derived 
tri-acylglycerol (TAG), are synthesized and assembled in the endoplasmic reticulum of 
the intestinal columnar epithelial cells or enterocytes, whence they are transported to the 
Golgi apparatus of the cells, before being released by exocytosis into the local 
extracellular spaces. The hepatocytes of the liver make TAG-rich very low density 
lipoproteins (VLDL) which are synthesized and secreted in a manner analogous to that of 
the enterocyte. 
Fat constitutes about 40 % of the kilojoules in an average diet of the industrialised 
countries, the daily "western" intake averaging about 100 grams a day. Most of this is 
in the form of TAGs; a small fraction (0.5 - 1 g/day) is in the form of cholesteryl 
esters, and about 10-30 g of phospholipids (derived from membranes of unprocessed 
food and from endogenous biliary secretions) are processed by the adult human gut daily 
(Bisgaier & Glickman 1983, Patsch 1987). The TAGs contain fatty acids mostly with 
chain lengths greater than 14 carbon atoms, and which may be saturated e.g. palmitic 
acid (Cl6:0) and stearic acid (C18:0), or unsaturated e.g. oleic acid (C18:l) and linoleic 
acid (C18:2) (Table 1.2). A small amount of cholesterol is also derived from salivary, 
gastric and biliary secretions as well as sloughed intestinal cells. While the absorption of 
dietary TAG is virtual! y complete ( > 95 % ) , cholesterol is usually absorbed at a level 
equal to between 20-50% of dietary intake (Bisgaier & Glickman 1983). 
The processes of lipid digestion and absorption have been comprehensively reviewed by 
Shiau (1987), Patsch (1987), Thomson & Dietschy (1981) and Westergaard & Dietschy 
(1986). A summary of the most relevant facts will be presented here. 
Dispersion of bulk fat into crudely emulsified particles begins in the stomach. 
Enzymatic lipolysis does, however, also occur in the stomach as a result of the acid-
11 
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Table 1.2. Examples of common unsaturated and saturated fatty acids. 
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resistant lingual lipase secreted from the serous glands of Van Ebner on the dorsal 
surface of the tongue. Lingual lipase works at the Sn-3 position in preference to the Sn-
1 position of the TAG molecule (Fig. 1.3) and the major products are di-acylglycerols 
(DAG) and fatty acids which are ejected into the duodenum. 
The upper small intestine (duodenum and jejunum) are the major sites of lipid digestion 
and absorption. As fat enters the duodenum, the hormones enterogastrone, secretin and 
pancreozymin-cholecystokinin are released from duodenal mucosal cells. Enterogastrone 
acts locally and reduces intestinal motility while secretin and pancreozymin-
cholecystokinin enter the blood stream and reach the gall bladder and pancreas, thus 
stimulating the release of bile and pancreatic juice which mix with the stomach-derived 
emulsion. The enzyme, pancreatic lipase, hydrolyses TAGs in the presence of a co-
factor protein, co-lipase, which is also found in pancreatic secretions and appears to 
assist pancreatic lipase in binding to the TAG and DAG close to the Sn-1 and Sn-3 
positions of the acylglycerol molecules. The hydrolysis of TAGs is a step-wise 
procedure, with one of the fatty acids being removed at a time, so that first a DAG then 
a Sn-2-monoacylglycerol (MAG) are formed sequentially (Fig. 1.3). The bile salts 
together with phospholipids (lecithin) and the MAGs produced early on enable 
emulsification to proceed. The bile salts on their own appear to be poor emulsifying 
agents but as lipolysis proceeds, more polar lipids are produced and further 
emulsification occurs. Dietary cholesterol in the form of cholesteryl esters is hydrolysed 
by a pancreatic cholesteryl esterase to produce free cholesterol and fatty acids. The 
enzyme phospholipase A2 hydrolyses phospholipids to yield lysophospholipids. The end 
products of lipid digestion are therefore fatty acids, glycerol, MAG, (very few TAG and 
DAGs), cholesterol, and lysophospholipids. 
The bile salts released from the gall bladder are present in concentrations in the small 
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Fig. 1.3. Structures of: (1) glycerol, (2) a tri-acylglycerol (or triglyceride), (3) a sn-1,2-di-
acylglycerol and (4) a sn-2 mono-acylglycerol. R represents a fatty acid residue. 
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are formed. These consist of negatively charged spherical aggregates with the polar 
hydroxyl and amino acid groups facing the aqueous environment and the non-polar 
steroid portions forming a hydrophobic core. The fatty acids, MAGs and cholesterol 
enter these bile salt micelles to form mixed micelles and in this form are able to traverse 
the unstirred water layer or aqueous layer immediately adjacent to the microvillar brush 
border of the enterocytes. (This layer is not in equilibrium with the bulk aqueous 
intestinal fluid contents). 
The precise mechanisms of absorption of the constituent lipid molecules from the mixed 
micelles (once they reach the vicinity of the aqueous-membrane interface) is 
controversial: the constituent lipids may partition into the cell membrane during direct 
interaction or collision between the micelles and the cell membrane or absorption may 
only take place through the monomer phase of the lipid molecules (the monomer phase 
being present in the unstirred water layer in equilibrium with the lipids in the micelles) 
(Westergaard & Dietschy 1986). Uptake of cholesterol by the small intestinal brush 
border membrane may be protein mediated (Thurnhofer & Hauser, 1990). The bile salt 
micelles are not absorbed in the upper small bowel but proceed to the terminal ileum 
where absorption takes place and repeated enterohepatic circulation cycles continue. A 
schematic representation of the luminal events of lipid digestion and absorption is 
presented in Figure 1.4. 
Only a small fraction of the dietary lipid ( < 2 % ) reaches the colon. The faecal lipids are 
mainly fatty acids or their salts and are derived largely from bacteria or shed colonic 
epithelial cells. These lipids are later chemically transformed by colonic bacteria and 
although the quantities involved are small, it has been suggested that these processes may 
be significant in the production of carcinogens and the aetiology of large bowel cancer. 
Returning to the upper small bowel, the products of lipid digestion enter the columnar 
epithelial cells of the small intestinal villi by passive diffusion across the microvillar 
membranes. Eventually they are all released on the serosal border by complex 
\ CONJUGATED 
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Fig. 1.4. A schematic representation of the intraluminal events of fat digestion. TAG = 
tri-acylglycerol, DAG = di-acylglycerol, 2-MAG = sn2-mono-acylglycerol. 
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mechanisms depending on the type of digestive product. Thus, short and medium chain 
fatty acids (less than 10-12 carbon atoms e.g. fatty acids of milk TAG) pass directly 
through the mucosal cells into the tissue spaces and are transported as free fatty acids 
bound to albumin in the portal system to the liver and other tissues. Free glycerol is 
readily soluble in water and is also transported by the portal blood. Absorbed MAG, 
cholesterol and fatty acids greater than 12 carbon atoms in length are re-esterified in the 
enterocyte to form TAGs and cholesteryl esters which are packaged using a monolayer of 
phospholipids, some free cholesterol and apolipoproteins as surface coating materials, to 
form chylomicrons. 
During the above processes, the free fatty acids first bind to one or more specific fatty 
acid binding protein(s) (FABP) (MW 15 and 14 kDa, respectively) which have a 
particularly high affinity for long chain unsaturated fatty acids (Bass et al. 1985). These 
proteins probably enable the fatty acids to be transported from the brush-border 
membrane to the smooth endoplasmic reticulum (ER) where esterification takes place. 
The fatty acids are first activated to their co-enzyme A derivative by the enzyme long 
chain fatty acid: Co-enzyme A ligase (LCFA:CoA ligase). The acyl co-enzyme A is 
then esterified by enzyme systems on the ER using 2 alternative metabolic pathways - the 
glycerol-3-phosphate pathway and the MAG pathway (Fig. 1.5). Of the two, the latter 
is quantitatively by far the most important and involves acylation of the Sn-2 MAGs 
(derived from the action of pancreatic lipase in the gut lumen) to Sn-1,2 diacylglycerols 
or Sn-2,3 DAGs and then to TAG (Johnston 1978). The enzymes of TAG biosynthesis, 
LCFA:CoA ligase, MAG transferase and DAG transferase are situated on the inner 
membrane of the smooth endoplasmic reticulum. 
Phospholipids constitute most of the surface monolayer of the chylomicrons but while the 
fatty acids of the TAG core reflect the fatty acid composition of ingested TAGs, the fatty 
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Fig. 1.5. The two pathways of tri-acylglycerol biosynthesis in the enterocyte. The major 
pathway is denoted by the heavy arrows. (Ref.: Johnston 1978). 
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composition, irrespective of diet. The phospholipid in the monolayer is largely 
phosphatidylcholine (lecithin), with small amounts of sphingomyelin and 
phosphatidylethanolamine. Phosphatidyl-choline may be synthesized de novo within the 
enterocyte from DAG and cytidine diphosphocholine. The DAG is formed via 
phosphatidic acid from the glycerol-3-phosphate pathway while the choline is derived 
from the intestinal lumen through dietary intake and biliary secretion. However, 
phosphatidylcholine may also be formed by the acylation of lysophosphatidylcholine 
(produced in the lumen by the action of phospholipase A2 on phospholipids) through the 
ER enzyme, lysophosphatidylcholine acyltransferase. As with TAG biosynthesis in the 
enterocyte, the relative importance of each pathway is determined by the substrate 
availability. In states of dietary lipid deprivation, for example, the glycerol-3-phosphate 
pathway for TAG synthesis is thought to become important, while in phospholipid 
biosynthesis, the lyso pathway would be expected to be quantitatively more important in 
choline-deficiency states. 
While the intestine has the capacity for de novo cholesterol biosynthesis, this appears to 
occur mainly in the crypt cells of the intestinal villus (Fig. 1.6) where the activity of the 
cholesterol biosynthetic enzyme 3-hydroxy 3-methylglutaryl-co-enzyme A (HMG CoA) 
reductase has been found to be highest and where the cholesterol requirement for rapidly 
dividing cells is greatest (Stange & Dietschy 1985). Lumen-derived cholesterol is 
thought to be mostly re-esterified within the enterocyte and "packaged" into the 
chylomicron core. The mechanisms for cholesterol re-esterification may be via the 
pancreatic enzyme, cholesteryl esterase, working "in reverse" inside the epithelial cell, 
or via the enzyme, acyl-CoA:cholesterol acyl tranferase (ACAT). The activity of this 
enzyme reveals a gradient opposite to that of HMG CoA reductase with respect to the 
villus tip-crypt axis: ACAT activity is highest in the cells of the villus tip, where most 
absorption takes place, and is lowest in the rapidly dividing crypt cells at the villus base, 
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Fig. 1.6. The intestinal villus in longitudinal section. The immature, mitotically active 
undifferentiated cells are found in the crypt; as they migrate up the villus they 
become progressively more mature and achieve full differentiation when they reach 
the upper one third of the villus. ·The cells of the tip degenerate and are sloughed into 
the bowel lumen. 
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The apolipoproteins are synthesized by the enterocytes on the rough ER. From there 
they appear to be transferred to the smooth ER and incorporated with the resynthesized 
TAG to form nascent chylomicrons. The chylomicrons then move to the Golgi cisternae 
and vesicles before they are released via exocytosis ("reverse pinocytosis") from 
secretory vesicles at the basolateral surface of the cell membrane (Fig. 1. 7). The three 
principal apolipoproteins synthesized by the enterocyte are Apolipoproteins B-48, A-IV 
and A-I (see later for a fuller review). 
The chylomicrons filter from the extracellular spaces into intestinal lacteals of intestinal 
lymph and eventually drain into the thoracic duct which empties into the subclavian vein. 
In so doing they give rise to the phenomenon of postprandial lipaemia. 
The digestion and absorption of short and medium-chain tri-acylglycerols (C4-12) (fatty 
acids of milk triglyceride) are of importance in infant nutrition and have become 
increasingly significant as a result of their clinical use in certain therapeutic diets. Two 
mechanisms have been proposed for the digestion and absorption of medium chain tri-
acylglycerols (MCT): 
(i) The MCTs are emulsified and then absorbed intact into the mucosa! epithelial 
cells without prior luminal hydrolysis. Once inside the enterocytes a mucosa! cell 
microsomal lipase completely hydrolyzes the MCTs to free fatty acids and glycerol. 
These products are readily soluble in aqueous environments and are partitioned into the 
venous blood where they are carried via the portal vein to the liver as free, ionised fatty 
acids, partly bound to albumin. 
(ii) MCTs may also undergo hydrolysis by pancreatic lipase in the lumen of the 
upper small bowel. Pancreatic lipase is known to be more effective in the hydrolysis of 
MCT than of the more abundant dietary long chain fatty acid-containing tri-acylglycerols 
and complete hydrolysis to free fatty acids and glycerol may occur. However, even in 
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Fig. I'. 7. A schematic representation ~f the events of fat absorption and chylomicron 
formation by the intestinal mucosa! cell (enterocyte). 
FF A = free fatty acid, ER = endoplasmic reticulum, TAG = tri-acylglycerol. 
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the absence of pancreatic lipase, the acid-resistant lingual (or gastric) lipase (secreted by 
the tongue and found in the stomach) is able to hydrolyse MCTs. This enzyme has a 
pH optimum of 4 and preferentially hydrolyzes MCT at rates 5-8 times faster than long 
chain TAGs. It is inhibited by the presence of bile salt micelles in the duodenum. In the 
neonatal period, when pancreatic function is immature, lingual lipase is thought to 
account for the digestion of 30 to 50% of ingested fat (Hamosh 1979). Breast milk also 
contains a milk lipase which is activated by bile salts in the duodenum and this enzyme is 
also of importance in the digestion of MCTs in the suckling infant. The milk lipase is 
able to hydrolyze fatty acids from all 3 positions on the TAG molecule and is therefore 
also able to completely hydrolyse 2 mono-acylglycerols derived by the action of 
pancreatic lipase (Hemell & Blackberg 1982). Milk lipase therefore complements 
pancreatic enzyme digestion in the newborn. The products of MCT digestion, viz. 
glycerol, free fatty acids and, perhaps, some MAG molecules as well, are readily soluble 
in water and easily partition into the unstirred water layer without the need for bile salt 
micelles. Their absorption rates are also higher than for long-chain fatty acid mono-
acylglycerols. Once in the intestinal epithelial cells they are readily transported to the 
serosal border of the cells whence they partition into the venous blood and to the liver. 
MCT absorption is thus largely independent of bile, pancreatic function and factors that 
impair apolipoprotein synthesis or obstruct lymphatic transport from the intestine. 
Synthetically prepared MCTs (C8-C10) are today commonly used as nutritional (caloric) 
supplementation in patients lacking the mechanisms for the normal absorption of long-
chain fatty acid TAGs, e.g. patients with chronic pancreatic insufficiency, parenchymal 
liver disease with reduced bile salt synthesis, abetalipoproteinaemia, chylomicron 
retention disease, and intestinal lymphangiectasia. 
The subsequent cellular metabolism of medium-chain fatty acids is also different from 
that of long-chain fatty acids. In general medium chain fatty acids are rapidly oxidised 
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to CO2 and H20) in the liver and, unlike long chain fatty acids, are incorporated into 
adipose tissue to a limited extent only. 
Little will be said here about the mechanisms underlying the absorption of the four fat-
soluble vitamins, A, D, E and K, respectively. Vitamin A may be ingested either as 
pre-formed vit. A or as carotene, its precursor. It appears that carotene absorption is 
independent of bile salt concentration and is enhanced by lowering the luminal pH. 
However, only 20-30% of carotene in a typical diet is believed to be absorbed 
unchanged. Most of it is oxidatively split into 2 molecules of retinal, which, in turn, is 
converted to retinal (Vit. A) and then esterified within the intestinal cells (Goodman et 
al. 1966). The retinyl ester is then incorporated into the chylomicron core, along with 
re-synthesized tri-acylglycerol and cholesteryl esters. Ingested retinyl ester is thought to 
be hydrolyzed by pancreatic and brush border esterases prior to absorption. Most of the 
absorbed vitamin A and D is carried via the lymphatics with only small quantities of both 
vitamins being transported via the portal system (Thomson 1971). Vit E is also 
transported via the lymphatics although portal transport has been demonstrated. Vit K is 
carried by lipoproteins in the lymphatics. 
In summary: 
The digestion and absorption of lipids differs from that of other macromolecules e.g. 
carbohydrates and protein, in that most of the material leaving the intestine at the end of 
the process is in the same form as that which entered the gastro-intestinal tract at the 
outset, i.e. as tri-acylglycerol. (Carbohydrates and protein are absorbed mainly in the 
form of their digestive end-products, the constituent monosaccharides and amino acids, 
respectively). Since tri-acylglycerol absorption is virtually complete under normal 
circumstances, the overall process may be viewed as essentially one of bulk fat transfer 
(Fig. 1.8). The lingual, gastric and pancreatico-biliary secretions provide the materials 
for the luminal digestive phase of the process while the intestinal epithelial cells provide 
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the mechanisms for tri-acylglycerol re-synthesis and packaging into water-miscible 
lipoprotein particles which eventually enter the circulation. Because of the complexity 
and scale of the process the intestinal epithelial cells may be expected to contribute a 
significant proportion of their overall metabolic activity to lipid absorption alone. 
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Fig. 1. 8. The process of lipid digestion and absorption is essentially one of bulk transfer: 
most of the material entering the gastro-intestinal tract is tri-acylglycerol (TAG); 
most of the material leaving the ii:itestine is also tri-acylglycerol. 
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1.3 MORPHOLOGIC STUDIES OF LIPID ABSORPTION 
A number of studies of the intracellular events of fat absorption and chylomicron 
formation using time-sequence electron micrographs have been reported in the literature 
(Jersild 1966, Strauss 1976, Sabesin & Frase 1977). Under fasting conditions the 
endoplasmic reticulum, Golgi apparatus and intercellular spaces are unremarkable 
structures. During fat absorption, however, smooth endoplasmic reticulum (SER) 
elements in the apices of the enterocytes distend with fat droplets as a result of the re-
synthesis of tri-acylglycerol from the newly absorbed fatty acids (Fig. 1. 7). Soon 
afterwards lipid droplets appear within vesiculated channels of the SER and the Golgi 
cisternae proliferate and distend with lipid droplets of chylomicron size in the supra-
nuclear region of the cell. Secretory vesicles form from the Golgi and these migrate to 
the basolateral surface of the cell. The secretory vesicles contain discrete vesicle 
membranes similar to coated pits. At these sites the secretory vesicles become 
incorporated into the lateral cell membrane and nascent chylomicrons are discharged into 
the intercellular space by reverse pinocytosis. The chylomicrons penetrate through the 
basement membrane and the lamina propria and enter the lumen of the lymphatics via 
gaps which form between the endothelial cells during lipid absorption. (During fasting 
the endothelial cells closely interdigitate with one another to form a continuous lining) 
(Fig. 1.7). 
The factors responsible for the directional intracellular movement of tri-acylglycerol and 
lipoproteins are not clear although there is some evidence to support the role of 
microtubules in the process. The exact mechanisms of the packaging of the intracellular 
lipid droplets with apolipoproteins, phopholipid and cholesterol to form the chylomicrons 
are not known. 
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1.4 LIPOPROTEINS PRODUCED BY THE INTESTINE 
Experimental evidence for the intestinal synthesis and secretion of chylomicrons, 
intestinal very low density lipoproteins (VLDL) and high density lipoproteins (HDL) has 
been obtained from the following sources: 
(1) Collections of intestinal lymph from cannulated mesenteric or thoracic ducts of 
rats; 
(2) Isolation of intracellular lipoproteins from subcellular organelles of intestinal 
mucosa or isolated epithelial cells (usually of rats); 
(3) Cultures of the human colonic carcinoma cell line (CaC0-2) which when 
confluent possess some properties of intestinal epithelial cells; 
(4) Chylous pleural effusions, urine, ascites and thoracic duct collections from 
humans, and 
(5) Postprandial plasma lipoproteins. 
1.4 (i) Chylomicrons 
Chylomicrons are a heterogeneous group of tri-acylglycerol-rich lipoproteins formed in 
the intestine during lipid absorption. They are the largest of the lipoprotein classes, with 
a size range of 750-6000 A (75-600 nm) in diameter, a mean diameter of 1200 A (120 
nm), and a density of around 0.93 g/ml (Sf 400-10 000) (Lossow et al. 1969, Fraser 
1970). The size of the chylomicrons depends on the lipid flux through the intestinal 
cells: under conditions of low lipid flux (e.g. at the start of lipid absorption), they are 
small; at peak lipid absorption they attain their largest size (Fig. 1.9). With increased 
luminal lipid load the production rate and size of the chylomicrons in intestinal lymph 
mcreases; however, the apolipoprotein content of the larger chylomicrons does not 
increase proportionally, suggesting a reduction in, or saving of, surface coating materials 
relative to lipid content (Green & Glickman 1981, Hayashi et al. 1990). Compositional 
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Fig. 1.9. Chylomicron size is dependent on the lipid flux through the intestinal cells. 
28 
29 
revealed the following (figures are expressed as % of the total particle mass): surface: 
phospholipid 6-8 % , protein 1-1.5 % ; core: tri-acylglycerol 86-92 % , cholesteryl ester 
0. 8-1. 4 % ; core and surface: free cholesterol O. 8-1. 6 % , of which 30 % is contained in 
the core and 70% on the surface (Fig. 1.10). 
The fatty acids of the TAG reflect the fatty acid composition of the ingested lipid 
(Kayden et al. 1963). There is, however, evidence that some endogenous lipid is also 
transported by chylomicrons. The composition of the phospholipid monolayer which 
coats the particle bears little resemblance to that found in the diet and remains relatively 
constant despite variations in dietary fatty acid composition (Green & Glickman 1981). 
Lecithin (phosphatidylcholine) comprises 70 to near 100% of chylomicron phospholipid 
with smaller amounts of sphingomyelin and phosphatidylethanolamine sometimes 
present. The bulk of the TAG and cholesteryl ester is contained within the oily core of 
the particle together with 30% of the free cholesterol. The shell or surface (coat) of the 
particle consists of a surface monolayer of phospholipids, the apolipoproteins, and 70% 
of the free cholesterol. It has been estimated that the phospholipids cover 80-90 % of the 
surface area with the apolipoproteins covering 10-20%. Chylomicron composition varies 
according to the site of isolation: nascent intracellular chylomicrons contain more free 
fatty acid, free cholesterol and protein but less phospholipid than chylomicrons from 
lymph; plasma chylomicrons contain more protein and less phospholipid compared with 
lymph chylomicrons (Green & Glickman 1981). 
The apolipoproteins (apoproteins) of rat lymph chylomicrons comprise apolipoprotein A-
I (MW -28 000) (38-50% of chrlomicron protein), apolipoprotein A-IV (MW -46 000) 
(7-13 % of chylomicron protein), apolipoprotein B-48 (apo B-48 or low molecular weight 
Apo B, Br) (MW -240 000) (10% of protein), apolipoprotein C (C-11 and C-III) (40%), 
and apolipoprotein E (5%) (Imaizumi et al. 1978). However, not all the apolipoproteins 
found on the chylomicrons in lymph are necessarily synthesized by the intestinal mucosa 
30 
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Fig. 1.10. Compositional analysis of chylomicrons from mesenteric ducts of fat-fed rats. 
Figures are expressed as a % of the total particle mass (Ref.: Green & Glickman, 
1981). 
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and may be acquired by the particle through exchanges of material with other particles 
e.g. HDL. Radio-isotope labelling studies have shown active intestinal synthesis of 
apolipoproteins B-48, A-I, A-IV and, to a lesser extent, apo C's (C-11 and C-III 
(Imaizumi et al. 1978, Glickman & Green 1977, Wu & Windmueller 1978). 
Studies of human thoracic duct chylomicrons and chylous unne have revealed the 
following distribution of protein: apo B (3.4%), A-I (15%), E (4.4%), A-IV (10%), and 
A-II and C's, (47.3%) (Green et al. 1979). 
Soon after leaving the intestinal cells and especially upon entering the plasma from the 
thoracic duct, chylomicrons acquire apolipoproteins E and C from HDL and other 
circulating lipoproteins. Apolipoprotein C activates the enzyme lipoprotein lipase and 
also inhibits chylomicron uptake by the liver so that TAG hydrolysis may occur in the 
circulation. Most of this breakdown takes place in the capillaries of fat and muscle 
tissue through the action of the endothelial-bound lipoprotein lipase. The mono- and di-
acylglycerols thus formed may be taken up by tissue or are further hydrolyzed in the 
plasma, while the free fatty acids are either taken up by tissues for oxidation or enter 
adipocytes where they are re-incorporated into TAG and stored as fat. Some of the 
released fatty acids may also be removed by binding to albumin which transports them to 
various tissues, including the liver. 
The shrinkage of the TAG core of the chylomicron particles as a result of lipolysis 
results in excess surface constituents. The apolipoproteins A-I and A-IV are transferred 
to HDL and in the process the intestine contributes significantly to the HDL 
apolipoprotein pool (epecially Apo A-I). Chylomicron phospholipid is also transferred 
to HDL and calculations suggest that even a small fraction of chylomicron phospholipid 
entering HDL could significantly raise the HDL phospholipid pool (Green & Glickman 
1981). Eventually the chylomicron remnant is formed. This small spherical particle 
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comprises only 4% of the original chylomicron mass and is considerably depleted in 
TAG but relatively more enriched in cholesterol ester, phospholipid and protein (as 
proportions of the total particle mass). With the transfer of Apo C back to HDL, Apo 
BL and Apo E are now the major protein constituents (Havel & Kane 1989, Tall 1986). 
Apo C removal results in rapid clearance by the liver of the chylomicron remnants via 
one or more as yet incompletely characterized specific "remnant" receptors which 
recognise a binding domain on Apolipoprotein E. Intestinal apo BL (B-48) is thought 
not to participate in chylomicron remnant uptake by the liver and lacks the receptor 
binding domain of apo B-100 for the LDL receptor (Scott 1989). Virtually all dietary 
cholesterol and the residual tri-acylglycerols are then delivered to the hepatocytes by 
endocytosis and the components of the particle are hydrolyzed in lysosomes. The 
cholesterol molecules released from hepatocyte lysosomes may undergo various fates: 
they may be used in the synthesis of bile acids, they may be secreted directly into bile as 
free biliary cholesterol, they may be incorporated into nascent hepatic lipoproteins 
(especially VLDL), or they may be esterified with long chain fatty acids and stored 
within the hepatocytes in lipid droplets (Tall 1986, Tall et al. 1979, Havel & Kane 
1989). A schematic representation of the events of chylomicron metabolism is shown in 
Fig. 1.11. 
1.4 (ii) Intestinal Very Low Density Lipoproteins (VLDL) 
Intestinal VLDL (p < 1.006, 280-750 A = 28-75 nm in diameter, Sf 20-400) is the 
major lipoprotein of the intestine found during fasting states and is believed to transport 
mainly endogenously derived (biliary) lipids (Ockner et al. 1969, Ockner & Jones 1970). 
Biliary diversion or cholestyramihe administration in the rat results in reduced intestinal 
VLDL production (below that of simple fasting) due to decreased biliary lipid flux. 
However, with lipid infusion into the bowel, luminal fatty acids are incorporated into 
VLDL-TAG to a small extent, indicating at least some exogenous lipid transport. The 
VLDL production does not, however, increase proportionally with increased lipid load. 
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Fig. 1.11. A schematic representation of chylomicron formation and catabolism. FFA = 
free fatty acid, MAG = mono-acylglycerol, TAG = tri-acylglycerol, CE -
cholesteryl ester, HDL = high density lipoprotein, A-1, C, B-48, A-IV -
apolipoproteins. (Ref.: Kane & Havel 1989). 
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During fasting about half of the cholesterol and TAG present in rat mesenteric lymph is 
found in the VLDL fraction (Ockner et al. 1969). 
Intestinal VLDL composition resembles that of chylomicrons rather than plasma or liver-
synthesized VLDL. Being smaller particles though, the content of surface constituents is 
greater (phospholipid 15%), free cholesterol 2.3% and protein 4%). The cholesteryl 
ester content (6%) is also greater than in chylomicrons (-1 % of total mass). The 
apolipoprotein content is similar to that of chylomicrons although Apo A-IV (20-30%) 
and Apo B content are greater, while the apo C content is lower (Green et al. 1979). 
Intestinal VLDL have thus often been regarded simply as "small chylomicrons" and their 
subsequent metabolic fate is also believed to be similar. However, studies by Tso et al . . 
(1984b & 1987) using the detergent Pluronic L-81 have shown selective inhibition of 
chylomicron synthesis by this chemical with the production of VLDL from the intestine 
left intact, thus suggesting independent pathways or mechanisms of production. Indeed, 
a study of the lipoproteins associated with the Golgi apparatus of rat intestinal epithelial 
cells by Mahley et al .. in 1971 showed subcellular compartmentalization of VLDL- and 
chylomicron-sized particles in secretory vesicles _with only limited mixing of the two. 
During fasting in normal rats the intestine was calculated to contribute about 11 % to the 
total plasma VLDL and this rose to 14-17% in (non-lipid) fed rats (Risser et al. 1978). 
However, in diabetic animals the amount of intestinal VLDL was twice that observed in 
normals suggesting an important role for the intestine in the pathogenesis of the 
abnormal lipid metabolism of diabetes mellitus (Popper et al. 1985). 
1.4 (iii) Low Density Lipoproteins (LDL) 
While LDL (p: 1.006 - 1.063 g/rnl) has been isolated from rat mesenteric lymph, the 
quantities are small and the particles are believed to originate from the catabolism of 
hepatic VLDL in the plasma rather than from de novo intestinal synthesis or chylomicron 
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catabolism (which results in chylomicron remnants). The mesenteric LDL therefore 
derives from plasma ultra-filtration and the increased LDL observed in the postprandial 
state probably represents increased bowel perfusion. However, some researchers have 
presented evidence to support an intestinal origin for a lipoprotein particle (p: 1.006 -
1.030 g/ml) found in the mesenteric lymph of rats fed a cholesterol-olive oil diet (Riley 
et al. 1980). While the lipid composition of this particle was similar to that of plasma 
LDL, apolipoprotein A-I was the major protein (compared with apo E in the case of 
plasma LDL), thus suggesting an intestinal source. 
Monolayer cultures of the human intestinal cell line, CaC0-2, secreted particles in the 
VLDL (p < 1.006), LDL (1.006 - 1.063) and HDL (1.063 - 1.21) density ranges into the 
basolateral medium (Traber et al. 1987). Apolipoproteins B-100 (57%) and E (30%) 
comprised the major [35s] methionine-labelled (i.e. newly synthesized) proteins of the 
LDL fraction. Half of all the newly synthesized Apo B-100 secreted by this cell line was 
found in the LDL density range with most of the rest recovered in particles less than 
density 1.006 g/ml. 
When CaC0-2 cells were incubated with [14c] oleic acid more than half the radio-
labelled lipid recovered was isolated from the LDL fraction with only 42 % found in the 
p < 1.006 fraction. Thus particles of LDL density while thought not to be significant 
secretory products of the normal rat intestine are significant lipoproteins of the CaC0-2 
cell line (Traber et al. 1987). 
1.4 (iv) Hii:h Density Lipoproteins (HDL} 
Using techniques of lipoprotein flotation-ultracentrifugation and electron microscopy of 
negatively stained (phosphotungstate) HDL lipoproteins, three distinct types of HDL 
particles (density 1.063 - 1.21 g/ml) have been described from rat mesenteric lymph: 
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(1) A normal spherical HDL particle, similar to that found in plasma, with a diameter of 
10-12 nm. Following fat feeding these particles have been found to increase in number 
as a result of increased (vascular) perfusion of the bowel and filtration into lymph 
(Glickman & Magun 1986a). 
(2) A discoidal HDL particle constituting 50% of lymphatic HDL in the fasted state and 
30% in the fat-fed state. These particles measure 19 by 5.5 nm in diameter and 
resemble nascent HDL found in liver perfusion systems (Hamilton et al. 1976). In 
lymph they are not reduced by biliary diversion (as are chylomicrons and VLDL) 
suggesting that they are not derived from chylomicron or VLDL breakdown. Unlike 
hepatic-derived HDL which contains mainly apo E, this discoidal lymph particle has 
apolipoprotein A-1 as its major protein constituent. It is also rich in phospholipid. 
(3) Small spherical HDL particles, 7.8 nm in diameter, are found especially in the 1.13 -
1.18 g/ml density range. The apolipoprotein constituents are mainly A-I (66%) and A-
IV. 
Intestinal HDL is thought to have a higher TAG content than plasma HDL (11 % versus 
2.8%) (Green et al. 1979). Under fasting conditions 85% of the apo A-1 in rat 
mesenteric lymph was found in the p > 1.006 g/ml fraction while in fat-fed states this 
dropped to 50% suggesting a redistribution of apo A-1 from HDL to lighter TAG-rich 
lipoproteins in the fat-fed state (Glickman & Green 1977). 
Firm evidence for intestinal synthesis and secretion of HDL was provided by Magun et 
al .. in 1985 who isolated nascent small spherical HDL from the Golgi organelles within 
rat enterocytes. No discoidal forms were obtained, however, although discoidal HDL 
has been isolated from the basolateral media of CaC0-2 cells (where both the small 
spherical and discoidal forms have been found) (Hughes et al. 1987). 
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Windmueller and Wu (1981) have identified newly labelled HDL apolipoproteins in the 
venous effluent of the isolated perfused intestine, suggesting direct in vivo secretion of 
lipoproteins into the portal vein system. In the absence of TAG absorption a greater 
proportion of intestinally synthesized apoproteins were secreted directly into the portal 
sytem. The quantitative, physiological significance of this route of secretion has not yet 
been determined although it may be important in the secretion of excess apolipoproteins 
not utilized in the processes of chylomicron assembly. Following secretion of the 
immature discoidal HDL into the plasma, it is believed to be processed into mature 
spherical HDL by the acquisition of unesterified cholesterol and phospholipid with 
subsequent esterification to cholesteryl ester mediated by the enzyme lecithin:cholesterol 
acyltransferase (LCAT) (which requires apo A-1 as a co-factor). Subsequent 
remodelling of the particle may occur through various apolipoprotein interchanges, the 
incorporation of surface remnant material from TAG-rich lipoproteins, and the actions of 
lipoprotein lipase, hepatic lipase and lipid transfer proteins. It is interesting to note that 
the plasma of patients with the rare recessively inherited disorder of LCAT deficiency 
contains HDL particles similar to the small spherical and discoidal forms described in 
mesenteric lymph (Forte et al. 1971, Soutar et al. 1982). 
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1.5 INTESTINAL LIPOPROTEIN UPTAKE 
Thus far the role of the intestine in the production of plasma lipoproteins or lipoprotein 
constituents has been emphasized. However, another function of this organ is that of 
lipoprotein uptake and clearance from the circulation. 
Low density lipoprotein (LDL), which results from the hydrolysis of TAG-rich, 
hepatocyte-derived VLDL in the plasma, is the major cholesterol-carrying lipoprotein of 
human plasma. It is taken up by a variety of tissues by receptor-dependent and receptor-
independent processes. Using techniques of constant radio-labelled LDL infusion into 
the circulation of hamsters, Dietschy and co-workers have been able to quantify the 
relative contributions of the various organs to LDL uptake (Spady et al. 1983a). In the 
hamster most of the LDL (73 % ) is taken up and degraded by the liver with 90 % of this 
uptake mediated by the LDL receptor. The intestine is the second most important organ, 
accounting for 10% of LDL turnover. The jejunum and ileum of the small intestine 
together account for 7% of LDL clearance. Unlike the liver, receptor-independent (as 
opposed to LDL-receptor-dependent) uptake is quantitatively more significant in the 
intestine, accounting for 44% of total intestinal LDL uptake. Only 10% of hepatic LDL 
uptake is mediated independently of the LDL receptor. 
While the hepatic LDL receptor is suppressed in hamsters fed a diet of cholesterol and 
saturated TAG causing an elevation of plasma LDL, the intestinal uptake of LDL 
appears to be unresponsive to dietary manipulation (which also produces a wide variation 
in intestinal cholesterol synthesis) (Stange & Dietschy 1983). However, it has been 
estimated that 4 times more cholesterol is acquired by the intestinal epithelial cells 
through local de novo synthesis than by LDL-cholesterol uptake, so LDL uptake appears 
from this evidence to be quantitatively unimportant from the point of view of meeting 
the intestinal cells' cholesterol needs for membrane synthesis and differentiation as well 
as chylomicron packaging (Stange & Dietschy 1985). Stange and Dietschy, using the 
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technique of Weiser (see Chapter 2.3(ii)) to fractionate enterocytes from the villus-crypt 
axis, found that the immature, dividing crypt cells took up more LDL than those of the 
mature cells nearer the villus tips (Stange & Dietschy 1983) (see Fig. 1.6). 
However, immuno-histochemical studies of the rat intestine using a mono-specific anti-
LDL receptor antibody by Fong et al. in 1989 showed that the greatest density of 
immune staining occurred in the cells of the villus base but that significant staining was 
also present at least up to the level of the mid-villus of the jejunum as well as duodenum 
and ileum. LDL receptor density in the crypt regions was consistently less than that of 
the base-mid villus but was uniform throughout the intestine. These findings 
contradicted the earlier Dietschy evidence and led the authors to speculate on a greater 
role of LDL in providing cholesterol for absorbing cells than previously thought. Since 
these epithelial cells later migrate to the upper tip of the villus and are ultimately 
sloughed into the lumen, much of the cholesterol acquired by LDL uptake (and not 
utilized for lipoprotein assembly or cell membrane synthesis), would be excreted from 
the body. The intestine is, in fact, the only organ involved in the excretion of 
cholesterol from the body, the luminal sterols being derived from unabsorbed dietary 
cholesterol, bile salts (synthesized from cholesterol in the liver), and sloughed epithelial 
cells. The faecal sterols coprostanol and cholestanone result from the actions of 
intestinal bacterial enzymes on cholesterol (Montgomery et al. 1977). 
In 1983 Suzuki et al .. provided evidence for specific high density lipoprotein (HDL) 
binding sites on isolated rat intestinal mucosa! cells. Sviridov et al.. (1986) also 
demonstrated saturable, high affinity, reversible binding of HDL with isolated human 
small intestinal epithelial cells. Internalization and degradation of [125I]HD~ was also 
observed. The intestine may thus be involved not only in the synthesis and secretion of 
HDL but also in its catabolism. HDL is believed to clear excess cholesterol from 
peripheral tissues by transporting it to the liver. By incorporation into bile salts the 
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cholesterol is eventually excreted into the bowel lumen. However, in the light of the 
HDL-intestinal cell interactions described it is possible that HDL may deliver cholesterol 
(and other lipoprotein components) directly to the intestinal epithelial cells for use in 
lipid transport or eventual excretion into the bowel lumen. 
The interactions of LDL and HDL with the intestine may provide an exogenous source 
of apolipoproteins for chylomicron assembly and lipid transport from the cells. The 
evidence available suggests that this is not true of apolipoprotein B where the isoform on 
newly synthesized intestinal lipoproteins is BL (apo B-48) rather than BH (apo B-100) 
which is found on circulating LDL. In the case of apolipoprotein A-1 only the immature 
precursor form or apolipoprotein-pro A-I is present on intestinally synthesized 
lipoproteins whereas circulating HDL contains the mature apo A-1 (the "pro-" peptide 
having been cleaved) (Assmann et al. 1989). 
1.6 THE CONTRIBUTION OF THE INTESTINE TO WHOLE-BODY LIPID 
DYNAMICS 
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The overall contribution of the intestine to whole-body lipid dynamics is summarized in 
Fig. 1.12 and involves both synthetic and catabolic functions in the production of 
lipoproteins and their clearance from the plasma. During TAG transport the intestine 
contributes significantly to the plasma apolipoprotein pool. In 1979 Wu and 
Windmueller performed isotope incorporation studies to determine the relative 
contributions of various organs to the plasma apolipoproteins of the rat. They found that 
the liver and the intestine were the only organs which synthesized and secreted plasma 
apolipoproteins. 19 % of the total apolipoprotein pool was synthesized in the intestine, 
and 81 % by the liver. The percentage contribution of the intestine to individual 
apolipoproteins was: apo A-IV, 59%; apo A-I, 56%; apo B, 16%; apo C-11, 10%; apo 
C-ill-0, 7%; apo C-ill-2(-1) < 10%; apo C-ill-3, < 1 %, and apo E, also < 1 %. The 
rat intestine was therefore a major source of apo A-1 and apo A-IV which are also the 
major proteins of plasma HDL. A subsequent study by Kraft et al. (1989) on plasma apo 
A-IV isoforms in humans showed no change following liver transplantation indicating 
exclusive intestinal synthesis of human plasma apo A-IV. 
In the plasma the surface components of TAG-rich lipoproteins (the apolipoproteins and 
phospholipid) are rapidly redistributed to the HDL fraction following lipolysis. The 
intestine is therefore intimately involved in plasma HDL metabolism. However, in 
addition to this indirect contribution to plasma HDL via the transfer of material, the 
intestine itself is a source of HDL through direct synthesis and secretion of nascent, 
immature HDL particles which are probably transformed in the plasma to mature HDL. 
The relative contribution of the intestinally synthesized HDL to the total plasma HDL 
pool is not known. The intestine also synthesizes VLDL which transports mainly 
endogenously derived lipid. According to one study intestinal VLDL contributes about 
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11 % of the total plasma VLDL in the fat-fed rat and about 14-17% in non fat-fed 
animals (Risser et al. 1978). 
Finally, the intestine is an important organ (second only to the liver) for the clearance of 
cholesterol-rich LDL from the plasma. There is also evidence for HDL binding and 
internalization by intestinal epithelial cells although the physiological significance of this 
process remains to be determined. 
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Fig. 1.12. Lipid fluxes across the intestinal epithelium and their relation to whole-body 
lipid dynamics. 
1. 7 QUESTIONS CONCERNING INTESTINAL LIPID TRANSPORT AND 
APOLIPOPROTEIN BIOSYNTHESIS 
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The complex nature of the process of lipid absorption and transport in itself raises 
several important questions regarding the regulation of the process in the short- and long-
term, the effects of any changes that may occur on whole-body lipid dynamics, and the 
implications that such changes may have with respect to certain disease states e.g. 
atherosclerosis and diabetes mellitus. 
The dietary lipid flux is periodic or episodic in nature. Most carnivorous mammals do 
not ingest food on a continuous basis but feed at certain times. The dietary lipid content 
(as a proportion of the total meal) and composition of the various lipids (saturated versus 
unsaturated fat, cholesterol content) may vary from meal to meal. Nevertheless, the 
intestinal epithelial cells have to provide the "packaging materials" for fat transport (the 
apolipoproteins, p_hospholipid and some cholesterol) whenever the lipid arrives and have 
to cope with varying lipid loads. This project aims in particular to examine whether the 
processes of apolipoprotein biosynthesis on the one hand, and lipid assembly and 
elaboration, on the other, are linked or co-ordinated and, if so, how this is achieved. 
Apolipoprotein availability is essential for lipid transport out of the epithelial cells and 
active apolipoprotein synthesis also appears to be necessary for the process (see Chapter 
1.8). The question is: how is this "availability" met? Is TAG absorption a specific 
stimulus (directly or indirectly) for active apolipoprotein synthesis; i.e., is 
apolipoprotein synthesis regulated by dietary lipid flux? If so, at what level is this 
regulation effected? By pre-translational gene activation and expression? By increased 
messenger RNA "translatability", or by post-translational protein activation? Are there 
factors other than TAG absorption which stimulate apolipoprotein synthesis and 
secretion? Over what time period do regulatory changes take place? The processes of 
lipid transport are, in fact, very rapid. Chylomicrons appear in the intercellular spaces 
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of the epithelial cells as little as 12 minutes after the instillation of lipid in the bowel 
lumen (Jersild 1966). Is there an intra-cellular pool of apolipoproteins available for lipid 
packaging? How large is this pool and to what extent is it able to meet the 
apolipoprotein "demands" of the cell? Do degradation mechanisms play a role in 
regulating intracellular apolipoprotein availability? Do the regulatory mechanisms differ 
according to various segments of the small intestine (e.g. jejunum or duodenum versus 
ileum)? Do they vary along the villus-crypt axis of the same bowel segment? 
Other questions also arise concerning the nature and composition of the intestinally 
produced lipoprotein particles under varying dietary perturbations. How does the 
chemical composition of the various intestinal lipoprotein particles change with variations 
in dietary lipid content and composition? Do meals rich in saturated fats and cholesterol, 
for example, cause the production of lipoproteins with a different apolipoprotein 
composition compared with those caused by meals rich in unsaturated fats? Do these 
differences affect the subsequent metabolism of the particles and, given the important 
contribution of the intestine to overall lipid dynamics in the body, do such alterations 
have implications in the aetiology of atherosclerosis? 
Finally, what are the effects of chronic alteration in diet on the processes of lipid 
absorption and apolipoprotein biosynthesis? Does chronic (as opposed to acute) dietary 
fat loading give rise to adaptations in the intestine e.g. enhancement in its capacity to 
absorb lipids and up-regulation of apolipoprotein biosynthesis? Do chronic high 
saturated fat and cholesterol diets result in alterations of apolipoprotein synthesis, 
secretion, chylomicron composi~on and subsequent metabolism, and do these chronic 
alterations play a role in atherogenesis? Adaptive changes are known to occur in the 
intestine e.g. the rate of lipase secretion by the pancreas is enhanced with chronic dietary 
lipid. In uncontrolled diabetes mellitus associated with polyphagia and increased 
metabolism generally, gut hypertrophy occurs. Adaptive changes are also seen in 
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various segments of the small bowel following surgical resection. The ability of the 
ileum to absorb fat, for example, may be significantly enhanced when it is chronically 
exposed to a higher nutrient load or following resection of part of the small bowel. 
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1.8 INTESTINAL APOLIPOPROTEIN BIOSYNTHESIS AND ITS REGULATION 
1. 8 (i) Apolipoprotein B 
The molecular and cell biology of apolipoprotein B has previously been reviewed by 
Scott (1989 & 1990). The most important facts will be summarised here: Two major 
isoforms of apolipoprotein B have been found in mammalian species: Apolipoprotein B-
100, a large hydrophobic glycoprotein of 4536 amino acids and a molecular weight of 
512 kiloDaltons, (also known as High Molecular Weight Apo B or Apo BH), and 
Apolipoprotein B-48 (48% of the size of Apo B-100 on SDS polyacrylamide gels), with 
2152 amino acid residues and a molecular weight of 242 kDa (also referred to as Low 
MW Apo B or Bu. Apo B-48 is colinear with the amino terminal half of Apo B-100 
and terminates at residue 2152 (isoleucine) of apo B-100 (Scott 1989). 
Both proteins arise from a common gene. The gene is expressed primarily in the liver 
and the intestine (Scott 1990). There is evidence for some expression in renal tubular 
cells (Hodges & Scott 1992). A unique post-transcriptional editing reaction results in the 
de-amination of a specific cytidine base of codon 2153 (nucleotide 6666) to a uridine, 
thus creating a "stop" codon (UAA) from a glutamine codon (CAA) (Powell et al. 1987) 
(see Fig. 1.13). Apo B-100 is synthesized in the mammalian liver. In humans the liver 
synthesizes apo B-100 only, while in rodent species both apo B-48 and apo B-100 are 
produced by the liver (Scott 1989). The editing mechanism - a site-specific, sequence-
specific cytidine de-aminase - manifests itself in the human intestine to produce B-48, 
although the editing mechanism itself has been found in other tissues and cell lines that 
do not express apolipoprotein B (Driscoll & Casanova 1990). 
Two sizes of apo B-48 (i.e. edited) messenger RNA are found in the intestine of 
different mammalian species: a 14 kilobase (kb) mRNA, equal in length to the mRNA 
for apo B-100 but with the stop codon), and a 7 kB mRNA. The latter is thought to 
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Fig. 1.13. A schematic representation of apo B mRNA editing to produce apolipoprotein B-
48 in the intestine. 
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arise through the activation of a cryptic polyadenylation signal immediately downstream 
from the stop codon, resulting in cleavage of the mRNA at this site and a polyA tail 
formation. Both mRNAs will, of course, still give rise to apo B-48 (Fig. 1.13). 
The mRNA editing activity is under developmental, hormonal and nutritional regulation. 
Early in development both liver and intestine express only unedited apo B mRNA 
(Glickman et al. 1986b). Around birth the intestinal mRNA becomes edited to a 
progressively greater extent and progresses to complete editing in adults. Editing is also 
induced in the rat liver but to a lesser extent and on a time-course independent of that of 
the intestine. Uninduced cells of the small intestinal-like cell line, CaC0-2, do not edit 
apo B mRNA whereas more differentiated cells do (Hodges & Scott 1992). Thyroid 
hormone induces apo B mRNA editing in rat liver (Davidson et al. 1988b & c) while 
fasting induces a decrease in editing activity. With carbohydrate re-feeding, which 
increases lipogenesis, near-complete editing of RNA results again (Baum et al. 1990). 
Studies by Glickman et al.. (1978a) showed that radioactive amino acids were 
incorporated into apo B associated with lymph chylomicrons during TAG absorption. 
Windmueller and Wu (1981) estimated that 5% of the plasma apo B pool under fasting 
conditions originated from the intestine. This increased to 16% during fat feeding (Wu 
& Windmueller 1979). The active synthesis of apo B (and other intestinal 
apolipoproteins) is essential for chylomicron formation. This was demonstrated by 
studies using inhibitors of protein synthesis which resulted in TAG droplet accumulation 
within intestinal epithelial cells and decreased lymphatic secretion of chylomicrons 
(Glickman et al. 1972). The chylomicrons that were secreted under these conditions 
were larger than usual and contained reduced amounts of apo A-1, although apo's A-IV 
and B were still present (Glickman & Kirsch 1973). 
The importance of apo B synthesis for lipid absorption and chylomicron formation is 
perhaps best illustrated by the autosomal recessive condition of abetalipoproteinaemia, in 
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which the liver and intestine are unable to form lipoproteins containing apo B and TAG 
droplets accumulate in these organs (Kane & Havel 1989). As a result, there is 
malabsorption of fat and fat-soluble vitamins; chylomicrons, VLDL and LDL are absent 
from the plasma, and levels of cholesterol and TAG are very low. Apo B has been 
shown to be absent from the enterocytes of some subjects with this condition, indicating 
an inability to synthesize the protein (Glickman et al. 1979); in others, though, increased 
quantities of polyadenylated apo B-100 were found, suggesting perhaps a defect in the 
post-translational modification of the protein. An interesting variant of this condition has 
been described by Malloy et al .. (1981): apo B-100 was deficient in the serum with 
severely reduced levels of plasma LDL-cholesterol, while intestinal apo B-48 synthesis 
and hence lipid absorption, chylomicron formation, and postprandial lipaemia were not 
affected. This patient therefore had a selective deficiency of hepatic apo B. 
Studies of the intracellular content of apo B in the intestines of various species have 
produced varied results. The enterogastric instillation of com oil in rats resulted in the 
apo B concentration (normally 80 µgig cell protein) rising two- to threefold after two 
hours (Schonfeld et al. 1978). Other studies using fluorescent antibodies suggested that 
the increase in the cellular apo B content was more rapid, occurring as early as ten 
minutes after exposure of the rat intestine to lipid (Glickman et al. 1979). However, 
studies on human intestinal biopsies showed a significant decrease in the apo B content 
post-prandially, suggesting depletion of a pool or a rate of chylomicron-apo B secretion 
exceeding the rate of apo B synthesis (Rachmilewitz et al. 1976). 
There is in fact some good evidence for a substantial intracellular apolipoprotein B pool. 
When protein synthesis inhibitors were administered to rats under conditions of no 
exogenous lipid absorption, only a 20% reduction in the apo B content of the cells was 
observed. Biliary diversion (which depletes the intestinal mucosa of TAG) also produced 
only a modest reduction in cellular apo B content. Finally, when protein synthesis 
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inhibitors were administered to rats actively absorbing TAG, the mucosal apo B content 
was reduced by about 50% but no more, suggesting a limit beyond which no further 
reduction in apo B could be achieved (Bisgaier & Glickman 1983). 
Ultra-structural, immuno-localization studies of apo B have demonstrated its presence in 
the rough endoplasmic reticulum and on TAG droplets in profiles of the smooth 
endoplasmic reticulum, suggesting that apo B was added early on in chylomicron 
formation (Rubin et al. 1980). 
Perhaps the most definitive experiments on the regulation of the synthesis of apo B-48 in 
the intestine have been provided by the group of Davidson, Glickman and co-workers in 
the 1980's. Rats were either fasted, fed fat-free chow or were administered an acute 
bolus of TAG. Under general anaesthetic a laparotomy was performed and radioactive 
amino acid instilled into a selected segment of the small intestine. After a nine-minute 
protein synthesis "pulse" (the labelling period was confined to 9 minutes to avoid the loss 
of labelled lipoprotein apolipoproteins by secretion from the cells) the tissue was 
removed, homogenized, and the incorporation of radioactive amino acids into apo B 
measured by immunoprecipitation. Results were expressed as a proportion of the total 
trichloroacetic acid-insoluble radioactive protein in the cell. These workers found no 
difference in apo B synthesis as a percentage of the total protein synthesis in both control 
and experimental groups of animals. Furthermore, the intracellular apolipoprotein B 
content (as measured by radio-immunoassay) remained virtually unaltered although it 
appeared to fall slightly for a short period only at the onset of the triglyceride flux. The 
authors concluded that apo B synthesis rates were not regulated by acute TAG flux 
(Davidson et al. 1986). 
Subsequently, using similar experimental techniques, the same authors showed that 
chronic lipid feeding (30% saturated or unsaturated fat as opposed to 0% fat but iso-
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caloric diets in controls, for six weeks) also failed to affect B-48 synthesis. However, an 
inverse relation was found between B-48 synthesis and mucosa! cholesterol absorption 
i.e., the higher the mucosa! cholesterol absorption, the lower the apo B-48 synthesis (as 
a % of total protein). Hypothyroidism (induced by the administration of propylthiouracil 
to rats) also resulted in decreased B-48 synthesis (Davidson et al. 1987). 
Prolonged (unphysiological) biliary diversion, however, resulted in a decline in the apo 
B-48 synthesis rate and this was restored with bile salt replacement in a dose-dependent 
manner. Despite the changes in B-48 synthesis rates, however, apo B mRNA size and 
abundance as determined by RNA blot hybridization remained unaltered (Davidson et al. 
1986, 1988a). 
In 1988 Magun et al .. utilized the technique of nitrogen cavitation to isolate nascent 
intracellular lipoproteins from the enterocytes of rat small intestine (jejuna! segments). 
They measured the distribution of apolipoproteins B-48 (and A-1) in 2 intracellular pools 
or compartments: (1), a non-lipoprotein-bound, membrane-associated (endoplasmic 
reticulum, Golgi) pool, and (2), a lipoprotein-associated pool. Both radio-immunoassays 
and radioactive amino acid incorporation were used in the measurements. They found 
that, under fasting conditions, less than 10% of the apolipoprotein was lipoprotein-
associated; with fat feeding, this % increased slightly, but most of the apolipoprotein 
remained associated with the microsomal membranes. They concluded that only a small 
fraction of a large intracellular apolipoprotein pool was mobilized during lipid absorption 
and that the apparent increase in apolipoprotein B secretion following lipid feeding 
resulted from a small shift away from the membrane-associated, to the lipoprotein-
bound, pool (Magun et al. 1988). The constant presence of this large pool meant that 
apolipoprotein synthesis was not the rate-limiting step in lipoprotein assembly or 
secretion. The model of apo B-48 synthesis that therefore emerges from these 
experiments is one in which a constant rate of synthesis occurs i.e. the B-48 gene is 
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constitutively expressed ("permanently up-regulated" by endogenous biliary lipid, 
perhaps) to provide a large intracellular pool of mainly membrane-associated 
apolipoprotein B which is more than sufficient to provide for the needs of the cell during 
acute (and indeed chronic) TAG flux through the intestine (Fig. 1.14). 
However, questions still arise about the fate of the "unutilized" excess apo B-48 during 
non-fat-fed (but also during fat-fed) conditions, since only a small portion is actually 
utilized in lipoprotein packaging. Are there high rates of apolipoprotein B-48 
degradation in the cell? On the face of it, this "strategy" of providing more than is ever 
needed appears rather wasteful of the cell's energy sources. Perhaps it is a mechanism 
to safeguard against the sudden appearance of a TAG flux, irrespective of the size of the 
lipid load? Secondly, can the intracellular pool of apo B ever be depleted? (30% 
fat/feeding for 6 weeks was not sufficient in the Glickman experiments). If such a 
depletion is possible, will this increase the rate of B-48 synthesis or is it already 
operating at "ceiling" levels? Will malabsorption occur under these conditions? 
Evidence for intracellular apolipoprotein B degradation in liver was provided by 
Borchardt and Davis in 1987 who showed significant intracellular turnover of 
apolipoprotein B during pulse-chase studies in cultured rat hepatocytes. In 1991 Dixon 
et al. . examined the effect of oleate on apolipoprotein B turnover and secretion in the 
hepatoma cell line, Hep G2. They showed that oleate stimulated the secretion of 
apolipoprotein B-containing lipoproteins by inhibiting the early intra-cellular degradation 
of apo B. In the absence of oleate, 58 % of the apo B synthesized during the labelling 
period was degraded within 20 min; when oleate was present, only 29 % of labelled apo 
B was degraded in the same period. The actual synthesis of apo B was minimally 
affected by the addition of oleate. The authors therefore concluded that the effects of 
oleate on apo B secretion were post-translational and involved some kind of protection of 
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Fig. 1.14. Schematic representation of the two intracellular apolipoprotein B-48 pools. 




A more recent study by White et al .. (1992) confirmed this finding. Using the Hep G2 
model and a series of carboxyl terminally truncated apo B constructs, they concluded that 
oleate had no effect on the translation of apo B mRNA but promoted the secretion of apo 
B-containing lipoproteins by reducing the pre-secretory degradation of those forms of 
apo B that were able to produce buoyant (:flotable) lipoproteins. 
Perhaps a similar model operates in the intestine. However, no studies of intestinal apo 
B-48 degradation have been reported in the literature to date. A number of other studies 
of apolipoprotein B synthesis have been reported. In the context of the present work, 
one other deserves mention: A study by Renner et al .. in 1986 showed that saturated fat 
feeding resulted in a selective increase in the apo B content of chylomicrons prepared 
from these animals compared with unsaturated fat-feeding. They also found small 
differences in the clearance of saturated versus unsaturated fat-containing chylomicrons 
when these lipoproteins were infused into a new set of animals, and they speculated that 
these differences might be significant with respect to the potential atherogenicity of 
saturated compared with unsaturated lipids. 
1.8 (ii) ApoliPQProtein A-1 
Apo A-1 is the major protein of plasma HDL and of TAG-rich lipoproteins from 
mesenteric lymph. It has a molecular weight of around 28 000 daltons in both rats and 
humans (Bisgaier & Glickman 1983, Green & Glickman 1981). In humans, apo A-1 is 
synthesized as a 267 amino acid residue pre-pro-apolipoprotein (pre-pro-apo A-1) which 
contains an 18 amino acid pre-peptide and a 6 amino acid pro-peptide. The pre-peptide 
is co-translationally cleaved inside the cell and the protein is secreted as pro-apo A-1 by 
the intestine into lymph and by the liver into the plasma. Plasma pro-apo A-1 undergoes 
intravascular post-translational cleaving to the 243 amino acid residue mature apo A-1 
(Assmann et al. 1989). In normal human plasma most of the apo A-1 is in the mature 
isoform. 
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Apo A-1 exhibits considerable a-helical structure. It is an activator of the enzyme 
lecithin: cholesterol acyltransferase (LCAT) which esterifies cholesterol on HDL using a 
fatty acyl residue of lecithin (phosphatidyl choline). Wu and Windmueller's study 
(1979) indicated that 56% of the total rat plasma apo A-1 was derived from intestinal 
synthesis. Estimates from chyluric patients have suggested a similar proportional 
contribution in humans (Green et al. 1979). 
Studies conducted in rats have demonstrated that approximately 130 to 140 mg per hour 
of A-1 is transported in mesenteric lymph under conditions of saline or glucose feeding 
(Imaizumi et al. 1978). During TAG absorption this value increases two-fold and is 
associated with a shift in the distribution of apo A-1 amongst the lipoprotein classes: a 
greater proportion of lymph A-1 becomes associated with the TAG-rich p < 1.006 g/ml 
fraction and a reduction in HDL-associated A-1 occurs (Glickman & Green 1977). 
In studies of humans with chyluria apo A-1 was found to comprise 15 % of chylomicron 
protein. However, this is thought to represent an underestimate because of the rapid 
transfer of apo A-1 that is known to occur from chylomicrons to HDL (Green et al. 
1979). 
Using immuno-fluorescence techniques, apo A-1 has been demonstrated in both rat and 
human enterocytes (Glickman et al. 1978a). Incorporation of radioactively labelled 
amino acid into apo A-1 by the small intestine or isolated enterocytes has also been 
demonstrated in both species (Rachmilewitz et al. 1978). 
In rats the intracellular apo A-1 content has been measured at 80 to 150 nanograms per 
mg enterocyte protein (Schonfeld et al. 1978) and a similar figure of 200 ng/mg protein 
has been obtained for human duodenal A-1 content in the post-absorptive state (Green et 
al. 1982). This apo A-1 has been shown to originate from the intestine and is not 
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derived from the circulation through filtration. A study by Imaizumi et al. (1978) 
showed that only 3-5 % of the apo A-1 on lymph chylomicrons could have originated 
from the plasma. 
Although fat-feeding has been shown to increase the secretion of apo A-1 into lymph and 
early immunofluorescence studies in both rats and humans have suggested an increase in 
the intracellular content of apo A-1 with lipid feeding, studies of the apo A-1 content 
using radio-immunoassays have not shown dramatic changes (Glickman et al. 1978b). 
The mucosa! apo A-1 content appears small relative to the lymphatic output. It has been 
estimated that the total intestinal mucosa! content of apo A-1 in the rat is only 2 µ.g, yet 
lymphatic secretion during fat feeding is 20 to 50 times that amount. Thus a high rate of 
mucosa! synthesis of A-1 might be expected (Bisgaier & Glickman 1983). 
A study by Gordon et al. (1982a) which first demonstrated that the primary translational 
product of rat intestinal apo A-1 mRNA was a pre-protein, also showed no increase in 
enterocyte A-1 mRNA following the intra-gastric feeding of corn oil to rats. These 
results were supported by Blaufuss et al. who showed no increase in pre-pro-apo A-1 
mRNA levels in rat intestinal mucosa following acute fat feeding although mRNA for 
another apolipoprotein, pre-apo C-m, doubled. Other workers have shown significant 
synthesis and secretion of apo A-1 in the absence of TAG absorption (e.g. in glucose-
infused, or bile-diverted, animals) (Windmueller & Wu 1981). 
The group of Davidson and Glickman has provided the most comprehensive study of the 
effects of dietary lipid on apo A-1 synthesis. Using the same techniques described in 
l.8(i) for apo B, they found that acute fat feeding resulted in no significant change in 
apo A-1 synthesis or in the intracellular content of apo A-1 in jejuna! enterocytes, 
compared with fasting, bile-diverted, or fat-free feeding. In contrast to the results 
obtained with jejuna! enterocytes, apo A-1 synthesis and content were significantly 
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depressed in ileal enterocytes following 48 hours of external bile diversion. This effect 
was reversed by the infusion of the bile salt, taurocholate, into the bowel (Davidson et 
al. 1985). Sustained changes of transmural TAG flux (30% TAG diet for six weeks) 
also had no effect on A-1 synthesis (Davidson 1987). Finally, as in the case of apo B-
48, they found that most of the intracellular apo A-1 was present in a membrane-
associated, non-lipoprotein-bound pool, and that fat-feeding resulted in a small 
redistribution to a lipoprotein-bound pool (Magun et al. 1988). 
The model therefore of apo A-1 regulation in the intestine derived from these 
experiments is the same as the one proposed for apo B-48: apo A-1 synthesis is not 
regulated by dietary lipid flux; the "constitutive" synthesis that occurs provides a large 
intracellular pool which is only slightly utilized for lipoprotein "packaging" during times 
of TAG flux. 
Whether transmural TAG flux has any effect on the post-translational modification of A-
l (from pre-pro-A-1 to pro-A-1 and eventually to mature A-1) is not yet known. 
l.8(iii) Apolipru>rotein A-IV 
Apolipoprotein A-IV is the third major apolipoprotein of chylomicrons that originates in 
the intestine. Human apo A-IV is a glycoprotein with a high proportion of a-helical 
structures, which result from the presence of multiple amino acid repeating sequences 
(Weinberg & Spector 1985, Elshourbagy et al. 1986). These amino acid repeats are 
amphipathic in nature and the integrity of apo A-IV's secondary structure is essential for 
its lipid-binding capacity (Elshourbagy et al. 1986, Boguski et al. 1984). Human apo A-
IV comprises 391 amino acid residues and this includes a 20 amino acid signal peptide 
which is cleaved co-translationally to yield a final protein of 371 amino acids (Gordon et 
al. 1982a & 1984). The protein has a calculated MW of 42500 Da (Boguski et al. 1984) 
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although apo A-IV derived from rat plasma HDL has a MW of 46000 on SDS 
polyacrylamide gels (Swaney et al. 1974). 
In the rat 60% of the apo A-IV is produced by the intestine (Wu & Windmueller 1979) 
and evidence based on the isoform pattern of apo A-IV from human liver transplant 
patients before and after liver transplantation showed no change in the isoform pattern 
(despite differences between the donor and the recipient before transplantation) indicating 
exclusive intestinal synthesis (Kraft et al. 1989). 
The metabolic fate of apo A-IV appears to differ between humans and rats. In rats, the 
A-IV is believed to be transferred to the HDL fraction of plasma during chylomicron 
catabolism (Tall et al. 1979); in humans the A-IV that leaves the chylomicrons is 
recovered mainly in the density > 1.21 g/ml fraction of the plasma. It has been 
suggested that as much as 80% of human apo A-IV circulates as a free apolipoprotein 
(Ghiselli et al. 1986). 
In abetalipoproteinaemia, where no chylomicrons are secreted, plasma apo A-IV levels 
are only about half those of normals, suggesting A-IV secretion unassociated with TAG-
rich lipoproteins, perhaps in association with nascent HDL or as a free apolipoprotein 
(Green et al. 1980). 
Unlike apo B-48 and apo A-1, there is greater consensus in the literature concerning the 
changes associated with apo A-IV during fat-feeding. In humans, the fasting intestinal 
mucosal A-IV content is 12 µg/mg protein; this rises to 46 µg/mg after lipid feeding 
(Green et al. 1982). A study by Apfelbaum et al. in 1987 showed that acute and chronic 
dietary TAG feeding increased apo A-IV synthesis in rat enterocytes, compared with 
controls. In the case of the acute TAG bolus administration, the increase was maximal 
at 4-6 hours post-feeding and occurred in both jejunum and ileum. Apo A-IV mRNA 
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abundance measured by an in vitro translation assay showed a significant increase at 4-6 
hrs (a 50% increase in the jejunum and a 350% increase in the ileum). These findings 
confirmed the results of an earlier study by Gordon et al. (1982b). Chronic saturated or 
polyunsaturated fat-feeding (for six weeks) showed a similar increase in jejunal A-IV 
synthesis but no change in ileal synthesis (Apfelbaum et al. 1987). In chyluric humans, 
apo A-IV secretion and intestinal content were markedly stimulated by fat-feeding 
(Green et al. 1980 & 1982). In normal human subjects, the plasma level of apo A-IV is 
also increased with fat-feeding (Green et al. 1980). Studies in mice have also confirmed 
a lipid-regulated increase in apolipoprotein A-IV expression in the liver (Williams et al. 
1989). 
A study by Hayashi et al. (1990) using the non-ionic hydrophobic surfactant, Pluronic L-
81, which inhibits chylomicron formation but does not affect lipid uptake or resynthesis 
inside the cell, provided some insight into the mechanism by which the TAG-related 
increase in apo A-IV synthesis is brought about. They showed that this increase did not 
occur when lipid was infused into the bowel lumen of rats when Pluronic L-81 was also 
infused; however, when the Pluronic L-81 inhibition was removed, A-IV synthesis was 
markedly stimulated and A-IV lymphatic secretion significantly increased. The authors 
concluded that the stimulus for apo A-IV synthesis by lipid was not mediated by the 
mere uptake of lipid into the enterocyte or by the TAG content inside the cell; rather, 
the events of chylomicron packaging and secretion (inhibited by Pluronic L-81) provided 
the stimulus for the increased A-IV synthesis. (The chylomicrons formed early on would 
presumably have been packaged using a preformed intracellular pool of A-IV, as in the 
case of apo B-48 and apo A-I). 
The physiological role of apo A-IV in the body is unclear. Recent studies by Fujimoto 
et al. (1993) have suggested that apo A-IV acts in the central nervous system as a satiety 
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Fig. 1.15. A proposed model for apolipoprotein A-IV fluxes in the intestine during periods 
of low and high lipid flux. With increased dietary lipid flux, apolipoprotein A-IV 
synthesis increases; the size of the intracellular A-IV pool increases and more apo A-
IV becomes lipoprotein-associated. The stimulus for the increased A-IV synthesis is 
probably derived from the greater rate of chylomicron formation occurring at the 




No unifying mechanism appears to exist whereby all intestinal apolipoproteins are 
regulated. Only apo A-IV synthesis is stimulated by dietary TAG; apo B-48 and apo A-
l are essentially unaltered by acute or chronic dietary lipid flux. It is interesting that apo 
A-1 and apo A-IV, which possess considerable sequence homology, are processed 
differently and appear to be controlled by different mechanisms. Studies of apo A-1 
synthesis have also suggested fundamental differences between the regulation in the 
jejunum and the ileum. Differences in the saturation of dietary TAG did not give rise to 
differences in apolipoprotein regulation for a given apolipoprotein. 
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1.9 PROJECT AIMS 
This project aimed to address the questions (discussed in Section 1. 7) of the effects of 
dietary lipid flux on the synthesis, secretion and degradation of the apolipoproteins B-48, 
A-N and A-1 in a novel system for the study of the intestinal epithelium, namely freshly 
isolated epithelial cell (enterocyte) sheets incubated in vitro. The cells were prepared 
from the small bowel of the Syrian Golden Hamster, Mesocricetus aureatus, using 
techniques described in Chapter 2. Following optimiz.ation and characterization of the 
system, the specific apolipoproteins were identified (Chapter 3) and measurements were 
performed of apolipoprotein synthesis, secretion and degradation under various dietary 
perturbations (Chapter 4). 
Specific questions that were addressed were: (i) Is TAG flux a specific stimulus for 
apolipoprotein biosynthesis? (ii) Does the composition of the TAG (saturated versus 
unsaturated fat) affect the rates of apolipoprotein synthesis and secretion? (iii) If acute 
dietary TAG does not stimulate or "upregulate" apolipoprotein biosynthesis, does more 
sustained feeding ( designed to deplete the intracellular apolipoprotein pool by prolonging 
the TAG flux and thus increasing the utilization of apolipoproteins for lipoprotein 
packaging) do so? (iv) Are apolipoproteins degraded within the epithelial cells? If so, to 
what extent? Are there differences in the degradation rates for low fat-fed as opposed to 
high fat-fed animals? (v) How does low fat feeding compare with an acute bolus 
administration of TAG, overnight high fat feeding (saturated or unsaturated) and 
chronic (6 week high fat feeding) with respect to apolipoprotein synthesis, secretion and 
degradation? 
Preliminary studies of intracellular pre- and post-translational modification of 
apolipoproteins were also performed using tunicamycin, an inhibitor of N-linked 
glycosylation. 
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AN ANIMAL MODEL AND A SYSTEM FOR THE STUDY OF INTESTINAL 
PROTEIN BIOSYNTHESIS AND SECRETION: FRESHLY ISOLATED SHEETS 
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(ENTEROCYTES) INCUBATED IN VITRO 
2.1 The Syrian Golden Hamster: A Small-Animal Model of Human 
Lipoprotein Metabolism . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 65 
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2.1 THE SYRIAN GOLDEN HAMSTER: A SMALL-ANIMAL MODEL OF 
HUMAN LIPOPROTEIN METABOLISM 
Adult Syrian Golden hamsters (Mesocricetus auratus) were chosen as a suitable small-
animal laboratory model for the study of human lipoprotein metabolism. The 
experimental evidence behind the choice has been provided largely by the work of 
Dietschy and co-workers. Unlike most other small experimental animals, the 
metabolism of cholesterol in these hamsters closely resembles that occurring in humans. 
The rates of total body and liver cholesterol synthesis are relatively low in both these 
species and equal to about one tenth the rates found in rats (Spady & Dietschy 1983b). 
Much of the plasma cholesterol in hamsters is carried in low density lipoprotein (LDL) 
particles. Receptor-dependent and receptor-independent mechanisms for the degradation 
of lipoproteins are important in both humans and hamsters for the turnover of plasma 
LDL. In the hamster, most of the LDL (73%) is taken up and degraded by the liver and 
90% of the LDL uptake is mediated by the LDL-receptor. The jejunum and ileum 
together account for 7% of LDL-clearance. Unlike the liver, receptor-independent 
uptake (as opposed to LDL-receptor-dependent uptake) is quantitatively more significant 
in the intestine, accounting for 44% of the total intestinal LDL uptake. Only 10% of 
hepatic LDL uptake is mediated independently of the LDL receptor. Increased dietary 
cholesterol and saturated tri-acylglycerol intakes elevate the plasma LDL-cholesterol 
concentrations in hamsters by suppression of hepatic LDL receptor activity and by 
increasing the production rate of LDL-cholesterol (Woollet et al. 1989). 
Hamsters develop atherosclerosis in response to an atherogenic, cholesterol and saturated 
fat diet (Nistor et al. 1987). The metabolism of bile acids and the composition of 
hamster bile resembles that found in humans more closely than that in the rat, and 
hamsters have also been used to study cholesterol gallstone formation (Matoba et al. 
1988, Pearlman et al. 1979). 
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Fig. 2.1. The Syrian Golden Hamster, Mesocricetus auratus. 
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The activity of cholesteryl ester transfer protein (CETP), which transports cholesteryl 
ester between plasma lipoproteins, has been measured in various mammalian species and 
an inverse relation appears to exist between the plasma levels of CETP and the relative 
resistance of different species to atherosclerosis e.g. dogs, rats and sheep have a low 
CETP activity and a high resistance to atherosclerosis while rabbits and humans have 
high CETP activity and are prone to develop atherosclerosis on high cholesterol diets. 
Measurements of the CETP activity in hamsters suggest that they too belong to the latter 
group (Stein et al. 1990). The Streptozotocin-treated Syrian Golden Hamster has also 
been used as an animal model for Diabetes Mellitus (Phares 1980, Rosenberg et al. 
1988). 
The digestive tract of the hamster (Fig. 2.2) has certain peculiarities (Borer 1985). 
Hamsters have large internal cheek pouches which they use to store and transport food. 
In addition, hamsters have a compartmentalized stomach consisting of a forestomach and 
a glandular stomach. The forestomach is similar to the rumen found in herbivores, and 
ruminant-type micro-organisms isolated from the hamster forestomach are capable of 
fermenting cellulose. Volatile fatty acids are produced and absorbed in the forestomach. 
Following ingestion, food first enters the forestomach and is thought to remain there for 
10 to 60 minutes. before passing into the glandular stomach. The caecum of the hamster 
is also a prominent structure and contains a microflora that promotes cellulose 
fermentation. Thus the forestomach and the caecum together allow the hamster to digest 
plant foodstuffs. The overall structural feature of the hamster gastro-intestinal tract 
characterizes the animal as a natural herbivore. Hamters feed every two hours. 
Experimentally induced longer inter-meal intervals are associated with weight loss and a 
reduction in the plasma insulin concentration (Borer 1985). 
In the 1960's the hamster small intestine was often used to study the mechanisms of 






















Fig. 2.2. The hamster gastro-intestinal tract. (Ref.: Borer, 1989). 
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1968). However it has seldom been used to study lipid absorption and transport. A 
morphometric electron microscopic analysis of the membranes and organelles of hamster 
small intestinal enterocytes was carried out by Buschmann and Manke in 1981. 
Following the instillation of com oil into the stomachs of male golden hamsters, a 
comparison was made between the enterocytes from the proximal jejunum of lipid-fed 
versus fasted hamsters. Following lipid instillation the enterocytes become engorged 
with lipid; the mean heights of the columnar epithelial cells increased by 20% and the 
enterocyte volume increased by 30%. This volume increase was accounted for largely 
by an increase in the endoplasmic reticulum and Golgi luminal volume with lipid. There 
was also a significant appearance of lipid in the cytoplasmic matrix, however, and the 
total nuclear volume also increased. The intercellular spaces at the basolateral margins 
of the enterocytes distended with chylomicrons. 
A few other studies related to hamster lipid absorption have been reported in the 
literature. The importance of calcium ions in the secretion of absorbed lipid was 
illustrated by a study involving the use of everted hamster jejunal sacs following in vitro 
incubation in a bile salt solution containing radio-labelled oleic acid. Calcium ions were 
presumed in this study to promote the exocytotic release of chylomicron-containing 
vesicles from the baso-lateral surfaces of the enterocytes (Strauss & Jacob 1981). In 1969 
an in vitro study of the effect of dietary fat content on the site of fat absorption in 
hamster small intestines showed that while most fat absorption took place from the 
proximal jejunum, increasing the lipid load enhanced lipid absorption from the distal 
ileum and had no effect on the proximal jejunum (Hoving & Valkema 1969). Under 




METHODS FOR STUDYING INTESTINAL ABSORPTION, APOLIPO-
PROTEIN SYNTHESIS AND LIPOPROTEIN PRODUCTION 
Various in vivo and in vitro techniques have been used in the study of intestinal 
absorption and lipoprotein production. The rat has proven to be the most popular small 
laboratory animal in this regard. 
2.2(A) In Vitro Techniques 
(i) The Lymph-fistula Rat Model 
This operatively complex system is one of the commonest methods used. It has the 
advantage of providing information not only with regard to digestion, absorption and 
intracellular metabolism of absorbed lipid, but also about rates of lipid transport into 
lymph. The method was first introduced by Bollman et al. in 1949 and was modified by 
Shepherd and Simmonds in 1959 to include a steady-state infusion of lipid by an intra-
duodenal cannula. The lipid may be infused for up to 6 hrs; the rates of flow and 
composition of lymph lipid at steady states may then be compared with the pre-infusion 
rates. Either the intestinal mesenteric lymphatic duct or the thoracic duct may be 
cannulated. The surgery is performed on an anaesthetized animal and recovery from the 
anaesthetic is usually rapid. Thoracic duct cannulation requires considerable experience 
and there is a major drawback in that the duct contents also contain lymph from the liver 
and, therefore, lipoproteins synthesized and secreted by this organ. The recovery of 
intestinal lymph is usually complete in the thoracic duct cannulation. In the mesenteric 
approach, intestinal lymph recovery may be incomplete as accessory ducts are also 
present that bypass the mesenteric duct at the usual cannulation site. Another 
disadvantage of both methods is that the lymph normally also contains some lipoproteins 
filtered from the plasma. Nevertheless, the system has been successfully used to study 
lipoprotein production following the infusion of micellar lipid preparations (often radio-
labelled) into the intestine (Tso & Simmonds 1984a). 
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In experiments performed by Glickman et al. the bile ducts of some animals were 
cannulated and exteriorized to provide external bile diversion and thus the experimental 
control conditions for no lipid absorption from the lumen. The synthesis of 
apolipoproteins in the intestine has also been studied by Glickman et al. using an in vivo 
pulse-labelling technique with a subsequent immuno-precipitation of the proteins of 
interest from lysed enterocyte preparations. Following prior dietary perturbations either 
through ad libitum feeding, the continuous infusion technique, or single dose instillation 
via a duodenal catheter, the rats were anaesthetized, a loop of proximal small intestine 
was created by ligaturing it around two ends, and a large quantity of radio-labelled 
amino acid (3H-leucine) was then instilled into the loop. The intestine was replaced 
intra-abdominally, the animals were kept warm, under general anaesthetic, for nine 
minutes, then sacrificed. The bowel loop was removed, flushed clean of unabsorbed 
labelled amino acid and enterocytes prepared from the bowel using the method of Weiser 
(1973) (see later). It is from such experiments in rats that much of the data on the 
regulation of apolipoprotein biosynthesis by dietary tri-acylglycerol has been derived 
(see, for example, Davidson & Glickman 1985, Davidson et al. 1987; Apfelbaum et al. 
1987). The surgical techniques involved in these experiments require expertise and are 
extremely difficult to perform in the hamster, an animal about one-third the size of the 
rat. Considerations of expense precluded the use of this technique in my experiments as 
large quantities of radio-labelled precursor amino acids are required to sufficiently label 
the proteins of interest. 
(ii) The Cori Procedure for Lipid Absorption Studies 
This technique was originally designed to study the absorption of sugars from the gastro-
intestinal tract but has since been modified to study lipid absorption. It involves 
administering a labelled lipid emulsion or solution by lavage followed, after a period of 
time, by killing of the animal, isolation of different segments or organs of the gastro-
intestinal tract by ligating them off, and then removing the various segments. 
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Unabsorbed luminal lipid is removed by washing and the effluents kept for analysis. 
The various organs as a whole or the scraped mucosa is then analyzed for lipid. By 
measuring the amount of infused lipid left in the organ, the amount of lipid absorbed, 
catabolised by the intestinal cell, and transported to the lymph, may be calculated by 
subtraction. The lipid transported as lipoproteins in lymph and in the blood cannot be 
quantified directly, however (Cori 1925). 
2.2 B In Vitro Techniques 
These have been successfully used in studying uptake and the intracellular events of lipid 
absorption but have, in the past, proven less helpful in studying the assembly and 
secretion of lipoproteins by the intestine. A major problem with in vitro techniques has 
been to validate the biochemical and physiological integrity of the systems used . Seven 
in vitro techniques will be reviewed: 
(i) Everted sacs; (ii) Ring Segment Incubations; (iii) the isolated perfused bowel loop; 
(iv) isolated intestinal epithelial cells; (v) subcellular organelles; (vi) morphologic 
studies, and (vii) cell culture. 
(i) Everted Sacs 
This technique was first described by Wilson and Wiseman in 1954. Eversion of an 
isolated intestinal sac segment exposes the mucosa! surface to a large volume of 
"external" medium for cell support (02, nutrients) as well as for absorption (Fig. 2.3). 
The absorbed and secreted products of absorption then accumulate in the inner serosal 
fluid and may be analyzed. However, the properties of the absorptive cell membrane in 
vitro may not be the same as in vivo and reductions in the absorption of certain nutrients 
have been noted in the in vitro system when compared with the in vivo situation. As in 
all in vitro techniques, the mucosa is isolated from its normal blood and nerve supply as 
well as the normal lymphatic drainage. This isolation may be critical when studying the 
intracellular events of lipid absorption viz. TAG re-synthesis, apolipoprotein biosynthesis 
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Fig. 2.3. A schematic representation of the everted sac technique. 
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and lipoprotein assembly and secretion. Deficiencies of nutrients, substrates, and lack of 
humoral mechanisms of control may seriously hinder the normal intracellular processes. 
There is in fact experimental evidence to show that the re-esterification of absorbed free 
fatty acids, for example, is less efficient in vitro than in vivo (Tso & Simmonds 1984a). 
Another deficiency of this method as a model of lipid absorption is the lack of significant 
transport of chylomicrons from the intestinal absorptive cells to the tissue fluid and 
serosal medium. The nascent lipoproteins are unable to be caught or trapped 
immediately following their secretion from the enterocytes. A study by Strauss & Jacob 
(1981) on the everted hamster jejunum showed, however, that by including Ca++ 2.5 
mM and Mg 1. 2 mM in both the mucosal and serosal media, the impairment of transport 
processes could be overcome (in part, at least). 
(ii) Ring segment incubations 
Thin transverse slices of intestinal tissue accumulate absorbed amino acids and sugars 
from the surrounding medium. These slices have been incubated for 4 hrs or longer in 
vitro with no apparent disintegration or autolysis of the epithelial cell layer (Crane & 
Mandelstam 1960). No studies of lipid absorption have been reported with this 
technique, although apolipoprotein biosynthesis using radio-labelled amino acids has 
been studied in ring sements incubated in vitro. 
(iii) Isolated. perfused bowel loop 
This method has been extensively used by Wu and Windmueller (1979) to study 
apolipoprotein secretion by the rat intestine. The procedure is complex and involves the 
preparation of an isolated intestinal segment with cannulation of the attached mesenteric 
lymph duct, superior mesenteric artery and superior mesenteric vein. The test meal is 
infused via a duodenal infusion tube; the vascular perfusate used is whole rat blood with 
added heparin and antibiotics. A 95% 0 2:5% CO2 mixture was used to continuously 
oxygenate the perfused blood. The addition of certain hormones to the vascular 
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perfusate was found to prolong the viability of the isolated small intestine for up to 5 hrs 
(as evaluated by microscopy and measurements of o2 uptake, etc). When free fatty 
acids were added to the duodenal infusion, chylomicrons were found in the lymph 
collected. Once again the hormonal influences normally present in the living animal that 
may regulate lipoprotein assembly and secretion are absent. An advantage of the system, 
though, is that newly secreted lipoproteins may be obtained prior to their catabolism in 
the general circulation. By controlling the constituents of the duodenal infusion and the 
vascular perfusate, it is at least theoretically possible to study, individually, factors that 
may regulate chylomicron formation and transport. 
(iv) Isolated Intestinal Epithelial Cells 
Kimmich (1975) has written a comprehensive historical account of the development of 
methods for isolating and studying intestinal epithelial cells in vitro. A review of the 
most relevant facts will be presented here. 
Systems for studying isolated intestinal epithelial cells were initially developed to 
elucidate the mechanisms of sugar and amino acid transport across the epithelial cell and 
the role of monovalent cation gradients in the process. Early methods of separating the 
mucosa! epithelium from the underlying mucosa depended on scraping techniques (using 
the edge of a glass microscope slide). This yielded epithelial cell sheets, fragmented 
villi, clumps of cells, individual cells as well as organelles from damaged cells. 
However, these cell preparations showed a rapid loss of glycolytic activity over a 20 to 
40 minute incubation period in a supportive medium in vitro. 
Subsequently, mechanical devices were constructed to peel the cells off in large sheets, 
including a vibrating motor to detach cells from an everted segment of intestinal tissue 
(Sjostrand 1968). Viability was usually assessed by measuring the glycolytic capacity of 
the cells e.g. rates of lactate production, but the cells were usually short-lived. 
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Subsequently, chemical and enzymatic methods, usually in combination with mechanical 
methods e.g. digital squeezing or stirring and shaking of the bowel, were employed to 
remove the cells from the intact tissue. Trypsin was used but poor viability (related to 
the duration of trypsin treatment of the intact bowel) was reported (Harrer et al. 1964). 
Lysozyme treatment resulted in a combination of villi fragments, connective tissue and 
muscle (Huang 1965). The chelating agent EDTA in a calcium and magnesium-free 
Krebs-Ringer phosphate was first used in 1967 when everted sacs were incubated for one 
hour at 4 °c, then subjected to vigorous shaking to detach the epithelial cells (Sognen 
1967). 
Mucus has often proved troublesome as cells tend to aggregate in its presence. The 
addition of hyaluronidase (1 mg/ml final concentration) was found by some to limit the 
extent of clumping (Kimmich 1975). In general, however, the presence of enzymes or 
chelators tended to reduce the metabolic capacity of the cells which deteriorated rapidly 
after preparation. The addition of bovine serum albumin (BSA) in the preparative media 
was found to limit cell breakdown. Kimmich et al. have used intact intestinal tissue 
incubated in the presence of Krebs-Ringer phosphate with hyaluronidase (1 mg/ml) and 
BSA (1 mg/ml). Clumping of cells remained a problem, though, and cell dispersion was 
achieved by drawing up the cell suspensions in a plastic pipette. Cell viability has been 
estimated using the Trypan Blue Dye Exclusion technique but this is often unsatisfactory 
when large suspensions or clumps of cells are present. The glycolytic activity measured 
by lactic acid production and 14co2 production from 14C-glucose has generally been 
used as a metabolic marker of cell viability, and glycolytic rates usually expressed as 
millimoles of lactate produced per milligram of cell protein per hour have often been 
used to compare different cell preparation techniques (Kimmich 1975). The success 
rates of the different methods often varied according to the animal species from which 
the bowel was obtained. Thus a method that may have yielded poorly viable cells from a 
rat intestine might produce a richly viable preparation from a hamster intestine. 
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A major theoretical disadvantage of the use of isolated intestinal cells in the study of 
lipid absorption and secretion is the exposure of the basolateral surface of the cells 
(normally "hidden" in vivo) to the constituents of the luminal fluids, especially the bile 
salts. Apart from the potential toxicity to the cells, the usefulness of isolated cells may 
be limited when attempting to elucidate the luminal uptake stage of absorption. In 1972, 
however, Yousef and Kuksis reported in vitro release of chylomicrons from isolated cells 
that had been "pre-loaded" in vivo by dietary-derived lipid. Another potential 
disadvantage of the use of isolated cells or cell sheets is the loss of the normal endocrine 
and paracrine influences that would be expected to operate in vivo as well as the loss of 
the effect of cell-to-cell contacts. Finally, any isolation procedure, however mild, may 
be expected to result in a change in the structural integrity of the cells. 
In this project, I have chosen to study intestinal epithelial cell sheets isolated from the 
hamster small intestine using a modification of a technique first described by Towler et 
al. in 1978. 
The cells are "pre-loaded" with dietary lipid by dietary modifications performed on the 
intact animal. Potential advantages of the isolated epithelial preparations are that large 
quantities of pooled cell suspensions may be easily obtained from a single animal and 
these may be aliquotted with reproducibility of results. Various time point incubations 
and in vitro experimental manipulations are possible. (The animal is, of course, killed at 
a single time point folloiwng the in vivo dietary modification). Isolated cell preparations 
generally require smaller quantities of radio-labelled precursor substances than do intact 
tissues or organs and are therefore relatively inexpensive. Finally, the primary, intact 
cell secretion products (lipoprotein particles and apolipoproteins) may be studied prior to 
the modifications they normally undergo soon after leaving the cells. 
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(v) Subcellular organelles 
The preparation of nascent intracellular lipoproteins from subcellular organelles has been 
extensively used in studying liver lipoproteins. The application of these techniques to 
the intestine, however, appears to have been limited by two problems: the presence of 
mucus in the small intestine, which interferes with subcellular fractionation, and the tiny 
quantities of material that are eventually obtained following isolation of the relevant 
subcellular organelle fraction. For instance, in order to perform chemical analyses on 
rat Golgi apparatus contents, at least 10 to 12 rats have had to be used in order to gain 
sufficient material (Mahley et al. 1971). (This would be equivalent to using 30 to 36 
hamsters when one considers the relative sizes of the animals). 
Before isolating the relevant subcellular fractions, the intestinal epithelial cells 
themselves have to be isolated from the whole bowel (see Sect 2.2(iv)). Cell disruption 
techniques including Dounce homogenization and nitrogen cavitation (the French 
Pressure cell and the Parr "bomb") have been used (e.g. Magun et al. 1988). The 
subcellular organelle of particular relevance to the nascent lipoproteins is the Golgi 
apparatus and this has usually been isolated by differential ultra-centrifugation techniques 
often involving the use of sucrose gradients. The final vesicle fraction obtained is then 
resuspended and broken to release the lipoproteins. Breakage techniques using 
sonication or chemical methods for dissolving the vesicle or organelle membranes (e.g. 
sodium carbonate or dilute bile salt solutions) have been employed (Fujiki et al. 1982, 
Howell & Palade 1982). Some of these methods, however, may affect the normal 
integrity and structure of the nascent lipoproteins. The lipoproteins are then harvested 
by flotation-centrifugation. Nascent high density lipoproteins, very low density 
lipoproteins and chylomicrons have been isolated using these techniques. Attempts have 
also been made to differentiate between immature and mature intracellular vesicles and to 
compare the lipoprotein composition in the 2 subpopulations (Mahley et al. 1971, Magun 
et al. 1985 & 1988). 
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(vi) Morphological studies 
Morphological studies of fat absorption usmg electron microscopy have yielded 
important information regarding lipoprotein assembly and transport by small intestinal 
epithelial cells (See Chapt 1.3). Transmission electron microscopy and negative staining 
of lymph lipoproteins with phosphotungstate has also helped in characterizing the shapes 
and sizes of the intestinally derived lipoproteins (Forte & Nordhausen 1986). 
(vii) Cell culture 
Attempts to maintain isolated intestinal epithelial cells in primary culture have been 
unsuccessful. However, since 1987, the human colonic carcinoma cell line, CaC0-2, 
has been extensively used as a cell culture model for the in vitro study of human 
intestinal lipoprotein metabolism (Hughes et al. 1987). This cell line, when grown in 
culture, develops many features characteristic of fully differentiated small intestinal 
mucosa! epithelium, including the expression of brush border hydrolases and structural 
characteristics typical of the small intestinal enterocyte; for example, the CaC0-2 cells 
possess brush border microvilli on the apical surface and tight junctions between cells. 
The cells form domes (resembling villi shapes) when grown on an impermeable support. 
When grown as monolayers on porous filters (Fig. 2.4), the cells secrete radio-labelled 
triacylglycerol-containing chylomicrons and other lipoproteins into the basolateral 
medium in response to the addition of 14c-labelled oleic acid bound to albumin to the 
apical medium (Traber 1987). CaC0-2 cells labelled with 35s-methionine produced 
apolipoprotein B-100, B-48, A-IV, A-I and C-III in the basolateral medium (Hughes et 
al. 1987 & 1988; Traber et al. 1987). 
CaC0-2 cell lines have been used in numerous studies of apolipoprotein synthesis and 
secretion as well as of cholesterol metabolism. The importance of calcium ions in the 
secretion of apolipoprotein B has also been demonstrated (Hughes et al. 1988). CaC0-2 
cells secreted cholesteryl ester transfer protein (lipid transfer protein-I or LTP-1) into 
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Fig. 2.4. A schematic representation of CaC0-2 cells grown as a monolayer on a porous 
filter. 
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the basolateral medium of the cells in response to fatty acid in the apical medium. The 
degree of cholesteryl ester transfer activity recovered was dependent on the concentration 
of fatty acid added (Faust & Albers 1988). 
Despite the above findings the use of this colonic carcinoma cell line as a model for 
normal small intestinal lipid absorption and lipoprotein secretion has been seriously 
questioned. The CaC0-2 cells appear to produce significant amounts of apolipoprotein 
B-100 in contrast to most studies of normal mammalian small intestine which have 
revealed the production of the smaller molecular weight Apo B-48 only. Glickman et al. 
(1986b) have previously reported that the isoform of apolipoprotein B synthesized by the 
intestine depended on the developmental stage of the tissue. At 11 weeks gestational age 
the fetal intestine produced more Apo BlOO than B-48, at 16 weeks the quantities of B-
48 and B-100 were approximately equal, while the adult small intestine produced B-48 
only (Glickman et al. 1986b). The CaC0-2 cells, therefore, may resemble fetal 
intestinal cells more closely than fully mature (adult) enterocytes. 
While the major lipoproteins isolated from the intracellular organelles and lymph of 
normal intestine have been chylomicrons, some very low density lipoproteins (VLDL) 
and high density lipoproteins, the CaC0-2 cell line appears to secrete significant 
quantities of low density lipoproteins (LDL) with small amounts of VLDL and HDL but 
no particles characteristic of chylomicrons (Traber et al. 1987). Studies of cholesteryl 
ester transfer protein (CETP) mRNA in various organs of the hamster have revealed only 
very small quantities in the small intestine compared with other organs such as adipose 
tissue and muscle, raising further questions about the physiological significance of the 
CaC0-2 findings (Jiang et al. 1991). More recently it has also been shown that fatty 
acid esterification to tri-acylglycerol in CaC0-2 cells occurs primarily via the glycerol 3-
phosphate pathway in contrast to normal intestinal absorptive cells where the mono-
acylglycerol pathway is dominant (Trotter & Storch, 1993). 
2.3 METHODS OF CELL PREPARATION, INCUBATION AND ANALYSIS 
2.3(i) The preparation of freshly isolated small intestinal 
epithelial cell (enterocyte) sheets: Towler method 
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Male Syrian Golden Hamsters weighing between 160 and 220 g were housed four to a 
cage and were exposed to a 12 hour light-dark cycle beginning at 3.00 pm. They were 
maintained on a standard laboratory rodent chow which contained 4 % fat (mainly 
polyunsaturated) by weight, and were allowed free access to water. The Guidelines on 
Animal Experimentation as set out by the South African Medical Research Council were 
strictly adhered to. On the morning of the experiment the animals were fasted for two 
hours prior to sacrifice. They were then anaesthetized using diethyl ether inhalation, 
weighed and exsanguinated by cardiocentesis. The blood was kept for subsequent 
analysis. The bowel was exposed by laparotomy and the caecum identified (see Fig. 
2.2). The entire small bowel was then removed from the caecal to the duodenal end by 
gently freeing it from the mesentery. 
A modified method of Towler et al. (1978) was used to obtain intestinal epithelial cell 
sheets. The small bowel was rinsed with chilled, oxygenated phosphate-buffered saline 
(PBS; 0.15 M NaCl, 0.0014 M NaPi, pH 7.25) introduced at one end of the bowel usin 
a 5 ml syringe and plunger, to remove food debris from the lumen. The proximal 
jejunal segment was identified (approximately one-fifth the length of the small intestine 3 
cm distal to the insertion of the hepato-pancreatic duct) and excised from the rest of the 
small bowel. The selected segment was rinsed with PBS, weighed and kept moist in a 
Petri dish containing chilled PBS while the two free ends were carefully attached to the 
tips of two 5 cc syringe barrels using nylon surgical tying material. Five mls of well-
oxygenated isolation medium (NaCl 160 mM, KCI 3 mM, Na2HP04 11.2 mM and 
KH2P04 16 mM containing glucose 10 mM, glutamine 2 mM, lactate 2.5 mM, 
penicillin 100 units per ml, streptomycin 100 µg/ml) was then introduced into the lumen 
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through one of the syringe barrels, placed in a 200 cc Erlenmeyer flask containing pre-
warmed PBS (T = 37°C), and incubated for 15 minutes (Fig. 2.5). 
The bowel and attached syringes were then removed, the isolation medium was 
discarded, and the loop rinsed with 5 ml quantities of chilled PBS until the effluent was 
clear. The loop was then filled with 5 mis of well-oxygenated suspension medium (NaCl 
137 mM, KCI 2.2 mM, Na2HP04 1.4 mM, glucose 10 mM, glutamine 2 mM, lactate 
2.5 mM; penicillin 100 units/ml, streptomycin 100 µg/ml, HEPES, pH 7.4, 20 mM), 
carefully placed on a chilled surface, and gently patted along its length for 30 seconds 
before being turned onto the other side and the patting repeated (see Fig. 2.6). The 
initial suspension obtained was decanted and discarded. The tapping procedure was 
repeated five times with sequential 5 ml quantities of suspension medium and increasing 
the vigour of patting with each fresh 5 ml of medium used. The cell suspensions thus 
obtained were decanted through the syringe barrels and pooled into a centrifuge tube on 
ice, then spun at low speed (1800 rpm, JA20 rotor, Beckman Model J-21C centrifuge 
machine) for 2 minutes. The suspension medium was decanted carefully so as not to 
disturb the cell pellet, the cell pellet was gently resuspended in suspension (wash) 
medium and the centrifugation repeated. Finally, the cell pellet was gently resuspended 
in 10 ml of Incubation Medium (Krebs-Ringer bicarbonate with phenol red as pH 
indicator; fuels and antibiotics: NaCl 118.46 mM, KCl 4.74 mM, KH2Po4 1.18 mM, 
MgS04 1.18 mM, NaHC03 24.88 mM, CaCl 2.54 mM, glucose 10 mM, glutamine 2 
mM, lactate Na 2.5 mM, Penicillin 100 units/ml and Streptomycin 100 µg/ml), final pH 
7.4. 
2.3 (ii) Enterocyte Preparation: Weiser Method 
Following the removal, rinsing and selection of jejuna! segment obtained as described 
above, it was everted over a glass rod so that the mucosa! surface was exposed to the 
outside (Fig. 2.7). The bowel was then tied at one end, the glass rod removed and the 
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Fig. 2.5. The Towler Method: Pre-incubation of the washed bowel segment prior to 
harvesting of cells (see text 2.3(i) for details). 
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. 2.6. The Towler Method: "Patting" procedure for loosening epithelial cell sheets from 
the bowel wall (see text 2.3(i) for details). 85 
Fig. 2. 7. The Weiser Method of preparing 
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bowel filled with 2.5 ml of PBS introduced by a syringe. The other end was then tied 
and the everted bowel sac containing PBS was incubated in 10 ml well-oxygenated 
isolation medium at 37°C for fifteen minutes. The isolation medium was then discarded 
and replaced with 7 .5 ml of suspension medium (as above) but also containing 1.5 mM 
Ethylenediamine Tetra-acetate (EDTA), pH 7.4. The EDTA-containing suspension 
medium as well as the air in the incubation flask was gassed with 100 % 02 and 
incubated again at 37°C in an orbital shaking water bath for 15 minutes. The 
suspension medium (containing freed epithelial cells) was decanted into a centrifuge tube 
and replaced with fresh suspension medium-EDTA, re-gassed, and incubated for 15 
minutes. The procedure was repeated a number of times (Weiser et al. 1973 & 1978). 
The cell suspensions thus collected were pooled in a centrifuge tube on ice and further 
washing of the cell suspension was carried out as in the modified Towler method already 
described. 
2.3 (iii) Cell Viability Estimation 
Following resuspension of the cell pellets in incubation medium and just prior to their 
incubation, cell viability was checked using the Trypan Blue Dye Exclusion Test (Adams 
1990). The reagent used was 0.4% Trypan Blue Solution in PBS, pH 7.2. 0.1 ml dye 
solution was added for every 1 ml cell suspension to yield a final dye concentration of 
0.04%. The two were mixed gently and examined under a light microscope at room 
temperature within I minute of being mixed. The proportion of viable cells (i.e. cells 
that excluded the dye, as opposed to those that took up the stain) was estimated and 
expressed as a percentage of the total number of cells in the high power field. 
2.3 (iv) Protein Synthesis Experiments and Radioactive Protein Quantification 
Precise amounts of freshly prepared enterocyte suspensions in incubation medium were 
dispensed into 2.5 ml Erlenmeyer incubation flasks containing radio-labelled precursor 
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amino acid (either 3H-leucine or 35s-methionine, 0.5 µCi for every 100 µl of cell 
suspension). Other constituents were added to the incubation medium as determined by 
the experiment protocol. The incubation flasks were sealed with rubber bungs and the 
atmosphere inside the flasks gassed with a 95 % o2 : 5 % CO2 gas mixture, until the 
phenol red indicator in the medium changed to pH 7. 4 colour. The flasks were 
incubated in an orbital shaker (75 rotations per minute) at a temperature of 37°C. At set 
time intervals the flasks were removed and placed on ice. Protein precipitation of the 
entire sample ( cells and medium) was carried out by the addition of ice-cold ttjchloro-
acetic acid (TCA), 10% final concentration, containing 5 mM leucine or methionine as 
cold carrier. The TCA-treated samples were kept on ice for thirty minutes and 
subsequently filtered using a Millipore filtration apparatus: a 2.5 cm diameter glass fibre 
filter disc (GF/C very fine glass microfibre paper) (1.2 µm pore size) was placed onto a 
sintered glass disc fitted into a rubber stopper which, in tum, fitted the neck of a 500 ml 
side-arm filtration flask. A cylindrical glass funnel was held in place on the filter disc 
and sintered glass, using a clamping device. Negative pressure was applied through the 
side-arm of the filtration flask. The TCA-treated sample was mixed well, decanted into 
the funnel, and filtered. The filter discs were washed five times with 5 % TCA 
containing 5 mM cold amino acid carrier and a sixth wash with 96% ethanol was carried 
out. The filter discs were dried and the radioactivity counted using 10 ml fluor 
(Beckman "ReadySolve" liquid scintillation cocktail for aqueous samples) in a liquid 
scintillation counter with a quench standard and a programme for tritium (3H) or 14c 
(for 35s-methionine labelled samples). 
When separate medium and cell radio-labelled protein analysis was required, the cell 
suspensions at the end of the incubation were transferred to 2 ml Eppendorf tubes and 
spun at 2000 rpms for 2 minutes in a refrigerated Beckman TJ60 centrifuge machine. 
The medium was aspirated and the cell pellet resuspended in homogenization buffer 
(NaCl 150 mM, Na2HP04 1.4 mM, cold amino acid carrier 4 mM, 1 % Triton X-100, 
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0.15% sodium dodecyl sulphate (SDS), benzamidine 1 mM and EDTA 1 mM, pH 7.4). 
The samples were then sonicated, on ice, for 5 seconds using a sonicator with a microtip 
probe (Ultrasonic Processor W-385, 40% duty cycle, setting "2" energy output). 
Aprotinin (10 i.u./ml and phenylmethylsulphonyl fluoride (PMSF) 1 mM, final 
concentration, were added to the sonicate and the sample was spun at 10 000 g for 10 
mins in a Beckman TM 11 microfuge machine. The supernatant thus obtained was used 
for further analysis. Protease inhibitors and preservatives were also added to the 
medium samples: PMSF 1 mM, aprotinin 10 i.u./ml, sodium azide 100 mg/1 and EDTA 
3.2 mM, pH 7.4 (final concentrations). The media were also spun at 10 000 g for 10 
mins to centrifuge down any cellular debris, and the supernatant from this spin kept for 
analysis. 
The filter-paper disc method of Mans and Novelli (1961) was used to quantify the 
radioactive amino acids incorporated into protein. Aliquots of the cell sonicates or 
media were spotted onto Whatman GFC filter discs, dried and then sequentially 
submerged using a filter disc carrier and dipping device, into the following solutions: (1) 
10 % trichloro-acetic acid (TCA) and 5 mM cold amino acid carrier, for 30 mins at 4 ° C; 
(2) 5 % TCA and cold carrier, for 15 mins at room temperature; (3) Ether:ethanol 
mixture (1:1 v/v) for 5 mins at room temperature; and (4) Ether, for 5 minutes at room 
temperature. The dried filter discs were then counted in a liquid scintillation counter. 
2.3 (v) Protein Estimations 
The results of protein synthesis experiments were expressed as dpm of radio-labelled 
amino acid incorporated into TCA-precipitable material per microgram cell protein. The 
cell protein was determined using the Markwell modification of the method of Lowry. 
This modification improves the solubility of proteins from lipid environments (e.g. 
lipoproteins and membranes in the reaction mix and involves the addition of sodium 
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dodecyl sulphate to Lowry Markwell Solution A and the replacement of Na-K tartrate 
with disodium tartrate (Lowry et al. 1951, Markwell et al. 1978). 
2.3 (vi) Enzyme Assays of Cell Stability 
The activities of lactate dehydrogenase (LDH), a cytosolic enzyme, and alkaline 
phosphatase, an integral brush border enzyme, were assayed in the cell lysates and media 
to determine cell stability and viability during a time course incubation. The degree of 
cell disruption achieved by the method of sonication in homogenization buffer as 
compared with other methods of cell disruption e.g. Dounce Homogenization, was also 
evaluated by measuring the release of LDH. The LDH assay was based on the reaction: 
Pyruvate + NADH + H+ - Lactate + NAD+ 
LDH 
At 340 nm the two forms, NAD+ (oxidized) and NADH (reduced) have large 
differences in their respective light absorption. The reaction mix consisted of Tris HCL, 
pH 7.4, 100 mM; Na pyruvate 5 mM, and NADH 0.2 mM. The absorbance at 340 nm 
(A340) of 1 ml of reaction mix in a cuvette was measured in a spectrophotometer at 
room temperature, a small aliquot of cell lysate or medium was then added, mixed 
quickly, and the rate of disappearance of NADH was determined by sequential A340 
readings at 30 second intervals for up to 3 minutes. The enzyme activity was expressed 
as mAU/min and divided by 6.2 to give the number of nanomols of pyruvate reduced 
per minute (Reeves & Fimognari 1963). In cell-medium comparisons the respective 
LDH activities were expressed as percentages of total LDH activity for a given time 
point. 
The assay of alkaline phosphate activity was based on the reaction: p-Nitrophenol 
phosphate - p-Nitrophenol + H3Po4. The product is yellow in colour with an Amax 
of 18.5 at 405 nm for a 1 cm light path. The reaction mix consisted of: NaCl 160 mM, 
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MgS04 1 mM, ZnC12 0.5 mM, glycine, pH 9.5, 49 mM, and p-Nitrophenyl phosphate 
(dicyclohexylammonium salt), 5 mM. The A405 of the reaction mix was measured in a 
spectrophotometer at room temperature. An aliquot of the cell lysate or medium sample 
was mixed with the reaction mix and incubated at room temperature for 15 to 30 
minutes, until a yellow colour appeared. The A405 was again measured and the elapsed 
incubation time noted. Alkaline phosphatase activity was expressed as: 
A4o5 in mAU/incubation time (minutes) i.e. A405 in mAU/min 
(Bessey et al. 1946, Chan & Atkins 1983). 
Once again the respective cellular and medium activities were determined for each time 
point incubation and expressed as percentages of the calculated total alkaline phosphatase 
activity (cells + medium). 
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2.4 RESULTS: CHARACTERIZATION OF THE SYSTEM AND 
OPTIMIZATION OF CONDITIONS 
The average hamster small intestine (from first part of duodenum to ileocaecal junction) 
measured about 42 cm in length. The proximal 17 cm segment (distal to the opening of 
the hepato-pancreatic duct in the duodenum) was used for the cell preparations (see Fig. 
2.2). The original method described by Towler et al. (1978) included the use of calcium 
sequestration (50 mM trisodium citrate in the isolation medium) to release the epithelial 
cells from the bowel wall. In the light of experimental evidence suggesting the critical 
role of Ca+ + ions in the secretion of nascent lipoproteins and the potential loss of 
viability induced by calcium sequestrants (e.g. Strauss & Jacob 1981), the citrate was 
omitted in our experiments. Nevertheless, cell yields expressed as milligrams of cell 
protein obtained per centimetre of proximal small bowel were similar for preparations 
with and without citrate. When examined histologically during the "tapping" procedure, 
the epithelial cells were seen to be removed en masse from the bowel wall with the freed 
cells coming off in large sheets that resembled the shapes of the villi from which they 
had been removed (Figs. 2.8 - 2.10). Most of the cells (>80%) were present in large 
sheets or clusters, a few smaller groups of epithelial cells were seen, and only a few 
individual cells were present. As far as could be assessed by light microscopy, virtually 
all the cells in the preparation had the morphological appearance of columnar epithelial 
cells. It is, however, conceivable that some stromal material (and thus non-epithelial 
cells) may have been obtained and were buried within the large villi-shaped clusters. It 
is also possible that some of the villus shapes seen may have represented severed villi 
tips containing stromal material. However, no cells other than columnar epithelial cells 
could be identified. 
In the case of the Weiser method in which calcium sequestration techniques were 
employed (citrate in the isolation medium and EDTA in the suspension medium) the cells 
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Fig. 2.8. A longitudinal section through the villi 
of jejuna! mucosa showing detachment of 
the epithelial cells from the stroma after 
the patting procedure. Stain: Haematoxylin 
and eosin. 
Fig. 2.9. The freed epithelial cells viewed in cross-section. Stain: Haematoxylin and eosin. 
Fig. 2.11. Epithelial cells released from the bowel 
wall using the Weiser Method. 
Individual cells are seen and they have lost 
their characteristic columnar shape. 
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Fig. 2.10. Appearance of the freed epithelial cell sheets 
viewed under light microscopy following the patting 
procedure. The sheets resemble the shapes of the villi 
from which they have been detached en masse. 
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were released either singly or m small groups. All the cells appeared agam to be 
squamous columnar epithelial cells although when present individually they tended to 
lose their columnar shape and to become rounded (Fig. 2.11). Cell viability as judged 
by the Trypan Blue Dye Exclusion technique, was estimated at greater than 95 % at the 
start of the incubation experiments for both the Weiser and Towler techniques. 
However, it should be pointed out that in the case of the Towler method the Trypan Blue 
technique represented at best, only a rough estimate, as most of the cells were present in 
large clusters and individual cells could not be accurately counted. 
Protein Synthesis Experiments 
Sheets of hamster jejunal enterocytes prepared by the Towler method and incubated in 
Krebs-Ringer HC03 containing fuels (glucose, glutamine and lactate), antibiotics and 
3H-leucine, incorporated radio-labelled amino acid linearly into protein for up to six 
hours in vitro; cells prepared by the Weiser method were less active and less sustained 
(Fig. 2.12). In all subsequent experiments, the Towler method was used. Ice-cold 10% 
TCA was used for protein precipitation. This method will in theory precipitate both 
protein and amino-acyl tRNA but I found that the use of hot TCA (95 °C) yielded TCA-
precipitable radioactivity only 5 % less than when cold TCA was used. In future 
experiments, therefore, cold TCA was used for protein precipitation. 
The protein synthesis observed was eukaryotic (enterocytic) in origin and did not derive 
from bacterial contamination or overgrowth, as demonstrated by the effects of adding 
cycloheximide, an inhibitor of eukaryotic protein synthesis at the concentrations used, 
and chloramphenicol, an inhibitor of bacterial protein synthesis, respectively (Fig. 2.13). 
In all preparative and incubation media penicillin 100 units per ml, and streptomycin 100 






0 - o---2 ~ c.... I 15 0. 0 / ~ l"""""'1 
1/1 l"""""'1 X QJ u 







0 i 1-1-• 
o v·-·-·-1----
0 2 4 6 8 
Time (hours) 
Fig. 2.12. Time course incorporation of 3H-leucine into TCA-precipitable material 
following an incubation of jejunal enterocyte suspensions from a chow-fed hamster 
with 0.5 µ.Ci of 3H-leucine. 
0 = Towler Method of cell preparation 
I = Weiser-Dietschy Method 
( = X ± SD) (mean of triplicate incubation samples) 
The experiment was performed thrice using jejunal enterocytes from a chow-fed 
hamster on each occasion. A representative result is shown here. 
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Fig. 2 .13. The effects of various concentrations of cycloheximide (I) and chloramphenicol 
(0) on the incorporation of 3H-leucine into TCA-precipitable protein following a 3 hr 
incubation of epithelial cell sheets from hamster jejunum. 
(Experiment performed twice & incubation continued for 5 hrs, although only the 3 
hour time point is shown here.) 
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Optimization of medium conditions was sought by varying some of the constituents of 
the Krebs-Ringer bicarbonate (KRB) medium. The standard KRB with 20 mM HC03 
and 2.54 mM Ca++ was found to be the optimal incubation medium (Fig. 2.14). More 
alkalotic conditions were well-tolerated by the cells while acidosis proved detrimental (as 
measured by the incorporation of 3H-leucine into protein after a 3 hour incubation). The 
beneficial effect of adding albumin to the incubation medium as reported by Kimmich 
(1975) was not shown in this study. The addition of 5 mM Na azide, an inhibitor of 
oxidative phosphorylation, resulted in a drastic reduction in protein synthesis (and 
probable cell death) (Fig. 2.14). 
The importance of the addition of exogenous fuels to the isolated epithelial cell sheets 
incubated in vitro was demonstrated (Fig. 2.15). Glucose 10 mM, glutamine 2 mM and 
lactate Na 2.5 mM were routinely added to all preparative media. The importance of 
these exogenous fuels appeared to increase with increasing duration of in vitro incubation 
time. 
Glutamine has been shown to be an important intestinal fuel especially during starvation 
and overnight fasting in mammals. It contributes 35 % of the CO2 production in the 
small intestine of the post-absorptive rat (Windmueller & Spaeth 1980) and is converted 
to glutamate which, following transamination, is eventually converted to malate and 
pyruvate. The pyruvate may then be oxidised via the tricarboxylic acid cycle. 
The extent of radio-labelled leucine incorporated into protein appeared to depend on the 
concentration of glutamine added (Fig. 2.16A & B). At 2.5 mM glutamine (final 
concentration in the incubation medium) cell suspensions synthesized protein more 
efficiently than those which lacked glutamine. (Both sets of cell suspensions, derived 
from a single chow-fed hamster, were incubated in the presence of 10 mM glucose and 
2.5 mM lactate and glutamine was added to both preparative media). 
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Fig. 2.14. The effects of various modifications of the standard Krebs-Ringer-bicarbonate 
incubation medium on the incorporation of 3H-leucine into TCA-precipitable material 
by hamster jejunal enterocyte sheets incubated for 3 hrs. All the incubation systems 
were derived from the jejunum of a chow-fed hamster. 
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Fig. 2.15. Time course incorporation of 3H-leucine into TCA-precipitable radioactivity by 
enterocyte sheets incubated in the presence (0) or absence (I) of exogenously added 
fuels in the incubation medium. The fuels were added to the preparative media 
(Suspension & Isolation medium) of both sets of incubations. The cell suspension 
was derived from a single hamster small intestine and the 2 cell suspensions split only 
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Fig. 2.16. (A) The effect of incubating jejunal enterocyte sheets in the presence (0) or 
absence (I) of glutamine (2.5 mM final concentration) in the incubation medium, on 
3H-leucine incorporation into TCA-precipitable radioactivity. 
(B) The effect of increasing concentrations of glutamine on 3H-leucine incorporation 
into TCA-precipitable material by jejunal enterocyte sheets incubated in Krebs-

















Cell stability and viability during incubations 
Only a minority of cells died or were damaged during a 5 hour incubation (Fig. 2.17 A & 
B). Lactate dehydrogenase is a cytosolic enzyme released by disrupted or dead cells 
while alkaline phosphatase is an integral brush border enzyme that may be released by 
both dead or damaged cells. 
While 3H-leucine was used in all optimization experiments, 35s-methionine was 
considered a more useful precursor amino acid when studying specific proteins of 
interest, as it had a much higher specific activity (1000 Ci/mmol as opposed to 3H-
leucine, 5 Ci/mmol) and a higher energy of radioactive decay so that fluorographic 
analysis of specific proteins could be made. Potential disadvantages of 35s-methionine, 
however, are its short half life (87.2 days compared with 3H, 12.26 years) and its 
relative chemical and especially radio-chemical instability. 35s-methionine was 
purchased from ICN (Trans 35s-label) and a typical batch contained about 70% 35s-
methionine and 20% 35s-cysteine with other 35s compounds such as methionine 
sulphoxide and 35s-cysteic acid constituting the other 10% (manufacturer's information). 
It was stored, aliquotted, at -70°C and gassed with nitrogen to prevent oxidation. Fig. 
2.18 demonstrated the non-linear incorporation of 35s-methionine into radioactive 
protein compared with 3H-leucine. Both cell suspensions were derived from the same 
small bowel preparation. That the problem of non-linear 35s-methionine incorporation 
did not lie with the cells themselves, was demonstrated by the experiment of Fig. 2.19 
(A & B) (see accompanying legend) . 
The most likely explanation for the result was that with increasing incubation time, more 
35s-methionine became chemically and radiolytically converted (e.g. to 35s-methionine 
sulphoxide), with consequent loss of specific 35s-methionine activity. The addition of 
fresh 35s-methionine at regular intervals replenished the supply and maintained the 
specific activity. For shorter incubation times, however, 35s-methionine incorporation 
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remained more or less linear (Fig. 2.20) and this proved useful later in pulse-labelling 
and pulse-chase experiments (See Chapters 3 & 4). 
Significant quantities of radio-labelled protein were released into the incubation medium 
with time. The nature of this release (secretion versus lysis) and the identity of the 
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Fig. 2.17. Measurements of the activities of (A) Lactate Dehydrogenase, and (B) Alkaline 
Phosphatase in cell lysates and media samples from a 5 hr time course incubation of 
jejunal enterocyte sheets. The activities of the enzymes in the cells and media are 
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Fig. 2.18 Time course incorporation of 3H-leucine (I) and 35s-methionine (0) into TCA-
precipitable radioactive material when enterocyte suspensions from a hamster jejunum 
were incubated with one or other of the 2 labelled precursor amino acids. 
The experiment presented here was representative of 3 similar experiments, all of 
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Fig. 2.19. (A) Time course incorporation of 35s-methionine into protein when all the 
radioactive methionine was added at T = O' (- line). 
(B) Incorporation of 35s-methionine into protein for 11/i hours when fresh 35s-
methionine was added (1) at T =O';A(2) at T = l1/i hrs (i.e. following a l1/2 hr 
incubation of the cell sheets with no radio-label)~and (3), at 3 hrs (i.e. following a 3 
hr incubation of the cells with no label)! 
When fresh 35s-methionine was added regularly during the incubation, the system was 
restored to linearity (o----o, A). 
The experiment was performed twice (2 animals, 2 sets of enterocyte preparations) 
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Fig. 2.20. Time course incorporation of 35s-methionine into TCA-precipitable cellular 




Using the Towler method, sheets of intestinal epithelial cells were isolated from the 
jejunum of adult male Syrian Golden hamsters, a useful small-animal model of human 
lipoprotein metabolism. These cells were found to linearly incorporate radio-labelled 
precursor amino acids into protein for up to 5 hours when incubated in vitro. Optimal 
incubation conditions were established and tests of cell stability and viability indicated 
that only a minority of cells died or were damaged during the incubation period. This 
system therefore appeared to be potentially useful as a method for studying the synthesis 
and secretion of specific proteins of interest. 
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3.1 THE PREPARATION OF A RABBIT-DERIVED. ANTI-HAMSTER 
APOLIPOPROTEIN ANTISERUM 
The technique of immuno-precipitation was chosen as the most suitable method in the 
enterocyte biosynthesis system for identifying and quantifying the specific proteins of 
interest. A rabbit-derived (polyclonal), anti-hamster apolipoprotein antiserum was 
prepared by immunizing rabbits with lipoprotein-associated (p < 1.21 g/ml) hamster 
apolipoproteins. 
3.1 (i) Antigen preparation 
(This method was first used in our laboratory by Dr A.D. Marais, and I wish to 
acknowledge his kind assistance in teaching me the techniques). 
A group of 20 hamsters, previously maintained on a standard laboratory chow, were 
administered sunflower oil by pipette (0.5 ml per animal) on the morning of the 
experiment. 3 hours later the animals were anaesthetized with di-ethyl ether and 
exsanguinated by cardiocentesis. The pooled blood was spun at 2000 g for 15 minutes in 
a Beckman J-21C centrifuge using a JA20 rotor and the lipaemic plasma supernatant was 
aspirated. (The aim of the initial lipid administration was to increase the quantities of 
post-prandial apolipoproteins in the plasma in order to maximize the potential antigenic 
material for immunization, although we had no proof that this was indeed the case. It 
did, however, make aspiration of floated lipoproteins easier as they could be readily 
identified as a creamy layer on the top). The protease inhibitor, phenylmethylsulphonyl 
fluoride (PMSF) (1 mM final concentration) was added to the plasma as a preservative 
and the lipoproteins (p < 1.21 g/ml) were prepared from the plasma by flotation-
ultracentrifugation as follows: The plasma was adjusted to a density of 1.25 g/ml using 
dried Potassium Bromide (K.Br) powder according to the formula: 
g/100 ml KBr = lOO(p desired - p of present solution) 
= 1.010 
1 - (0.312 x p desired) 
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p = density (g/ml) 
p desired = 1.25 g/ml 
p of present solution = p plasma = 1.010 g/ml 
The plasma was underlayered into a solution of saline-EDTA-KBr (p = 1.21 g/ml) in a 
centrifuge tube for the Beckman Type 60 Ti rotor (see Fig. 3.1). This was followed by 
a 48 hour spin, at 60 000 rpm, using a Ti60 rotor (K factor = 63) in a Beckman L5-65 
ultracentrifuge, in order to float all lipoproteins of density < 1.21 g/ml (i.e. 
chylomicrons, VLDL, LDL and HDL) (Segrest & Albers 1986). 
At the end of the centrifugation the floated material which formed a creamy layer on the 
surface was aspirated using a pipette and dialysed over 3 days in dialysis tubing 
(Spectropor Membrane Tubing, MW cutoff 12-14000) against saline-EDTA (p = 1.006) 
to remove the KBr. The external dialysis medium was changed daily. 
A protein estimation of the retentate was performed using the Markwell modification of 
the Lowry method and a sample of the dialysed material was separated on a 5-20% SOS-
gradient polyacrylamide gel and a 4% polyacrylamide stacking gel (Hoefer "Sturdier" 
Gel Apparatus, Hoefer Scientific Instruments, San Francisco) based on the original 
method of Laemmli. Prior to loading, the samples were denatured at 95°C for 2 minutes 
using a gel-solubilizing mix containing 2.5% SDS, 10% glycerol, 5% 2-mercaptoethanol 
and 65 mM Tris HCl, pH 8.0. The proteins were electrophoresed initially at 10 mA for 
45 minutes and thereafter at 35 mA until completion of the run (approximately 5 hrs), 
using a Pharmacia Electrophoresis Power supply (EPS 500/400). 
The gel proteins were stained with a 0.125 % Coomassie stain solution, destained, and 
dried onto blotting paper using a gel drying apparatus set at 60°C (Dual Temperature 
Slab Gel Dryer Model SE 1150, Hoefer Scientific Instruments, San Francisco) and 
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Fig. 3.1. Preparation of gradients for lipoprotein flotation (p < 1.21 g/ml) from hamster 
serum by ultra-centrifugation. 
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Fig. 3.2. A photocopy of Coomassie-stained proteins separated on a 5-20% SDS 
polyacrylamide gradient gel of floated material (p < 1.21 g/ml) obtained from 
postprandial, lipaemic hamster serum. The positions of MW standards (kDa) are 
shown, as are the probable identities of the prominent protein bands on the gel. 
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attached to a vacuum pump with a suction pressure of O torr. Coomassie-stained protein 
bands corresponding to the expected positions, respectively, of apolipoprotein B-100, 
albumin, apolipoproteins E, A-IV, A-I and C's, were present (Fig. 3.2). Densitometric 
scanning of the gel lane revealed that the putative apo B-100 band constituted about 10% 
of the total protein in the antigen mixture. 
3 .1 (ii) Immunization and Antiserum Collection 
It was decided to immunize each rabbit with at least 100 µg of apo B in the antigen 
mixture. This corresponded to a volume of 375 µl of the original dialysed antigen 
material (not the SDS-denatured material used in the gel analysis) which was mixed with 
an equivalent volume of Freund' s Incomplete Adjuvant (FICA) and injected 
subcutaneously at multiple sites (4 to 5) over the back of each animal. A control rabbit 
was immunized with lipoprotein-depleted serum (LPDS). Control (pre-immune) rabbit 
serum was also obtained. Four weeks later a second innoculation of the same antigen 
mixture was repeated and subsequent boosts were performed at four to six weekly 
intervals with bleeding of the animals 2 weeks after the boosts (Garvey et al. 1977). 
The rabbits were venesected using a paediatric scalp vein set attached to a syringe and 
inserted into the major ear vein of the animals. The blood was allowed to clot for 30 to 
60 minutes at 37°C; the clot was separated from the sides of the collecting vessel 
("ringing") using a straightened paper clip and the clot allowed to contract by 
maintaining the sample at 4 °C overnight. The serum was then decanted from the clot on 
the following morning and heated at 56°C for 30 minutes to inactivate complement. 
Thiomersal (0.08 mg/ml) and sodium azide (0.02 % ) (final concentrations respectively) 
were added to the antisera which were aliquotted into small volumes and stored at -
70°C. Samples were thawed only once prior to use. Subsequent tests of the antisera 
using biosynthetically labelled enterocyte lysates (see later) revealed that the rabbit 
designated "Rabbit 5" produced the best antibody responses and this animal's antiserum 
will henceforth be referred to as "RS antiserum". 
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3.2 OTHER SOURCES OF ANTISERA AND ANTIBODY PREPARATIONS 
(i) "OSAN", a polyclonal, rabbit-derived, anti-human apolipoprotein B antiserum, 
was purchased from Behring Diagnostica. 
(ii) A polyclonal, rabbit-derived, anti-rat apolipoprotein A-IV antiserum was a gift 
from the laboratory of Dr R.M. Glickman, Gastro-intestinal Unit, College of 
Physicians and Surgeons, Columbia University, New York. 
(iii) A polyclonal, rabbit-derived, anti-rat LDL antiserum was donated by Dr R. Hay 
from the laboratory of Dr G.S. Getz, University of Chicago. 
(iv) Anti-Acylation Stimulating Protein (ASP) IgG, purified using Protein A from 
rabbit polyclonal antiserum, was provided by Dr K. Cianflone, McGill Unit for 
the Prevention of Cardiovascular Disease, Montreal, Canada. 
(v) A polyclonal rabbit-derived, anti-rat apolipoprotein A-1 antiserum was obtained 
from the laboratory of Dr G.S. Getz, University of Chicago. 
(vi) Goat-derived, anti-human Lipid Transfer Protein-I (LTP-1), was given by Dr 
Janet Adolphson, Northwestern Lipid Research Laboratory, Seattle, Washington. 
(vii) Antisera to "hepatic" Fatty Acid Binding Protein (hFABP) and "intestinal" Fatty 
Acid Binding Protein (gFABP) were obtained from Dr N.M. Bass, Dept. of 
Medicine and Liver Center, University of California School of Medicine, San 
Francisco. 
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3.3 IMMUNO-PRECIPITATION TECHNIQUES 
3.3 (i) Cell lysate and media preparations 
The preparation of cell lysates and media samples following an in vitro incubation of 
enterocyte suspensions with radio-labelled [35s]-methionine, has been described in 
Chapter 2.3. The final (radioactive) cell lysate in a 1 % Triton-XlOO and saline-EDTA 
homogenization buffer solution (pH 7.4) containing antiproteases, was used for immuno-
precipitation studies. Protease inhibitors were also added to the media samples which 
were spun at 10 000 g for ten minutes to remove any cellular debris. 
3.3 (ii) Protein A 
Initial immuno-precipitation experiments utilized Protein A as the precipitating agent. 
Formalin-treated, bacterial cell wall-derived Protein A (Pansorbin, Calbiochem) has a 
high adsorption capacity for the Fe portion of many mammalian immunoglobulins 
including rabbits, humans, and guinea pigs (Langone 1982). The original method 
utilizing Protein A to immuno-precipitate antigen-antibody complexes was first described 
by Kessler in 1975 but a modified technique devised by Davidson and Glickman in 1985 
was used in my experiments. 
Heat-killed, formalin-treated Staphylococcus aureus cells (Pansorbin, Calbiochem) were 
washed well using a "NETI AM" buffer (0.15 M NaCl, 5 mM Na2 EDT A; 1 % Triton 
XlOO; 0.1 % bovine serum albumin; 2 mM methionine; 0.02 % Na azide, 65 mM Tris 
HCI, pH 7.40) and used within 24 hours of washing. Equivalent volumes of 
"NETI AM" and Protein A were mixed and spun for one minute in an Eppendorf 
microfuge at 10 000 g. The supernatant was discarded, the Protein A pellet was 
resuspended in the same volume of NETT AM, mixed, and spun again. After a second 
wash, the final pellet was resuspended in the same volume of NETTAM to maintain a 
Protein A concentration of 10% (w/v). 
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In the "pre-clearing" step, washed Pansorbin was added to a measured quantity of the 
cell lysate. (200 µl of 10% Protein A was used for every 100 µg antibody intended for 
use in the immuno-precipitation. Cell lysate volumes of 200 µI were generally used). 
The mixture was incubated at room temperature for 15 minutes and then at 4 °C for 30 
minutes. Following a 10 000 g spin for 10 mins in a refrigerated microfuge (Beckman 
TM 11), the supernatant obtained (i.e. cell lysate pre-cleared with Protein A) was added 
to 200 µI of NETT AM and excess antiserum (25-50 µI) was added. (A control sample 
with non-immune serum was also included). The mixture was incubated at 4°C for 18 
hrs. On the following day 200 µl Pansorbin were added and the mixture re-incubated for 
45 minutes at 4 °C. The cell pellet was then collected by centrifugation (10 000 g x 10 
mins, 4°C), resuspended in 100 µI of NETTAM buffer and layered over a cushion of 
600 µI of 1 M sucrose-NETTAM (3.423 g sucrose dissolved in a final volume of 10 ml 
NETTAM). This was then centrifuged (10 000 g x 10 mins), the supernatant was 
aspirated and the pellet resuspended in 100 µI of NETT AM buffer and once again 
layered over a sucrose-NETT AM cushion. A total of three resuspension-wash-
centrifugations were performed. 
Following the final wash the Protein A pellet (containing bound antigen-antibody 
complexes) was resuspended in 100 µI of a 2.5% sodium dodecyl sulphate (SOS), 10% 
glycerol, 5 % 2-mercaptoethanol, 65 mM Tris HCl pH 8.0 gel sample application buffer 
solution, heated at 95 ° C for two minutes, then pelleted at 10 000 g for 10 mins. The 
supernatant fraction thus obtained was further analysed using SDS polyacrylamide gel 
electrophoresis and fluorography (see 3.3 (v)). 
3.3 (iii) Protein G 
In some immuno-precipitation experiments goat antiserum was used. Polyclonal goat 
IgG is not bound by Protein A but Protein G, a cell surface protein derived from 
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Streptococcus Lancefield Group G, exhibits strong binding (Bjorck & Kronvall 1984; 
Akerstrom et al. 1985). Protein G (G-Sorbin, Zymed, No. 10-1351) was used as a 
substitute for Protein A in immuno-precipitation experiments using goat antisera. One 
ml of a 10% suspension of G-sorbin binds 2 mg of rabbit immunoglobulin. 
3.3 (iv) Protein A-Sepharose 
A second technique of immuno-precipitation using Protein A linked to sepharose CL-4B 
beads (Protein A-Sepharose, Sigma, Catalogue No. P-3391) was also employed and later 
became the standard method for all experiments in which quantitative measurements of 
apolipoprotein synthesis, secretion and degradation were made. 
Measured quantities of cell lysates obtained following in vitro incubation of freshly 
isolated enterocytes from hamster jejunum with [35s]-methionine were reacted with 
small volumes of specific antisera. Non-immune serum control reactions were also 
performed. 50 µl of cell lysate suspension were mixed with 150 µl of "NETIAM" (see 
3.3 (ii)) containing 0.1 % bovine serum albumin (BSA) and then reacted with 50 µl of 
antiserum. The cell lysate-antiserum reactions were carried out in 1.5 ml sealed 
Eppendorf microfuge tubes which were constantly rotated overnight (for around 12 hrs) 
at 4 °C to allow for continuous mixing. 
On the following morning Protein A-Sepharose was weighed out for the day's immuno-
precipitations. 8 mg of Protein A-sepharose was used for each immuno-precipitation 
(IP). (Thus, for 4 IPs, 32 mg of Protein A-Sepharose was weighed out). 
N.B.: The amount of Protein A-Sepharose that would be required for each IP was 
initially estimated from the following information: 
(i) the average IgG serum concentration in mammals is 12.5 mg per ml (Range: 8-
18 mg/ml). Thus, in 50 µl antiserum there would be around 0.625 mg = 625 µg IgG; 
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(ii) the binding capacity of swollen Protein A-Sepharose (as supplied by the 
manufacturers) was that 1 ml of swollen gel bound 20 mg of human IgG; i.e., 20 µg 
lgG would require 1 µl swollen gel. 
Hence 625 µg IgG would require 31 µ1 swollen gel which is approximately equal to 8 
mg of Protein A-Sepharose. The binding capacity was, however, only known in terms 
of human IgG although it might have been expected to be similar for rabbit IgG which 
was used in most of my immuno-precipitations. Experiments, however, using 12 and 16 
mg Protein A-Sepharose instead of the standard 8 mg revealed no further increase in the 
amount of radio-labelled immuno-precipitated protein product on the subsequent 
fluorogram. In any case, the completeness of the IP was checked in all cases by 
attempting a re-immuno-precipitation of the relevant protein in the initial cell lysate 
supernatant obtained from the first IP (see Chapt. 3.4). 
The weighed out Protein A-Sepharose was then swollen using 0.6 ml of the NETTAM 
IP Wash solution containing 0.1 % BSA. The Protein A-Sepharose swelled to 4 times its 
original weight in volume (i.e. 8 mg swelled to 32 µl). The swollen Protein A-
Sepharose was washed 3 times using NETTAM - 0.1 % BSA IP Wash solution by brief 
centrifugation in a microfuge (10 000 g x 1 min) and careful removal of the supernatant 
by pipette aspiration so as not to disturb the Protein A-Sepharose pellet. The pellet was 
then resuspended in 0.6 ml of NETTAM - 0.1 % BSA, and re-spun. The washed Protein 
A-Sepharose pellet was finally resuspended in a volume of NETTAM-BSA equivalent to 
that to which it originally swelled. 55 µl of the swollen Protein A-Sepharose (equivalent 
to 8 mg) was added to each lysate-antiserum mixture which had been incubating 
overnight; the contents were mixed by repeated flushing of the pipette tip in the 
solution, and the tubes were mixed by rotation at 4 °C for l1/2 hours. Thereafter the 
samples were spun in an Eppendorf microfuge at 10 000 g for 2 minutes at room 
temperature and the resulting pellets were washed 6 times in total - 3 times usmg 
NETTAM-0.1% BSA and, for the latter 3 washes, NETTAM in the absence of 0.1% 
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BSA. (The BSA was removed to avoid interference with the interpretation of the 
specific immuno-precipitated protein product on the subsequent SDS gel and 
fluorographic analysis). Finally, the washed pellets were resuspended in 100 µl of the 
gel sample application buffer (see 3.3 (ii) above), mixed, heated at 95°C for 2 mins, 
spun at 10 000 g for 3 minutes, and the supematants (containing IgG, antigen/specific 
immuno-precipitated protein and Protein A) analyzed on SDS gels. 
3.3(v) SDS Polyacrylamide gel electrophoresis and fluorography 
The denaturation of samples for SDS polyacrylamide gel electrophoresis using the gel 
sample application buffer and the gel system used has already been described (see 3.1 
(i)). A lane consisting of a set of Rainbow Molecular Weight standards (Amersham 
Rainbow TM Protein MW Markers, Code RPN 756) was included on each gel. 
Following completion of the run, the 5-20% SOS-gradient gel was submerged and gently 
mixed in 2 solutions: destain I, a 50% methanol and 10% acetic acid solution, for 1 
hour (with a change in the solution after 30 minutes), followed by destain II, (5% 
methanol, 78% acetic acid), overnight. On the following day the gel was rinsed in 
deionized, distilled water for 30 minutes to remove acetic acid prior to soaking the gel in 
a 1 M sodium salicylate solution for a further 30-45 mins (sodium salicylate, a fluor for 
converting the 13 radiation from the 35s-labelled protein atoms into light energy, 
precipitates in the presence of acetic acid). 
The salicylate-treated gel was then dried onto a sheet of blotting paper or Whatman 3 M 
paper using a gel drying apparatus at a temperature of 60°C (Dual Temperature Slab 
Dryer Model SEl 150, Hoefer Scientific Instruments, San Francisco) attached to a 
vacuum pump. The dried gel was allowed to cool before being tightly juxtaposed onto a 
Kodak X-OMAT AR Diagnostic X-ray film in a metal cassette in a photographic dark 
room. The sealed cassette or holder was placed in a deep freeze (-70°C) for 2 to 5 days. 
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The film was developed using a standard automated developing system in the Radiology 
Department of the Groote Schuur Hospital, Cape Town. 
The fluorogram obtained was aligned with the original gel and the positions of the 
"Rainbow" MW markers which were present on the dried gel were traced onto the 
fluorogram. Where necessary further exposures of gel to film at -70°C were carried out 
for shorter or longer periods to obtain optimal fluorographic pictures. 
N.B.: Gels intended for 35s fluorography were generally not stained with Coomassie 
solution as this was found to cause significant quenching of radioactivity and thus poorer 
quantification (see 3.6(ii)). 
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3.4 DEMONSTRATION OF IMMUNO-PRECIPITATED PROTEIN PRODUCTS 
IN CELL LYSATES AND INCUBATION MEDIA 
The general protocol for experiments performed to demonstrate the presence of specific 
immuno-precipitable protein products following the incubation of freshly isolated jejunal 
enterocyte sheets with [35s]-methionine is summarized in figure 3.3. Details of the 
methods used in each step are referenced in the flow chart. Specific details regarding the 
duration of enterocyte incubation, the type of antiserum or antibody preparation used and 
the immuno-precipitation technique followed will be provided for each fluorogram 
presented. 
3 .4 (i) Apolipoprotein B-48 
When freshly prepared jejunal enterocyte sheets were incubated in Krebs-Ringers-HC03 
medium together with fuels, antibiotics and [35s]-methionine (2 ml cell suspension & 15 
µCi 35s-methionine) and the subsequent radiolabelled protein products from the cell 
lysate and medium were reacted with a specific anti-apolipoprotein B antiserum, a single 
immuno-precipitation (IP) product of MW -200kDa and corresponding to the known 
MW of apolipoprotein B-48 was observed. There was no protein product at the larger 
B-100 position (see Figs. 3.4 & 3.5). The immuno-precipitations were quantitative 
when a specific antiserum was used since no additional apolipoprotein B-48 could be re-
immuno-precipitated from the cell lysate supernatant of the first IP and the apo B-48 
band disappeared in the medium supernatant. The "neat" medium (not reacted with 
antiserum) gave rise to 2 additional bands of protein with MW's of -44 & 28 kDa, 
respectively (Fig. 3.4). These corresponded to the MW's of apolipoproteins A-IV and 
A-I, both known to be products of intestinal synthesis and secretion. 
In addition to the aforementioned proteins, immuno-precipitations using the rabbit 5 (or 
rabbit 2) antisera directed against all proteins associated with hamster plasma 
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Fig. 3. 3. General protocol used to demonstrate the presence of specific radiolabelled 
protein products in cell lysates and media from freshly isolated hamster jejunal 
enterocyte sheets incubated with 35s-methionine. Details of the methods used are 
referenced in each step. 
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Fig. 3.4. Immuno-precipitation (IP) of apolipoprotein B-48 from a jejunal enterocyte lysate 
and mediu_m sample. 
The protocol outlined in Fig. 3.3 was followed. Freshly isolated jejunal enterocyte 
sheets were incubated in the presence of 35s-methionine for one hour before the cells 
and media were separated and analyzed for apo B-48 using a polyclonal, rabbit-
derived, anti-rat Apo B antiserum and Protein A as the precipitating agent. 
Key to lanes: 
a = Cell lysate, starting material for IP. 
b = Cell lysate, pre-bound to Protein A ("clearing step"). 
c = Cell lysate from supernatant after IP. 
d = Human VLDL standard. Traced lines from the Coomassie-stained gel 
show the positions of apolipoprotein B-100, albumin and apolipoprotein E 
(MWs 350, 67 & 35 kDa, respectively). 
e = Cell lysate IP without specific antiserum (non-immune serum used) . 
f = cell lysate IP with anti-apoB antiserum, showing a single bond at MW -
200 kDa, = expected position of Apo B-48. No apo B-100 band. 
g = medium, starting material for medium IP. 
h = medium supernatant following specific IP, showing disappearance of the 
putative B-48 band, but retention of 2 bands at the expected positions of 
apo A-IV (MW - 44 kDa) and apo A-I (MW - 28 kDa), respectively. 
i = medium IP with non-immune serum. 
j = medium IP with anti-apo B antiserum showing single IP band 
corresponding to the expected position of apo B-48. 
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Fig. 3.5. IP of intestinal enterocyte apo B-48 using "OSAN", a commercially available 
anti-human apolipoprotein B antiserum (Behring Diagnostica), and IP of protein 
products using "rabbit 5" antiserum (prepared by immunizing a rabbit with floated 
hamster lipoproteinsp < 1.21 g/ml). 
The protocol of Fig. 3.3 was followed in the main. However, a pulse-chase method 
of cell incubation was used. Initially, the freshly prepared jejuna! enterocyte sheets 
from a fat-fed hamster were incubated with 35s-methionine for twenty mins. "Cold" 
methionine (in Krebs-Ringer -HC03) was then added to the incubation flasks to a 
final concentration of 2 mM. The flasks were re-..gassed, re-sealed and the incubation 
continued for an additional sixty minutes. The Protein A-Sepharose method of IP was 
used. 
Key to lanes: 
a = cell lysate, t=20' incubation = O' chase, IP with non-immune serum 
(NIS). 
b = cell lysate, t=O' chase + "OSAN" IP. 
c = cell lysate, t=60' chase, + "OSAN". 
d = celJ Jysate, t=O' chase, + rabbit 5 (R5) antiserum. 
e = cell lysate, t=60' chase, + R5 antiserum. Note bands at: MW - 200 kDa 
(apo B-48), MW - 54-64 kDa (see Chapt. 6), MW - 45 kDa (? apo A-IV) 
and at 28 kDa (? apo A-1). 
f = MW standards (see RHS of figure for key) 
g = medium, t=O' chase ("neat" medium, no IP) 
h = medium, t=60' chase ("neat") 
i = medium, t=60' chase + IP with NIS 
j = medium, t=60' chase + IP with "OSAN" 
k = Re-IP of supernatant from IP lane b i.e. supernatant from 1st IP + 
"OSAN" IP. No additional protein precipitated. 




:,' .. '~ ( k OG ) 
' " -100 
- 30 
11.S 
. - u •. 3 
123 
124 
lipoproteins of density < 1.21 g/ml, revealed an additional unknown fourth protein with 
a broad MW band of -54-64 kDa (see Fig. 3.5). Further attempts at identification of 
this material will be discussed in chapter six. 
Immuno-precipitations (IPs) using rabbit 5 were not entirely quantitative. About 80-90% 
of the apolipoprotein B-48 and the putative apolipoprotein A-I (MW -28 kDa) were 
precipitated in the first IP (as opposed to the re-IP of the supernatant from the first IP). 
These relative quantities were assessed by densitometric scanning (see Fig. 3.6). 
3.4 (ii) Apolipoprotein A-IV 
The presence of this protein, suspected from the previous IPs using R5 antiserum (Figs. 
3.5) and the appearance of the neat medium (Fig. 3.4), was confirmed using a specific 
rabbit-derived, anti-rat apolipoprotein A-IV antiserum. Conditions were also set for 
optimal quantitative IP of this protein from fat- and non fat-fed hamster enterocyte 
preparations (see Fig. 3.7). 
3.4 (iii) Apolipoprotein A-I 
The protein at MW -28 kDa was specifically immuno-precipitated from the enterocyte 
lysate of a fat-fed hamster using a specific rabbit-derived, anti-rat apolipoprotein A-I 
antiserum. However, the quantity of protein obtained using the specific anti-AI 
antiserum was smaller than that obtained with the rabbit 5 antiserum although the MWs 
of both antisera corresponded exactly (see Fig. 3.8). The rabbit 5 antiserum was 
therefore deemed to be more quantitative (volume for volume) and in the re-IP 
experiment previously discussed (Fig. 3.6 ) was indeed shown to immuno-precipitate 
80% of apo A-I in the first IP compared with a second re-IP. 







Fig. 3.6. IP using rabbit 5 antiserum of enterocyte and medium proteins following the 
incubation of jejuna! enterocytes, prepared from a fat-fed hamster, with [35s] 
methionine. 
Incubation of 4 flasks of cells with analysis at 20', 40', 60' and 80' incubation time, 
respective! y. Protein A-Sepharose technique of IP. 
Key to lanes: 
a = cell lysate + rabbit 5 (R5) antiserum, t=20'. 
b = cell lysate + R5 antiserum, t=40'. 
c = cell lysate + R5 antiserum, t=60'. 
d = cell lysate + NIS, t=80'. 
e = cell lysate + R5 antiserum, t=80'. 
/ = cell lysate, supernatant from IP (lane e), re-IP with R5 antiserum. 
g = MW stds. 
h = medium, t=20', "neat". (No IP). 
i = medium, t=60'. 
j = medium, t=80'. 
The R5 IP was not quantitative at the 1st attempt, although 80-90% of the apoB 
(MW - 200 kDa) and apo A-I (MW - 28 kDa) immuno-precipitated, did so in the 
first IP (compare lanes e & f). The relative quantities precipitated in the 1st as 
opposed to the 2nd IP were assessed by densitometric scanning of the 2 lanes using 
a "Cliniscan" densitometer (Helena Laboratories), slit width of light beam, 8.5 
mm, and wavelength = 610 nm. 
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Fig. 3.7. IP of Apolipoprotein A-IV. 
Cell lysates were prepared according to the protocol of Fig. 3.3. However, both a 
low fat-fed animal (not administered sunflower oil on the A.M. of the experiment, but 
also previously on standard chow and also fasted for 2 hrs prior to anaesthesia) as 
well as an acutely fat-fed animal were used. The IP was performed using a rabbit-
derived, polyclonal anti-rat apolipoprotein A-IV antiserum and the Protein A-
Sepharose technique for immuno-precipitation. 
Key to lanes: 
a = cell lysate (starting material), low fat-fed animal, following a 20' 
incubation with 35s-methionine. 
b = cell lysate (starting material), fat-fed animal, following a 20' incubation 
with 35s-methionine. 
c = MW markers. 
d = 11a11 cell lysate material + IP using 50 µl anti-A-IV antiserum. 
e = 11h11 cell lysate material + NIS. 
f = 11 b 11 cell lysate + IP using 25 µl anti-A-IV antiserum. 
g = 11h11 cell lysate + IP using 50 µl anti-A-IV antiserum. 
h = Re-IP of supernatant from ''/' IP. 
i = cell lysate supernatant from IP of lane II d 11 • 
j = cell lysate supernatant from IP of lane "g 11 • 
Note: (i) IP was quantitative when 50 µl anti-A-IV antiserum was reacted with 200 µl 
of the cell lysate preparation but was incomplete when 25 µl were used. 
rom the whole cell lysate supernatant (compare lanes a & i and b & j, i.e. lysate 
material before and after IP). 






















Fig. 3.8. IP of apo A-I using a polyclonal rabbit-derived, anti-rat apo A-I antiserum. 
Jejunal enterocyte sheets from a fat-fed hamster were incubated for 20' with 355_ 
methionine (2 ml cell suspension and 15 µCi of 35s-methionine). 
IPs of the resulting cell lysate were carried out using: 
a, a polyclonal, rabbit-derived, anti-rat apo B antiserum; 
b, a polyclonal, rabbit-derived, anti-rat apo a-I antiserum; 
c, "rabbit 5" antiserum (to floated hamster apolipoproteinsp < 1.21 g/ml) and, 
d, "rabbit 2" antiserum (also directed against total floated lipoprotein-associated 
hamster proteins ,o < 1.21 g/ml). While a specific band corresponding to the 
expected position of apolipoprotein A-I (MW - 28 kDa) was 
immunoprecipitated in lane b, the quantity of protein was much less than the 
band of corresponding MW obtained when rabbits 5 or 2 antisera were· used 
(lanes c & d). 
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3.4 (iv) Conclusion 
Freshly isolated hamster jejunal enterocytes synthesized apolipoproteins B-48, A-IV and 
A-I when incubated in vitro in a supportive medium containing [35s] methionine as the 
radiolabelled precursor amino acid. Two of these proteins, B-48 and A-IV, could be 
quantitatively immuno-precipitated from the cell lysates prepared from such incubations; 
all three radiolabelled proteins were also clearly visible in the untreated media samples 
(i.e. without specific immuno-precipitation). A fourth labelled protein product is as yet 
unidentified (see below). 
With the development of these specific techniques for quantifying the radiolabelled 
protein products, it now appeared possible to measure the relative quantities of 
apolipoproteins synthesized, secreted and degraded in the in vitro system following 
dietary perturbations performed on the intact animal during life. (See Chapter 4). Some 
subsidiary questions had first to be addressed, however. 
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3.5 BIOSYNTHETICALLY LABELLED APOLIPOPROTEINS IN THE 
INCUBATION MEDIUM: CELL L YSIS OR CELL SECRETION IN VITRO? 
The appearance of proteins in the incubation medium of enterocytes may have been due 
to cell lysis or cell secretion. It is contended that the evidence presented thus far would 
favour a secretion rather than a lytic model. 
Firstly, when incubation conditions were characterized and optimized (Chapt. 2 .4), it 
was found, using assays of actate dehydrogenase and alkaline phosphatase in the cell 
lysates and incubation media, that only a tiny minority of cells died or were damaged in 
vitro. Such overall cell stability and integrity over a five-hour incubation period is 
unlikely to result in significant release of intracellular protein into the medium through 
cell lysis. If protein did appear in the medium under such conditions, physiological 
secretion rather than lysis would be a more likely explanation. 
Secondly, the nature of the proteins released into the medium as demonstrated in the 
fluorograms of Chapt. 3.4 (especially Fig. 3.4) strongly suggests cell secretion. The 
process appears highly selective for 3 proteins which are known, in any case, to be 
secretory products of the mammalian small intestine - viz. the apolipoproteins B-48, A-
IV and A-1. If lysis were operating the medium protein profile would be expected to 
resemble that of the whole cell lysate and perhaps to show increasing resemblance with 
increasing incubation times. Neither of these phenomena is seen in the fluorograms. 
In order to definitively resolve the question of secretion versus lysis, 2 experiments (of 
which a representative example is presented here) were performed using sodium azide, a 
small water-soluble compound which inhibits oxidative phosphorylation by binding 
reversibly to cytochrome oxidase. 
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In 1988, R. Persson et al. showed that by incubating isolated rat hepatocytes (with 35s-
methionine) in the presence of graded concentrations of sodium azide (2 - 10 mM), they 
could proportionally arrest the transport of secretory proteins. By studying glycosylation 
patterns of the retained protein, they were able to show the steps in the secretion pathway 
(e.g. transfer of protein from medial to trans Golgi complex) which were more or less 
sensitive to ATP depletion. The use of sodium azide in their study had the additional 
advantage over other hydrophobic uncouplers of oxidative phosphorylation of not 
affecting cell membrane permeability as well. At 10 mM sodium azide concentration the 
secretion of albumin from viable isolated hepatocytes was completely blocked. 
In my experiments, enterocytes were prepared from fat-fed hamsters according to the 
protocol in Fig. 3.9. (A non fat-fed animal not administered sunflower oil at 07h30 was 
included in the experiment as a control). 1 ml aliquots of the cell suspension from the 
fat-fed animal were incubated (each with 8 µCi 35s-methionine) in small Erlenmeyer 
flasks. Following a twenty minute incubation period, cold methionine was added to 2 of 
the flasks (to a final concentration of 2 mM) and sodium azide, 10 mM final 
concentration, was added to one of the flasks. A further 60' "chase" incubation period 
followed. At the end of this period the cell lysates and media samples were analysed on 
SDS-polyacrylamide gels and fluorography. (No specific immuno-precipitations were 
carried out) The results are shown in Figs. 3.10A & B. The first fluorogram (A) was 
exposed for 1 day, the second (B) for 5 days. 
In the incubation system "chased" with cold methionine but no azide, significant 
quantities of the apolipoproteins B-48, A-IV and A-I appeared in the incubation medium. 
However, in the system "chased" in the presence of 10 mM azide, much smaller 
quantities appeared in the medium (lane j versus lane i). In the azide-treated system apo 
A-IV even appeared to accumulate in the cells (compare the band in the A-IV position, 
lane f versus lane g in the fluorograms of Fig.3.10). 

Fig. 3.10 A & B. Fluorograms showing azide inhibition of apolipoprotein release into the 
medium of incubated jejuna! enterocyte sheets. 
A. = fluorogram following 1 day exposure of gel to X-ray film. 
B. = after 5 days exposure. 
Key to lanes: 
a = cell lysate, A, low fat-fed animal, 20' incubation 
b = cell lysate, A, low fat-fed animal, 60' incubation 
C = II 
d = II 
11 
, B, high fat-fed 11 , 20' incubation 
11 
, B, 11 11 11 11 , 60' incubation 
e = MW stds. (Key on LHS of fluorograms) 
f = cell lysate, B, after 20' pulse & 60' chase, in 
absence of azide 
g = cell lysate, B, after 60' chase in presence of azide 
h = medium of A, after 60' incubation 
i = medium of B, after 20' pulse & 60' chase, in absence 
of azide 
j = medium of B, after 20' pulse & 60' chase, in presence 
of azide. 
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This result shows that the release of proteins into the media of my enterocyte suspensions 
was azide-sensitive and, therefore, ATP-dependent. This is in keeping with what is 
known about physiological secretion (Persson et al. 1988). Cell lysis is not ATP-
sensitive and is, in fact, likely to be exacerbated by ATP depletion. 
Finally, additional evidence for secretion as opposed to lysis is also provided by the 
comparison of the media of the fat-fed versus the non fat-fed hamster enterocytes (lanes 
h and i, Fig. 3.10): the medium of the non fat-fed animal's enterocyte suspension 
contained no visible proteins even on the more exposed fluorogram; the medium from 
the fat-fed animal's cells contained prominent apolipoprotein bands. Thus the 
appearance of apolipoproteins in the medium appeared to depend on whether fat loading 
or fat absorption had taken place or not and this is consistent with some of the evidence 
(presented in Chapt. 1.8) of increased apolipoprotein secretion with lipid feeding. (The 
question of the effects of high versus low fat diets on apolipoprotein synthesis, secretion 
and degradation will be more comprehensively addressed in Chapter 4). 
In conclusion, it can be assumed that incubated jejuna! enterocytes synthesized and 
secreted radiolabelled apolipoproteins into the incubation medium. 
3.6 
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TECHNIQUES FOR QUANTIFYING THE RADIO-LABELLED. IMMUNO-
PRECIPITABLE. PROTEIN PRODUCTS 
Although complete immuno-precipitation of apolipoproteins B-48 and A-IV was 
demonstrated, an important aim of this project was to perform quantitative comparisons 
of the synthesis, secretion and degradation of the apolipoproteins under various dietary 
perturbations in different animals. Since the incorporation of amino acids by different 
preparations of enterocytes was unpredictably variable, a more precise expression of the 
results of such experiments was required, and a way of standardizing the results was 
needed in order to make valid comparisons of different animal experiments. 
(i) Trichloro-acetic acid precipitation {TCA) 
Since the immuno-precipitation of apolipoproteins B-48 and A-IV (using specific 
antisera) yielded single protein bands on the fluorograms, one method of quantifying the 
amount of radiolabelled protein immuno-precipitated would simply be to count the TCA-
precipitable, immuno-precipitable radioactivity in the final (resuspended) Protein A (-
Sepharose) pellet. So, following solubilization (including heating and spinning) of the 
Protein A-Sepharose pellet in gel sample application buffer (see Chapt. 3.3(ii)), a small 
quantity - usually 10 !-!l - was applied (in duplicate) onto filter discs and the TCA-
precipitable, immuno-precipitated radioactivity determined using the method of Mans 
and Novelli (1961) (see Chapt. 2.3 section (iii)). TCA-precipitable, IP-radioactivity 
from non-immune serum control IPs was subtracted from the TCA-precipitable IP 
radioactivity of specific protein IPs to give the true IP counts. Results were then related 
to the total TCA precipitable radioactivity of the system (cells and media). 
Thus: percentage synthesis of a specific apolipoprotein 
immuno-precipitated, TCA-precipitable 
= 
dpm in cells and media ( expressed 
per µg cell protein)at Time x 
Total TCA-precipitable radioactivity 




The synthesis, of a particular protein was therefore expressed in terms of its abundance 
relative to the total quantity of radioactive protein synthesized. In all instances the 
protein dpm were normalized to the measured amount of cell protein in each incubation, 
since the quantity of cell protein actually incubated (i.e. number of cells incubated) 
varied from animal to animal and from flask to flask in the same animal experiment 
(although variation in the latter was far smaller than that of the former). The method, 
therefore, of direct measurement of IP radioactivity by TCA-precipitatioan of the final 
IP material was valid as long as fluorographic analysis could demonstrate a "clean" IP of 
a single protein. It could not be used, for example, when rabbit 5 antiserum (which 
immuno-precipitated multiple apolipoproteins and lipoprotein-related proteins) was used. 
3.6 (ii) Quantification using the fluorogram 
This technique was more tedious than the direct TCA precipitation method but was 
nevertheless useful when multiple proteins were present in the same sample or gel lane, 
e.g. analysis of proteins in the media or the products of "rabbit 5" immuno-
precipitations. It depended on the establishment of a linear relation between the amount 
of radioactivity present in the protein and the degree of "blackness" imparted onto the X-
ray film (i.e. the amount of silver deposited by the 13 radiation from the 35s protein and 
its conversion to light energy in the presence of the fluor, sodium salicylate). The 
original method for eluting silver grains from autoradiograms and quantifying the 
amounts by spectrophotometry was described by Suissa in 1983. 
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Standardization was achieved in the following way: a solution of 14c-methylated a-
casein was obtained from Dr Jane Arnold. This protein sample was separated on 
duplicate SDS-polyacrylamide gels with increasing amounts of the protein loaded in each 
of 5 lanes (e.g. lane a, IO µl; lane b, 20 µl, lane c, 50 µl, etc.). One of the gels was 
stained with Coomassie-blue and dried. The casein appeared as a double band at around 
MW -32 kDa. The double band from each of the five lanes was excised and completely 
oxidized using a Packard Tricarb Sample oxidizer. The l 4co2 released was trapped 
using a strong alkali solution (Carbosal, Packard) and the total radioactivity obtained 
counted in a Packard Liquid Scintillation Counter using a scintillation system 
(Permafluor V, Packard) for 14c. A blank segment of the dried gel not stained with 
Coomassie was also excised, oxidized and used as a background subtraction. 
The second (duplicate) gel was not stained with Coomassie-blue since staining was found 
to reduce the density of the bands on the fluorogram by 25 % compared with an unstained 
gel. The gel was fixed, dried and a fluorogram of the radio-labelled 14c-casein bands 
was obtained. The film was cleaned with 96% ethanol, dried and wiped with an 
antistatic cloth. The darkened bands on the film (corresponding to the Coomassie-
stained bands from the first gel) were excised, weighed and submerged in a solution 
consisting of 1 ml of 1 M NaOH for at least 3 hours in order to elute the silver from the 
film slices (see Fig. 3.11). An appropriate "blank" portion of the fluorogram 
(corresponding to the background darkness of the film) was treated in the same way and 
served as the blank subtraction. 
Once all the silver grains had eluted from the film slice, glycerol was added to the 
solution to a final concentration of 30% and the sample mixed well before the 
absorbance of the solution was measured in a spectrophotometer at 500 nm. Absorbance 
readings were all corrected for the mass of fluorographic slice excised. A standard 
graph was then plotted of the radioactivity in the excised, oxidized gel bands versus the 
['(c1sion of 
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Fig. 3 .11. Quantification of fluorographic (protein) bands by elution of si
lver using 1 M 
NaOH. A "background" area of the fluorogram was similarly processed to




absorbance obtained from excision and silver extraction of the corresponding bands on 
the fluorogram (see Fig. 3.12). The relationship was linear from around 1000 to 10 000 
dpm of 14c protein. Thus, in subsequent experiments in which this method of 
quantification was used, the second dried, unstained gel strip containing the 5 14c casein 
bands was exposed to the same X-ray film and for the same duration as the gel from the 
experiment. By excising the bands on the fluorogram of the proteins of unknown radio-
activity from the experiment as well as the fluorographic bands of the standard 14c-
casein samples, the radioactivities in the experiment could be derived fromm the standard 
graph. 
This method was valid provided the radioactivity in the experiment proteins fell within 
the range of radioactivity of the standard casein bands. 
N.B. A 14c labelled protein was chosen as the standard for 2 reasons: firstly, 14c has 
a similar energy of radiation as 35s which was used in the experiments (both are "soft" 
8-emitters, i.e. decay by negatron emission and are counted using the same "window" 
settings in a liquid scintillation counter). Secondly, 14c is more stable than 35s (t1/2 
14c = 5760 years compared with 35s, 87.2 days). So the 14c standards would be 





















Fig. 3.12. The linear relationship between the quantity of 14c radioactivity in the protein 
standard ( 14c-casein) and the amount of silver eluted from the corresponding 
fluorographic band. 
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3.7 LIPOPROTEIN-ASSOCIATED VERSUS "FREE" APOLIPOPROTEIN 
SECRETION 
Radio-labelled apolipoproteins have thus far been immuno-precipitated from Triton X-
100 solubilized cell homogenates or from whole (neat) media samples. No attempt was 
made to determine whether the apolipoproteins in the media were present in a free form 
or in association with lipoprotein particles. While it would seem unlikely that the large 
relatively hydrophobic apolipoprotein B-48 molecule could exist in any form other than 
in association with lipid (i.e. as part of a lipoprotein), it is possible that the smaller 
apolipoproteins A-IV and A-I may have been secreted as free apoproteins. 
Following a sixty minute pulse-labelling of jejuna! enterocytes derived from an acutely 
fat-fed hamster with 35s-methionine, the medium was removed, adjusted to a density of 
1.25 g/ml using KBr (according to the formula, section 3(ii)), and underlayered in a 5 
ml Beckman SW 65 Ti centrifuge tube containing saline-EDTA (p = 1.006 g/ml) (see 
Fig. 3.13B, "lipoprotein flotation p < 1.006 g/ml"). The sample was then centrifuged 
at 100 000 g (38 000 rpm, SW 65 Ti rotor) for 18 hours at l5°C in a Beckman L5-65 
ultracentrifuge machine. At the end of the centrifugation the floated material 
(p < 1.006 g/ml) was aspirated from the top of the tube. 
Both the aspirated material (p < 1.006 g/ml) as well as the infranatant (p > 1.006 
g/ml) were then denatured using a gel solubilizing buffer (see section 3.3(v)), heated for 
2 minutes, cooled, spun, and the supernatant (solubilized proteins) separated on a 5-20% 
gradient SDS reducing polyacrylamide gel electrophoresis. Coomassie blue staining of 
the dried gel showed no bands corresponding to the expected MW positions of 
apolipoproteins B-48 (-200 kDa), A-IV (-44 kDa) or A-I (MW - 28 kDa), respectively, 
in both the > 1.006 and < 1.006 g/ml density fractions. Fluorographic analysis (see 
3.3(v)), however, demonstrated the 3 bands in both fractions of the media. The pattern 
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of bands in the fractions was similar to that shown in fig. 3.4 (lane g) with apparently 
more material in the infranatant compared with the floated material. 
This single experiment indicated that the apolipoproteins B-48, A-IV and A-I were found 
in the medium associated with particles both denser and less dense than 1.006 g/ml. 
Material less dense than 1.006 g/ml would be expected to comprise chylomicrons and 
intestinal VLDL while that denser than 1.006 g/ml would include nascent intestinal HDL 
(see review, section 1.4) as well as free apolipoproteins. The experiment design did not 
permit differentation between free apolipoproteins and apolipoproteins associated with 
particles greater than p 1.006 g/ml. 
It is possible that HDL-like lipoprotein particles may arise during the centrifugation 
process through "budding off'' from large chylomicrons. Apolipoproteins may therefore 
have been found in denser lipoprotein particles that were artefactually produced. 
Apolipoprotein B-48 has also been described as a constituent apoprotein of nascent HDL 
(Hamilton et al. 1976). The origin of apolipoproteins in the denser than 1.006 g/ml 
fraction is therefore unclear. 
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3.8 ATTEMPTED ISOLATION OF INTRACELLULAR LIPOPROTEINS 
A tight-fitting Dounce homogenizer was used in the preparation of an initial jejunal 
homogenate from an acutely fat-fed hamster (see protocol, Fig. 3.13A). Techniques of 
differential centrifugation were then employed to prepare microsomal fractions. These 
were based on standard methods previously developed for preparing subcellular fractions 
from rat liver homogenates (Griffiths 1981) but were also adapted for use in enterocytes 
(e.g. Magun et al. 1988; Mahley et al. 1971). 
In releasing the microsomal contents by disruption of the microsomal membranes, 2 
methods were attempted: (1) a chemical method, utilizing Na2C03 at high alkaline pH, 
to dissolve the microsomal membranes, first described by Fujiki et al. in 1982 and 
utilized by Howell & Palade (1982) to resolve hepatic Golgi fractions into membrane and 
content subfractions; and (2), sonication, to resuspend and disrupt the spun microsomal 
pellet (on ice). While the latter method appeared more likely to result in damage to the 
lipoprotein particles, I found that the microsomal pellet remained firmly stuck down to 
the bottom of the ultracentrifuge tube following the 100 000 g spin for 1 hour when 
using the Na2co3 technique alone, with insufficient material available for subsequent 
column chromatographic analysis. In practice, a combination of Na2co3 treatment and 
sonication was used (Fig. 3.13A). 
The released material (microsomal content fraction) was separated from the microsomal 
membranes, and material less dense than 1.006 g/ml or 1.21 g/ml was prepared by 
flotation-ultracentrifugation (Fig. 3.13B). The floated material was subsequently 
analysed by gel exclusion column chromatography (Rudel et al. 1986). A 4% cross-
linked agarose column (Sepharose CL-4B, Pharmacia) was used. It measured 30 cm in 
length, with an internal diameter of 0. 7 cm, a cross-sectional area of 0.385 cm2, a bed 
volume of 12 cm3, and a 35 µm exclusion filter at the base (Biorad 838-1252). The 
elution buffer ("SEAP") comprised NaCl 0.015 M, NaH2P04 0.002 M, NaN3 0.01 g% 
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and EDTA, 3.2 mM, pH 7.34. The column was run using hydrostatic pressure with a 
flow rate of 2.55 ml/hr. A sample volume not exceeding 1 % of total volume (VT) was 
loaded for each run and the absorbance of the eluent was recorded using an ultraviolet 
monitor (LKB 2158 Uvicord SD monitor and recorder) at 280 nm. Fractions were 
collected at 15 minute intervals. 
The typical column profile of floated material (p < 1.006 g/ml) derived from jejunal 
microsomes of a fat-fed hamster is shown in Fig. 3.14A. A large peak corresponding to 
the void volume (Vo> of the column and a much smaller peak close to the total volume 
(VT) are seen. Chylomicrons and VLDL (MW > 10 x 106 daltons) would be expected 
to elute in the V
O 
and the apparently high absorbance of this peak is likely to relate to 
the light-scattering properties of the particles rather than to a true absorbance. The 
second peak near the VT of the column (MW < 85 000 daltons) could be caused by free 
apolipoproteins as well as other proteins such as albumin which may adhere to the 
chylomicrons. 
The second column profile (Fig. 3.14B) of jejunal microsomal contents (p < 1.21 g/ml) 
from a fat-fed animal has been compared with a superimposed profile of hamster plasma 
lipoproteins (p < 1.21 g/ml) prepared from the same animal. (The plasma HDL peak 
was identified by running purified 1251-labelled human HDL through the same column 
under the same conditions as for the hamster plasma and microsomal contents, and 
measuring the 1311 radioactivity in the eluted fractions). Two peaks are seen on the 
second profile (Fig. 3.14B): one, a small peak coinciding with the V
O 
(MW > 10 x 106 
daltons), and a second larger peak nearer the VT but smaller than the peak for hamster 
plasma HDL. This peak could represent nascent intestinal HDL (HDLn), free 
apolipoproteins, or other "contaminating" proteins that are known to attach to HDL (e.g. 
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Degradation of the larger chylomicrons probably also occurred in the longer (p < 1.21 
g/ml) ultracentrifugation procedure and some of the material seen in the VT may be 
accounted for by apolipoprotein constituents or smaller particles that have "budded off' 
from the chylomicrons during the 48 hr spin. The shorter centrifugation time of the 
p < 1.006 g/ml spin (18 hrs as opposed to 44 hrs) might have left more chylomicrons 
intact, hence the larger V
O 
peak in the first profile (Fig. 3.14A). 
Unfortunately, the quantity of material obtained precluded any subsequent SDS-
polyacrylamide gel analysis of the proteins eluted in the pooled fractions corresponding 
to the 280 nm absorbance peaks. 
The results of these preliminary experiments therefore indicated that particles of 
chylomicron/VLDL size as well as smaller particles (possibly nascent HDL) were 
released from the microsomes of jejunal enterocytes prepared from a fat-fed hamster. 
However, verification of the preparative procedures (especially the effects of sonication 
on the lipoprotein particles) and positive identification of the known apolipoproteins in 
the column fractions has yet to be carried out. 
3.9 
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IDENTIFICATION OF OTHER PROTEINS POSSIBLY RELATED TO 
LIPOPROTEIN METABOLISM 
Enterocyte lysates incubated with 35s-methionine were also tested with a variety of 
antibody or antisera preparations directed against various proteins related to lipoprotein 
metabolism, one of these was Acylation Stimulating Protein (ASP), a small 14 kDa 
protein present in human plasma which rises dramatically following an oral fat load. 
This protein was first described by Cianflone et al. in 1989 and appears to be a potent 
stimulator of triglyceride synthesis in human skin fibroblasts and adipocytes. The exact 
tissue of origin of this protein is unknown but attempted immuno-precipitations of this 
protein from incubated hamster jejunal enterocytes using an anti-ASP IgG obtained from 
Dr Cianflone were unsuccessful. 
Immuno-precipitations were also attempted using antisera against "hepatic" Fatty Acid 
Binding Protein (hF ABP), a 14 kDa protein found in both rat hepatic and intestinal 
tissue, and "intestinal" FABP (gFABP), a -15 kDa protein found in rat intestine. The 
role of these proteins in the intracellular transport of fatty acids has previously been 
discussed (see Chapter 1.2). Unfortunately, neither protein could be immuno-
precipitated from my enterocyte lysates. 
The negative results obtained more likely reflect the cross-species differences between 
the rat and hamster proteins rather than the absence of the proteins from the hamster 
enterocyte preparations. The polyclonal antisera were produced in rabbits and therefore 
should have reacted with Protein A-Sepharose which was used as the precipitating agent. 
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3.10 DO HAMSTER SMALL INTESTINAL ENTEROCYTES SYNTHESIZE AND 
SECRETE CHOLESTERYL ESTER TRANSFER PROTEIN (CETP) I LIPID 
TRANSFER PROTEIN-I (LTP-1}? 
3.10 (i) Introduction 
When cell lysates and medium samples prepared from low and high fat-fed hamster small 
intestines were reacted with a rabbit-derived, anti-hamster apolipoprotein antiserum, a 
prominent though variable feature on the resultant fluorographic analysis of the immuno-
precipitated products was a broad molecular weight band of around 63 kilodaltons. This 
did not correspond to the MW of any of the known intestinal apolipoproteins; it was not 
a major band on the original antigenic mixture of floated hamster lipoprotein-associated 
proteins (p < 1.25 g/ml) used to immunize the rabbit (Fig. 3.2) although it may have 
been obscured by the large albumin band in the same region; this protein nevertheless 
appeared highly antigenic but did not cross-react with specific anti-apolipoprotein B or 
anti-apolipoprotein A-IV antisera, respectively; nor was it present when non-immune 
rabbit serum was used. When additional "cold" apolipoprotein B (in the form of hamster 
LDL) was added to the immuno-precipitation mixture, it was not displaced (as was 
radio-labelled apolipoprotein B). The unknown protein did not correspond to the 
expected MW of the thrombin-derived apolipoprotein B degradation products 
(B-48 - "B-26" & "B-22"). 
An antigenic mixture of all proteins in the p < 1.25 fraction would be expected to 
include not only the integral lipoprotein apolipoproteins but also other proteins or 
enzymes that might associate with lipoproteins especially high density lipoproteins. 
These would include lecithin:cholesterol acyltransferase (LCAT) MW 66 kDa, acid 
phosphatase (54 kDa) and cholesteryl ester transfer protein (CETP), MW 58 - 64 kDa 
(James et al. 1988). 
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CETP (also known as lipid transfer protein-I or LTP-1) is a relatively heat-stable 
glycoprotein with a MW of 54 kDa (as derived from cDNA studies) which contains 4 
potential sites for N-linked glycosylation (Drayna et al. 1987). It mediates the transfer 
of neutral and negatively charged lipids such as cholesteryl ester, tri-acylglycerol and 
phosphatidylcholine between plasma lipoproteins but is also believed to have important 
functions in modulating the activity of the enzyme LCAT and to play an important role 
in the process of reverse cholesterol transport where cholesterol from extra-hepatic 
tissues is transported to the liver, secreted into bile and thus cleared from the body 
(Tollefson & Albers, 1986). Its activity measured in the serum varies considerably 
among different mammalian species and Stein et al. (1990) have noted an apparently 
inverse relation between the plasma levels of CETP and the relative resistance of 
different species to the induction of atherosclerosis. Dogs, rats, sheep and cows have a 
low CETP activity and a high resistance to atherosclerosis while rabbits, humans, 
chickens and turkeys have a high CETP activity and are prone to develop atheroscelrosis 
when fed cholesterol. 
A study of CETP activity in the hamster revealed values apparently intermediate between 
those of rats and humans. An increase in plasma activity was obtained when the 
hamsters were fed 2 % cholesterol as opposed to a standard diet and this increase was 
even more pronounced when butter or margarine was added to the cholesterol in the diet. 
The increase in hamster plasma CETP activity correlated with the rise in the plasma 
cholesterol and triacylglycerol levels. 
Another interesting study by Faust and Albers in 1988 demonstrated that the human 
enterocyte cell line, CaC0-2, secreted functional CETP (LTP-1) vectorially into the 
basolateral medium when grown as monolayers on a permeable culture membrane. 
Furthermore, this secretion was regulated in a dose-dependent manner by the addition of 
free fatty acids bound to albumin in the apical ("luminal") medium. The LTP-1 activity 
in the basolateral medium could also be inhibited by a goat anti-human LTP-1 antiserum. 
151 
The human hepatoma cell line, HepG2, was also shown in the same study to secrete 
LTP-1 but this was not subject to regulation by medium free fatty acids. It was thus 
postulated that dietary fat might upregulate LTP-1 levels in the postprandial state and 
that the intestine was a major source of regulatable LTP-1. 
In 1988, however, another study failed to detect CETP mRNA in the rabbit intestine and 
this finding was confirmed in a comprehensive study by the group of Tall and co-
workers in 1991 who analyzed the levels of CETP mRNA in various mammalian tissues 
including the hamster (Jiang et al. 1991). They found that adipose, heart and muscle 
tissue were the major sources of CETP mRNA and that high cholesterol diets increased 
the CETP mRNA abundance in these tissues. The levels of CETP mRNA in adipose 
tissue and heart correlated with the plasma CETP concentration. Small intestine CETP 
mRNA showed a much lower activity compared to these tissues although high fat and 
cholesterol feeding significantly increased the intestinal levels (but still well below those 
of adipose tissue and heart). 
3.10 (ii) Tunicamycin. Pulse-chase Experiments and Attempted Immuno-precipitation 
with an Anti-LTP-1 Antiserum 
Freshly isolated intestinal epithelial cell sheets from the proximal small bowel of an adult 
male hamster fed a mixture of rice and sunflower oil (20% oil w/w) in the preceding 18 
hrs were pulse-labelled with 35s-methionine for twenty minutes at 37°C, either in the 
absence or presence of tunicamycin, an inhibitor of N-linked glycosylation (10 µg/ml 
final concentration). At the end of the twenty minute pulse period, cold methionine 
(final concentration 2 mM) was added to both systems and a subsequent 60 minute chase 
incubation at 37°C was carried out. The cell lysates were immuno-precipitated using the 
rabbit-5 anti-hamster apolipoprotein antiserum while the media samples at 60 mins chase 
time were analysed directly on SDS-PAGE. The 35s-labelled protein products were 
demonstrated by fluorography and molecular weights determined relative to a set of 
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Rainbow MW standards on the original gel. 
3.10 (iii) Results 
A band of MW 54 kDa appeared more prominent below the 59-67 kDa band (mid. MW 
64 kDa) in the tunicamycin-treated versus the control experiment suggesting that this 
protein was indeed glycosylated through N-linked sugars. The prominent additional 
band following tunicamycin treatment corresponded to the cDNA-derived MW for CETP 
(see Fig. 5.1). A goat-derived anti-human LTP-1 peptide antiserum directed against a 
26 amino acid peptide corresponding to the active site at the carboxy-terminus of the 
molecule, was received from Dr J. Adolphson in Dr Albers' laboratory. (The amino 
acid sequence of hamster CETP bears close homology with that of the human protein and 
the 26 amino acids in the active site differ in the 2 species in the last amino acid only) 
(Fig. 3.15). Protein G (which binds goat immunoglobulin) was used as the immuno-
precipitating agent. Unfortunately, no specific protein product could be precipitated. A 
positive control for the Protein G was provided by a concomitant successful immuno-
precipitation of apolipoprotein A-IV using another anti-A-IV-specific, goat-derived 
antiserum (Fig. 3.16). 
Thus, although some features of the 59-64 kDa protein present in my enterocyte lysates 
were consistent with those of CETP, an attempted immuno-precipitation using a specific 
anti-LTP-1 antiserum was unsuccessful. The true identity of this protein therefore 
remains obscure. 
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Fig. 3 .15. The putative active site of lipid transfer protein- I (L TP-1). The amino acid 
sequence of hamster L TP-1 bears close homology with that of the human protein and 
the 26 amino acids in the active site differ in the 2 species in the last amino acid only. 
(Ref: Dr J. Adolphson, NW Lipid Research Laboratory, Seattle, personal 
communication). 
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Fig. 3.16. Attempted IPs of LTP-1. 
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3.11 CONCLUSION 
Using specific antisera and the Protein A or Protein A-Sepharose techniques · of immuno-
precipitation, freshly isolated hamster jejuna! enterocyte suspensions have been shown to 
synthesize and secrete apolipoproteins B-48, A-IV and A-I during in vitro incubations. 
Methods have been devised to quantify the radio-labelled immuno-precipitable protein 
products. Column chromatographic analysis of the nascent intracellular lipoprotein 
particles has suggested that particles of chylomicron/very low density lipoprotein and 
nascent high density lipoprotein size were produced by enterocytes from a fat-fed 
animal. The system offers certain clear advantages as a method for studying the 
regulation of apolipoprotein synthesis, secretion and degradation following various 
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4.1. DISCUSSION 
From the previous review of the experimental evidence to date concerning the regulation 
of apolipoprotein biosynthesis and secretion (chapt. 1.8), the picture that appeared to 
emerge for apolipoprotein B-48 and A-I was one in which neither acute nor chronic tri-
acylglycerol (TAG) flux had any apparent effect on the synthesis of these apolipoproteins 
although the synthesis of apolipoprotein A-IV was significantly increased. Further 
evidence pointed to the existence of a large intracellular pool of Apo B-48 (and of Apo 
A-I) which was mainly membrane-bound rather than lipoprotein-associated, and which 
could not easily be depleted with either acute or chronic dietary TAG stimulation. 
Evidence gathered in various laboratories from studies on hepatocytes has suggested that 
the mechanism accounting for the increased secretion of apo B (and, therefore, apo B-
containing lipoproteins) caused by lipid (oleate) is that of inhibition of the early 
intracellular degradation of apo B by some kind of "protective" effect on the protein. 
The availability of apo B for lipoprotein assembly may therefore be regulated at the level 
of varying rates of degradation rather than changes in the rates of synthesis. No studies 
of apolipoprotein degradation have been reported in the intestine; indeed the systems of 
study mostly used, e.g. the in vivo pulse-labelling technique of Glickman described in 
chapt. 2.2, did not permit such studies. 
The technique of incubating freshly isolated enterocyte sheets from the hamster small 
intestine does, however, enable controlled studies of synthesis, secretion and degradation 
of the apolipoproteins to be performed. The dietary perturbations e.g. low fat feeding, 
acute bolus administration of TAG, overnight high fat feeding and chronic high fat 
feeding, were performed in advance of in vitro experimentation on intact animals; once 
active absorption was in progress, the animals were killed and enterocyte sheets prepared 
and incubated. The fundamental assumption in this system was that the cells in vitro 
continued to behave in a manner analogous to that of the in vivo state just prior to killing 
of the animal. 
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4.2.(i) PULSE-CHASE EXPERIMENTS: EXPRESSION OF RESULTS 
The method of pulse-chase labelling enabled studies of degradation to be performed in 
the incubated sheets of cells. Following a labelling period of twenty minutes, during 
which the cell sheets were incubated in the presence of 35s-methionine (8 µCi for every 
1 ml cell suspension), "cold" (non-radioactive) methionine was added to a final 
concentration of 2 mM, and a ten minute "equilibration" incubation time was allowed for 
the specific activity of the radio-labelled amino acid to become significantly diluted in 
the medium, in the intracellular pool and, indeed, in the methionylacyl transfer RNA 
pool, (the true precursor pool for [35s]-methionine-labelled proteins). From then on a 
"chase" period of 90 minutes was effected, during which the rate of appearance of 
proteins in the medium (secretion) and the overall loss of protein radioactivity from cells 
and media i.e. the rate of protein degradation, were measured in respect to total protein 
as well as specific (immuno-precipitated) apoproteins. 
Fig. 4.1 shows the total 35s methionine-labelled protein dynamics of a typical pulse-
chase experiment. Each time point on the graph represents the mean TCA-precipitable 
radioactivity from a duplicate set of incubation flasks. The enterocyte sheets from all the 
flasks were derived from the proximal small bowel Gejunum) of a single animal. 
In initiating the "chase" period, the "old" radioactive medium was not changed but 
simply diluted with excess cold methionine at the point arrowed (20 mins after the start 
of the incubation). (The start of the chase period - T=O' on the X-axis - was defined 10 
mins after the addition of the cold methionine). A medium change would have 
necessitated centrifuging the cells, removing the old medium, and perhaps even washing 
the cells once or twice before resuspending them in fresh medium. This was attempted 
on two occasions, but the viability of the cells appeared to be compromised by such 
procedures. In any case, when great care was taken to centrifuging and washing was the 
same, i.e. no significant differences m residual labelled protein was 
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Fig. 4.1. TCA-precipitable 35s-methionine labelled material in cells, media and total, 
following a typical pulse-chase experiment. Each point on the graph represents the 
mean TCA-precipitable radioactivity from a duplicate set of incubation flasks at a 
given time. The total TCA-precipitable radioactivity was obtained by adding those of 
the cells and media, respectively. The enterocyte sheets used for all the time points 
were derived from the jejunum of a single animal. 
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Fig. 4.2. A schematic representation of the definitions of "secretion" and "degradation" for 
a hypothetical (secreted) protein studied using the pulse-chase method. 
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observed between the 2 techniques. The less "traumatic" method was therefore 
favoured. 
It should be noted that the protein-synthesis inhibitor, specific for eukaryotic systems, 
cycloheximide, was not used during the chase periods. Although this inhibitor has been 
used in pulse-chase experiments involving cells in culture, its use has been criticized 
because of its potential role in inhibiting the synthesis of proteins normally responsible 
for the degradation of other proteins, so that unphysiological and abnormally long 
protein half lives have been obtained in the presence of this agent. 
Protein degradation (in the entire system i.e. general protein degradation, or of a specific 
apolipoprotein) was expressed quantitatively in the following way: 
OR 
Total TCA precipitable 
Degradation of total dpm in cells & media, 
protein in the system = of T=O' - T=60' x 100 
Total TCA-precipitable 
dpm in cells & media, 
T=O' 
Specific Immuno-precipitated 
TCA-precipitable dpm in cells 
Degradation of a = & media, of t=O' - T=60' x 100 
specific apolipoprotein Specific immuno-precipitated, 
TCA-precipitable dpm in cells 
& media, T=O' 
i.e. degradation was expressed as a percentage per hour. The immuno-precipitations of 
specific apolipoproteins from the cells and media were performed separately. N.B.: all 
TCA/IP dpm were corrected per µg cell protein. 
Synthesis of a particular protein was expressed as: 
Immuno-precipitated, TCA-precipitable 
dpm in cells & media. T=O' chase x 100 
Total TCA-precipitable dpm in cells 
media, T=O' 
Synthesis was therefore expressed as the proportional contribution of a particular protein 
to the total TCA-precipitable counts in the system at T=O' chase. 
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Finally, secretion was expressed as: 
IP precipitable, TCA ppt. apolipoprotein 
dpm in medium. (T=60' - T=O') x 100 
Total IP ppt, TCA-ppt apolipoprotein 
dpm in cells, T=O' 
i.e. that proportion or percentage of protein, present in the cells at T=O', that entered 
the medium after a 60' chase period. 
The definitions of secretion and degradation are represented schematically for a 
hypothetical (secreted) protein in Fig. 4.2. 
4.2.(ii) STANDARDIZATION OF PROTEIN SYNTHESIS EXPERIMENTS 
As we shall see, the rates of incorporation of radio-labelled amino acid into general 
protein varied markedly from one enterocyte preparation to the next. One possible 
factor that might have accounted for this variation was the relative sizes of the 
intracellular methionine pools in the different preparations. An enterocyte preparation 
with a relatively small intracellular methionine pool would result in a high specific 
activity of the radio-labelled methionine and, therefore, high rates of incorporation into 
protein; conversely, a preparation with a high intracellular methionine pool would dilute 
the specific radioactivity to a greater extent and thus produce lower rates of incorporation 
into protein. 
In an attempt to standardize for this potential source of variation, a "high methionine" 
protein synthesis incubation was also performed in each experiment; in these flasks, the 
enterocyte suspensions were incubated with 35s-methionine in the presence of 0.5 mM 
cold methionine in the medium. (This concentration was lower than the 2 mM 
methionine used in the pulse-chase technique). If variations in the intracellular 
methionine pool existed prior to incubation, these would be considerably reduced by the 
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dilutional effect of the large amount of cold methionine added since any endogenous 
variation in the intracellular pool would be swamped by the exogenous methionine. The 
specific activities of the radiolabelled amino acid would therefore be similar in all 
enterocyte preparations. The incorporation into protein of the "high methionine" 
systems was also corrected in each flask by measuring the microgram quantity of cell 
protein present, so that direct comparisons of the protein synthesis activity in different 
preparations could be made. 
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4.3. EXPERIMENT AIMS 
The experiments attempted to answer some of the questions addressed in chapt. 1. 7 using 
the established system of freshly isolated incubated jejunal enterocytes, viz: 
(1) Are the processes of lipid assembly and apolipoprotein biosynthesis linked or co-
ordinated? Is TAG flux a specific stimulus for apolipoprotein biosynthesis? 
(2) If TAG flux does stimulate apolipoprotein synthesis, does the composition of the 
TAG (saturated versus unsaturated fat) produce differing quantitative effects on 
the rates of apolipoprotein synthesis and secretion? 
(3) If an acute dietary TAG challenge does not stimulate or "up-regulate" 
apolipoprotein biosynthesis, does more sustained feeding (designed to deplete the 
intracellular pool of apolipoproteins by prolonging the TAG flux and therefore 
increasing the utilization of apolipoproteins for lipoprotein packaging) do so? 
How does low fat feeding ("baseline" control) compare with an acute TAG bolus 
administration, overnight high fat feeding and chronic (6 week) high fat feeding? 
(4) Are apolipoproteins degraded? If so, to what extent? Are there differences in 
the degradation rates for low fat-fed as opposed to high fat-fed animals? 
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4.4 DIETS 
The adult male Syrian Golden hamsters were maintained on a standard laboratory chow 
("Epol" pellets) prior to entering the experimental dietary regimes. This standard chow 
contained about 4% fat w/w (mainly plant or polyunsaturated fat). Cooked, polished 
rice was chosen at the baseline low fat diet since it contains the lowest fat content of 
almost any foodstuff (0.1 % fat, w/w, Geigy Scientific Tables). It was not administered 
for periods greater than 20 hours since it was not a "balanced" nutritious diet although it 
was eagerly consumed by the animals. The "single lipid meal" consisted of the bolus 
administration of sunflower oil (0.5 ml) fed to the animals by pipette. This material was 
also accepted by the hamsters who are known for their fondness of sunflower seeds. The 
animals were sacrificed two hours later to allow for gastric emptying, peristalsis and the 
establishment of an active transmucosal flux of TAG. The bowels removed from these 
animals were, in fact, obviously engorged with fat and the plasma was lipaemic, 
indicating active lipid transport from the intestine. In all experiments the TAG content 
of the enterocyte lysates and the plasma TAG concentrations were determined using a 
commercially available TAG assay kit (Triglycerides - GPO, Human GmbH, Germany). 
This enzymatic colorimetric test involved the determination of TG after enzymatic 
hydrolysis with lipases. It was linear up to a TG concentration of 1000 mg/dl (11.4 
mmol/1). A typical standard graph is shown in Fig. 4.3. Experiment sample volumes 
for the TG assay were chosen in such a way that they fell within the range of the 
standards. 
The "high unsaturated fat" feed consisted of a mixture of rice and sunflower oil (- 20% 
oil w/w) i.e. 80 g rice + 20 nil oil, mixed in a foodmixer to produce a soppy pulp 
which was homogeneous enough that the animals could not selectively eat the rice or the 
oil separately. The "high saturated fat" feed consisted of a mixture of rice and lard (80g 
rice + 20 g lard), also mixed to a palatable pulp. The chronic (6 week) high fat diet 
was devised by Dr A.D. Marais. The salt mix was based on a report published by 
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Fig. 4.3. A typical standard graph for the enzymatic-colorimetric TAG assay. 
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Cameron-Clarke and Manchester (1985). The diet comprised (w/w) oats (29%), maize 
(29%), skimmed milk powder (29%), Brewer's yeast (0.36%), multivitamin & mineral 
capsules (opened to release the powder), (0.71 %), sunflower oil (9.26%), and a salt mix 
consisting of sodium chloride, calcium lactate, disodium hydrogen phosphate, iron 
citrate, magnesium sulphate, calcium phosphate, potassium iodide and potassium 
hydrogen phosphate (2.1 %). The total fat content was approximately 10% (w/w), 
mainly polyunsaturated, and contributed 20% of the total calorific content of the diet. 
The composition of the various diets, their calorific contents and fatty acid composition 
are shown in Table 4.1. 
It should be noted that the high fat diets were obviously not isocaloric with the low fat 
diets. However, the aim of the experiments was to compare high fat with low fat 
feeding in terms of apolipoprotein synthesis, secretion and degradation. A high fat diet 
would inevitably contain more calories since fat has a higher energy content per gram 
than protein or carbohydrate. Secondly, the calorific differences between the diets (per 
unit mass of the foodstuff) would be compensated, at least in part, by an established 
observation about the eating habits of hamsters - they tend to adjust their intake 
according to their energy requirements (Borer 1985). A caged animal will eat 
approximately twice as much carbohydrate as fat to maintain the same energy intake in a 
20 hour feeding period, say. This was confirmed by my own observation that they 
consumed more than double the quantity of rice compared with the rice:20% oil mixture 
in an equivalent period. The total caloric consumption was therefore similar. The fatty 
acid composition of lard and sunflower oil was verified by gas chromatography with the 
assistance of Dr J. Cohen at the Medical Research Council Nutritional Research Institute 
(RIND), Parow, South Africa. 
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Table 4.1. A & B. Composition of experimental diets. The figures were calculated using 
information from Geigy Scientific Tables, Vol. One (8th Ed.), 1981. Ciba-Geigy 




The enterocyte sheets were, in any case, supplied with exogenous fuels in the incubation 
medium, so "endogenous pre-loading" of the cells with fuels in vivo would not, 
generally have been likely to account for differences in their in vitro behaviour. 
N.B.: Food was always provided in excess so that the animals were never starved during 
the feeding period. However, a fasting period of 2 hours following the last meal and 
prior to sacrifice was adopted in all the experiment protocols. Animals were always 
allowed free access to water. 
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4.5 MEASUREMENTS OF THE RATE OF BIOSYNTHESIS OF 
APOLIPOPROTEINS B-48, A-IV AND A-I UNDER CONDITIONS OF LOW 
AND HIGH FAT FEEDING 
4.5.(i) Protocol and Aims 
This set of preliminary experiments was designed to determine: 
(i) whether acute dietary TAG challenge stimulated or "up-regulated" apolipoprotein 
biosynthesis, and 
(ii) whether more sustained feeding, by prolonging the TAG flux and thus the 
utilization of apolipoproteins for lipoprotein assembly and secretion, depleted the 
intracellular pool of apolipoproteins and therefore stimulated apolipoprotein 
biosynthesis. 
Four dietary regimes were followed: A low fat (rice only) control, a single bolus 
administration of TAG (0.5 ml of sunflower oil pipette-fed to the animal), a 20 hr 
("overnight") feed consisting of a rice:20% sunflower oil mixture, and a chronic feeding 
regime, comprising 6 weeks on a 10% w/w fat diet (see 4.4). the dietary perturbations 
were performed on a duplicate set of animals. 
The experiment protocol is outlined in figure 4.4. Enterocytes prepared from these 
animals were incubated for 20' in the presence of 35s-methionine. The cells and media 
were immuno-precipitated using specific anti-apoB, anti-A-I, and anti-A-IV antisera and 
the fluorograms were quantified using the NaOH-silver elution technique (see 3.6ii) . 
Results were expressed as 
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Fig. 4.4. Experimental protocol for determining the effects of acute dietary TAG challenge, 
overnight fat feeding, and sustained lipid feeding for six weeks, on the synthesis of 
apolipoproteins B-48, A-IV and A-I, respectively. A low fat-fed control was included 
in the protocol. 
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4.5.(ii) Results 
Two animal experiments were performed for each dietary treatment. 
Low fat feeding <Rice only) (expts. 1 and 2) 
Expt. One: 
Expt. Two: 
Mass of animal = 143.9 g 
Average quantity of cell protein incubated 
(per incubation flask) = 0.390 mg 
Cell TAG content (per incubation flask) = 50 µg 
Cellular TAG content (µg)/cell protein (µg) = 0.146 
Plasma TAG concentration at time of killing of 
animal = 181 mg/dl 
Rate of general protein synthesis, T=20' = 8083 dpm/µg 
cell protein 
"High Methionine" system (20' incubation): 551 dpm/µg 
protein 
Apo B-48 as % of total radio-labelled protein 
synthesis (after 20' incubation) : 1.32 % 
Apo A-IV: 7% 
apo A-I: 2.0% 
Mass of animal = 145.3 g 
Average quantity of cell protein incubated = 0.492 mg 
Cell TAG content (per incubation flask) = 13 µg 
Cell TAG content (µg)/cell protein (µg) = 0.235 
Plasma TAG concentration at time of killing of 
animal = 177 11?-g/ dl 
Rate of general protein synthesis, T = 20' 
= 11 307 dpm I µg cell protein 
"High Methionine" system (20' incubation): 292 
dpm/ µg cell protein 
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Apo B-48 as % of total radiolabelled protein 
synthesis: 1.24% 
Apo A-IV : 4.5 % 
Apo A-I: 2.6% 
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Single fat meal (bolus administration of 0.5 ml sunflower oil following 20 hr rice only 
diet) (expts. 3 and 4) 
Expt. Three: Mass of animal = 167.4 g 
Average quantity of cell protein incubated (per 
incubation flask) = 1.017 mg 
Cell TAG content (per incubation flask) = 270 µ.g 
Cellular TAG content (µg)/cell protein (µg) = 0.271 
Plasma TAG concentration = 1401 mg/dl 
Rate of general protein synthesis, T=20' = 3596 dpm/µg 
cell protein 
"High Methionine" system (20' incubation) = 256 dpm/µg 
protein 
Apo B-48 as % total protein synthesis: 0. 73 % 
Apo A-IV : 3.9% 
Apo A-I: 3.9% 
Expt. Four: Mass of animal - 132.6 g 
Average quantity of cell protein incubated (per 
incubation flask) = 1.937 mg 
Cell TAG content (per incubation flask) = 603 µg 
Cellular TAG content/cell protein = 0.334 
Plasma TAG concentration = 164 mg/dl 
Rate of general protein synthesis, T=20' = 4019 dpm/µg 
cell protein 
"High Methionine" system (20' incubation) : 153 dpm/ µg 
cell protein 
Apo B-48 as % total protein synthesis: 1.46% 
Apo A-IV: 4% 
Apo A-I: 1.1% 
20 Hour high fat feeding (Rice: sunflower oil mixture) 
(Expts. 5 & 6) 
Expt. Five 
Expt. Six: 
Mass of animal: 134.2 g 
Average quantity of cell protein incubated (per 
incubation flask) = 0.300 mg 
Cellular TAG content (per incubation flask) = 318 µg 
Cellular TAG content/cell protein = 1.03 
Plasma TAG = 269 mg/dl 
Rate of general protein synthesis, T=20', = 12 769 dpm/ µg 
cell protein 
Apo B-48 as % total protein synthesis: 0.77% 
Apo A-IV: 6.0% 
Apo A-I: 2.6% 
Mass of animal: 116.5 g 
Average quantity of cell protein incubated (per 
incubation flask) = 0.850 mg 
Cellular TAG content (per incubation flask) = 1763 µg 
Cellular TAG content/cell protein = 2.06 
Plasma TAG concentration: 204 mg/dl 
Rate of general protein synthesis, T=20', = 7291 dpm.µg 
cell protein 
"High Methionine" system (20' incubation): 293 dpm/ µg 
cell protein 
Apo B-48 as % total protein synthesis: 0. 73 % 
Apo A-IV: 4.8% 
Apo A-I: 2.8% 
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Chronic fat feeding (10% fat diet, for 6 weeks) 
ffixpts. 7 & 8) 
Expt. Seven 
Mass of animal: 188.7g 
Average quantity of cell protein incubated (per incubation 
flask) = 1.381 mg 
Cellular TAG content (per incubation flask) = 1008 µg 
Cellular TAG content/cell protein = 0.634 
Plasma TAG = 254 mg/dl 
Rate of general protein synthesis, T=20', = 5411 dpm/µg 
cell protein 
"High Methionine" system (20' incubation): 350 dpm/ µg 
cell protein 
Apo B-48 as % of total protein synthesis: 1.4 % 
Apo A-N: 3.8% 
Apo A-1: 1.3% 
Expt. Eight 
Mass of animal: 178.6 g 
Average quantity of cell protein incubated (per incubation 
flask) = 1. 744 g 
Cellular TAG content (per incubation flask) = 708 µg 
Cellular TAG content/cell protein = 0.425 
Plasma TAG concentration = 235 mg/dl 
Rate of general protein synthesis, T=20' : 10 567 dpm/ µg 
cell protein 
"High Methionine" system (20' incubation) 348 dpm/ µg 
protein 
Apo B-48 as % total protein synthesis: 0. 71 % 
Apo A-IV: 4.5% 
Apo A-1: 1.5% 
174 
175 
4. 5. (iii) Discussion of Results 
The animal-to-animal variation even within a given dietary treatment was large. 
Compare, for example, the tenfold difference in the post-prandial plasma TAG content 
between the 2 animals both fed a single lipid meal. Reasons for these large differences 
probably relate to varying rates of gastric emptying of a lipid meal. Peculiarities of the 
hamsters' digestive tract and its feeding habits are likely to account for these differences 
(see discussion, section 4.8). Nevertheless, the rates of synthesis of the apolipoproteins 
B-48, A-IV and A-I do not differ significantly from one dietary group to the next (see 
Tables 4.2 A,B & C). 
These results are consistent with previous findings regarding the synthesis rates of 
apolipoprotein B-48 and A-I under conditions of low and high dietary fat intake. They 
are not in keeping, however, with data on Apo A-IV where a significant increase in the 
synthesis of this protein following acute and chronic dietary fat feeding has been reported 
(Apfelbaum et al. 1987). Possible reasons for this seemingly anomalous result will be 
discussed in section 4.8. 
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Table 4.2. The synthesis of (A) apolipoprotein B-48, (B) apolipoprotein A-IV, and (C) 
apolipoprotein A-I (expressed as the % contribution of the radio-labelled, 
immunoprecipitated apoprotein to the total TCA-precipitable labelled protein 
synthesis), under four dietary treatments (2 experiments per dietary group). 
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4.6 EFFECTS OF DIETARY FAT SATURATION ON SYNTHESIS OF 
APOLIPOPROTEINS B-48 AND A-I 
4.6.(i) Aims and Protocol 
In the preceding set of experiments, unsaturated dietary fat did not alter the rates of 
synthesis of the apolipoproteins B-48, A-IV and A-I compared with low fat controls. 
Given, though, the epidemiological and experimental evidence implicating saturated as 
opposed to unsaturated lipids in the genesis of hypercholesterolaemia, and in the light of 
previous experimental work suggesting that chylomicrons prepared from saturated fat-fed 
animals were selectively enriched in Apo B compared with unsaturated fat fed controls 
(Renner et al. 1986), a series of experiments was performed comparing the rates of 
synthesis of apolipoproteins B-48 and A-I encountered after administration of saturated 
and unsaturated fat diets. The experiment protocol is outlined in figure 4.5. The diets 
have been discussed in section 4.4 (Table 4.1). Only the 20 hr ("overnight") mode of 
feeding was employed. Because of a shortage of anti-apo A-IV antiserum, only the rates 
of B-48 and A-I synthesis were studied. 
4.6.(ii) Results 
Low fat feeding (expts. 9 & 10) 
(Rice only) 
Expt. Nine 
Mass of animal: 153.06 g 
Average quantity of cell protein incubated per flask: 1228 µg 
General rate of protein synthesis, T=20': 247 dpm/µg cell protein 
Apolipoprotein B-48 as % total protein synthesis: 2.19% 
Apo A-I: 2.14% 
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Fig. 4.5. Experiment protocol for determining whether dietary fat saturation has any effect 
on the synthesis of apolipoproteins B-48 and A-I respectively. 
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Expt. Ten: 
Mass of animal: 173.65 g 
Average quantity of cell protein incubated per flask: 1248 µg 
General rate of protein synthesis, T=20': 138 dpm/ µg cell 
protein 
Apo B-48 as % total protein synthesis: 1.38% 
Apo A-I: 0.50% 
20 hr High unsaturated fat feeding (Rice-sunflower oil) 
(Expts. 11 & 12) 
Expt. Eleven: 
Mass of animal: 166.15 g 
Average quantity of cell protein incubated per flask: 1284 µg 
General rate of protein synthesis, T = 20' : 269 dpm/ µg cell 
protein 
Apo B-48 as % total protein synthesis = 0.90% 
Apo A-I: 0.90% 
Expt. Twelve: 
Mass of animal: 171.80 g 
Average quantity of cell protein incubated per flask: 1400 µg 
General rate of protein synthesis, T=20': 2285 dpm/µg cell 
protein 
Apo B-48 as % total protein synthesis: 0.45 % 
Apo A-1: 1.60% 
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20 hr High saturated fat feeding (Rice:lard) 
(Expts. 13 & 14) 
Expt. Thirteen: 
Mass of animal: 177.68 g 
Average quantity of cell protein incubated per flask: 1256 µg 
General rate of protein synthesis, T=20': 344 dpm/µg cell 
protein 
Apo B-48 as % total protein synthesis: 1.24 % 
Apo A-1: 1.04% 
Expt. Fourteen: 
Mass of animal: 153.16 g 
Average quantity of cell protein incubated per flask: 1397 µg 
cell protein 
Apo B-48 as % total protein synthesis: 1.03% 
Apo A-1: 1.08% 
4.6.(ii) Discussion 
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Fat saturation, in this set of experiments, did not affect the synthesis of apolipoproteins 
B-48 and A-I in freshly isolated jejunal enterocytes from hamsters fed a saturated or 
unsaturated fat-enriched diet (see Tables 4.3A & B), compared with controls. Davidson 
et al. (1987) also found no change in Apo B-48 or Apo A-I synthesis following sustained 
feeding (six weeks) of a 30% saturated or unsaturated fat diet. The study by Renner et 
al. in 1986 showing a selective enrichment of saturated fat-containing rat chylomicrons 
by apolipoprotein B did not specifically measure the protein synthesis rate; the origin of 
the additional apo B (whether it was derived from recent de novo intestinal synthesis, 
from a pre-existing intracellular pool, or from apolipoprotein exchanges with other 
particles) was therefore not established. 
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A LOW UNSAT. SAT. 
FAT FEEDING FAT FEEDING, FAT FEEDING 
2.1, o.<tO I. 21.. 
I. lj o.r..s L03 
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Table 4.3. (A) Apo B-48, and (B) apo A-1, as %s of total radio-labelled protein synthesis 
under conditions of low dietary fat intake, high unsaturated fat intake and high 
saturated fat intake, respectively. (Duplicate expt. results per dietary group). 
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4. 7 STUDIES OF APO B-48 AND APO A-IV SYNTHESIS, SECRETION AND 
DEGRADATION UNDER CONDffiONS OF LOW AND HIGH FAT 
FEEDING 
4.7.(i) Protocol 
The pulse-chase technique (see 4.2(i)) was used to study the degradation and secretion of 
apolipoproteins B-48 and A-IV under conditions of low and high fat feeding. The 
experiment protocol and the methods used in calculating and expressing the results of 
synthesis, secretion and degradation studies, are outlined in figures 4.6 and 4.7, 
respectively. 
4. 7. (ii) Results 
Apolipoprotein B-48 was specifically immuno-precipitated by a polyclonal, rabbit-
derived anti-human apolipoprotein B antiserum ("OSAN", Behring) and the immuno-
precipitated product had a molecular weight approximately the same as that of the 200 
kDa MW standard on a 5-20% reducing SOS polyacrylamide gel. Apolipoprotein A-IV 
was quantitatively immuno-precipitated using a polyclonal rabbit-derived anti-rat apo A-
IV antiserum and had a MW of 44.5 kDa on a 5-20% reducing SOS polyacrylamide gel. 
All immuno-precipitations (IPs) resulted in a single protein band (of the expected MW 
for that protein) on the subsequent gel and fluorogram. Thus, in the calculations of rates 
of synthesis, degradation and secretion, the TCA-precipitable, IP counts (dpm) (minus 
the non-immune serum control IP dpm) were considered to originate exclusively from 
the specific IP protein product. 
Results: Histology 
Figs. 4.8 and 4.9 show transverse sections through the villi of the proximal jejunum of 2 
animals fed the low and high fat diets, respectively. The sections were stained with 
lO~r low 
f•t f udin3 





Ad olt Mcalt s,r1•n 
Goldtn HQmsu.rs, on 
sundord chow 
01h30 o.rn. or hpt. 
~,.~in' •t•pptd. 
A"'tmol s f'' oct cl in 
ceperott dtotl u3ts 
with wottr 
07h30 - 01h!Otm. foad 




ru p• r111t1on 
20 hr high 
fot fud1°n3 
fl iu. : oil mivtur«. 
= zoi. oil 
Incultni,n wit" KS- rmmuno-prt<ipi-
111c.thienint ( i,.1 ttll tcation •f Apo· 
S"-'ptnai,n, 'i #Id 3SS) -----· lipopn~eins 
1.0'p"lst. Q-t3()'..,.~1)' I-~, I. A·IV f,.," 
.... qo· chost '.Su. u<t:. ctlls ... ffltcfia 
k.1 
Quontif fr.a,ian •'j 
-----1. TCA ppt. •f t.-111"no-
pruipiu1tlt ,,m 
SPS- Pel,«<t~l-
111-------1 IQ\ICft 311, 
ftuar•3rerh~ 
Fig. 4.6. Protocol for studying the synthesis, degradation and secretion of apolipoproteins 
B-48 and A-IV under conditions of low and high fat feeding. 
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Fig. 4. 7. Expression of results of apolipoprotein synthesis, degradation and secretion. 
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Haematoxylin and Eosin and the fat-fed preparation showed a large number of 
vacuolated and distended intestinal epithelial cells indicating previous lipid engorgement. 
Results: Experiments 
Low fat feeding (expts. 15-18) 
Expt. Fifteen 
Mass of animal: 177 g 
Length of small bowel: 37 cm 
Length of proximal jejunum chosen for enterocyte 
preparation: 17 cm 
Mass of bowel chosen: 1.182 g 
Average quantity of cell protein incubated: 96 µg 
Average cellular TAG content, per incubation flask: 39 µg 
Cell TAG/protein ratio: 0.41 
Plasma TAG concentration: 107 mg/dl 
General rate of protein synthesis (T=O' chase) 4874 dpm/µg 
cell protein 
"High Methionine" incubation (20' pulse labelling) 995 dpm/ µg 
cell protein 
Total protein degradation/hr (0'-60' chase time): 2.9% nett 
synthesis 
Total protein "secreted" /hr: 7. 6 % 
Apo B-48: synthesis (as % total protein synthesis at 
T=O' chase): 4.1 % 
degradation (0' -60' chase time): 65 % hr 
"secretion" (0'-60' chase time): 0%/hr i.e. 
undetectable in medium 
Fig. 4.8. A cross-section of jejunal villi from a low fat-fed hamster (Haematoxylin-Eosin 
staining). 
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Fig. 4.9. A cross-section of jejuna! villi from a high fat-fed hamster (Haematoxylin-Eosin 
staining) showing numerous distended, vacuolated cells indicating lipid engorgement. 
The lipid has been washed out by the fixing and staining procedure. 
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Apo A-IV: synthesis: 0.4% 
degradation: 60% nett synthesis of A-IV observed 
(i.e. more apo A-IV present after 60' chase 
than at T=O' chase) 
"secretion": 0 % /hr 
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Figures 4.10 and 4.11 depict the fluorograms of the pulse-chase labelling for 
apolipoprotein B-48 and A-IV, respectively. 
Expt. Sixteen 
Mass of animal: 171 g 
Length of small bowel: 44.5 cm 
Length of proximal jejunum chosen for enterocyte 
preparation: 17 cm 
Mass of bowel chosen: 1.154 g 
Average quantity of cell protein incubated: 875 µg 
Average cellular TAG content, per incubation flask: 144 µg 
Cell TAG/protein ratio: 0.16 
Plasma TAG concentration: 127 mg/dl 
General rate of protein synthesis (T=O' chase): 712 dpm/µg 
cell protein 
"High Methionine" incubation (20' pulse-labelling): 15 dpm/ µg 
cell protein 
Total protein degradation/hr (0'-60' chase): 4.9% of nett 
synthesis 
Total protein "secreted"/hr: 22.4% 
Apo B-48 synthesis (as % total protein synthesis at 
T=O' chase): 2.2 % 
degradation (0'-60' chase): 43. 7% 
"secretion" (0'-60' chase): 0% 









Fig. 4.10. Fluorogram showing pulse-chase labelling of apolipoprotein B-48 (MW - 200 
kDa) following imnmuno-precipitation (IP) from enterocytes prepared from a low fat-
fed animal (expt. 15) and incubated with 35s-methionine. 
OSAN = a commercially available rabbit-derived anti-human apolipoprotein B 
antiserum. 
Key to lanes: 
a = O' chase, cells & medium, combined IP using 11 0SAN 11 
b = 30' " " " " " " 
c = 60' 11 , II II " ·" II 
d = 90' II , II II " " II 
e = MW standards 
f = O' chase, cells only; IP with 11 0SAN 11 
g = 0' 11 , medium only, 11 11 11 
h = 60' 11 , cells only, 11 11 11 
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Fig. 4.11. Fluorogram showing pulse-chase labelling of apolipoprotein A -IV 
(MW - 44.5 kDa) following immuno-precipitation (IP) from enterocytes prepared 
from a low fat-fed animal (expt. 15), and incubated with 35s-methionine. 
Key to lanes: 
a= MW stds. 
b = 30' chase, cells & medium combined, IP of apo A-IV 
c = 60' 11 
d = 90' 11 
II II II " " " " 
If ,, .. ,, 
e = O' chase, cells only, IP of apo A-IV 
f = O' 11 , medium only, 11 11 11 11 
g = 60' 11 , cells only, 11 11 " " 





degradation: 69. 7% 
"secretion" : 0 % 
Mass of animal: 165 g 
Length of small bowel: 43 cm 
Length of proximal jejunum chosen for enterocyte 
preparation: 17 cm 
Mass of bowel chosen: 1.147 g 
Average quantity of cell protein incubated: 1000 µg 
Average cellular TAG content, per incubation flask: 114 µg 
Cell TAG/protein ratio: 0.11 
Plasma TAG concentration: 76 mg/dl 
General rate of protein synthesis (T=O' chase): 1128 dpm/µg 
cell protein 
"High Methionine" incubation (20' pulse-labelling): 18 dpm/ µg 
cell protein 
Total protein degradation/hr (0'-60' chase): 4.3% 
Total protein "secreted" /hr: 8. 8 % 
Apo B-48 
Apo A-IV 
synthesis (as % total protein synthesis at 
T=O' chase): 0.9% 
degradation (0'-60' chase): 80.8% 
"secretion" (0' -60' chase): 0 % 
synthesis: 1. 6 % 
degradation: 78 % 
secretion: 0 % 
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Expt. Eighteen 
Mass of animal: 221 g 
Length of small bowel: 43 cm 
Length of proximal jejunum chosen for enterocyte 
preparation: 17 cm 
Mass of bowel chosen: 1.350 g 
Average quantity of cell protein incubated: 1260 µg 
Average cellular TAG content, per incubation flask: 198 µg 
Cell TAG/protein ratio: 0.16 
Plasma TAG concentration: 128 mg/dl 
General rate of protein synthesis (T=O' chase): 2143 dpm/ µg 
cell protein 
"High Methionine" incubation (20' pulse-labelling): 30 dpm/ µg 
cell protein 
Total protein degradation/hr (0' -60' chase): 13. 2 % nett 
synthesis 
Total protein "secreted"/hr: 25% 
Apo B-48 
Apo A-IV 
synthesis (as % total protein synthesis at 
T=O' chase): 2.6% 
degradation (0' -60' chase): 0 % /hr 
"secretion" (0' -60' chase): 13 % 
synthesis: 2 .5 % 
degradation: 9 % nett synthesis 
"secretion": 20%/hr 
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Results: High fat feeding experiments (19-22) 
Expt. Nineteen 
Mass of animal: 166 g 
Length of small bowel: 45 cm 
Length of proximal jejunum chosen for enterocyte 
preparation: 15 cm 
Mass of bowel chosen: 1.120 g 
Average quantity of cell protein incubated: 1510 µg 
Average cellular TAG content, per incubation flask: 517 µg 
Cell TAG/protein ratio: 0.34 
Plasma TAG concentration: 327 mg/dl 
General rate of protein synthesis (T = 0' chase): 7797 dpm/ µg 
cell protein 
"High Methionine" incubation (20' pulse-labelling): 34 
dpm/ µg cell protein 
Total protein degradation/hr (0' -60' chase): 13. 2 % nett 
synthesis 
Total protein "secreted"/hr: 7.4%/hr 
Apo B-48 
Apo A-IV 
synthesis (as % total protein synthesis at 
T=O' chase): 2.2% 
degradation (0' -6-' chase): 3. 5 % 
"secretion" (0'-6-/ chase): 28.9% 
synthesis: 3. 7% 




Mass of animal: 199 g 
Length of small bowel: 46.5 cm 
Length of proximal jejunum chosen for enterocyte 
preparation: 17 cm 
Mass of bowel chosen: 1.234 g 
Average quantity of cell protein incubated: 1390 µg 
Average cellular TAG content, per incubation flask: 1710 µg 
Cell TAG/protein ratio: 1.23 
Plasma TAG concentration: 274 mg/dl 
General rate of protein synthesis (T=O' chase): 3713 dpm/ µg 
cell protein 
"High Methionine" incubation (20' pulse-labelling): 30.5 dpm/ µg 
cell protein 
Total protein degradation/hr (0'-60' chase): 13.7% /hr 
Total protein "secreted"/hr: 10.3% /hr 
Apo B-48 
Apo A-IV 
synthesis (as % total protein synthesis at 
T=O' chase): 1.3% 
degradation (0'-60' chase): 34.6% /hr 
"secretion" 25. 9 /hr% 
synthesis: 4.5 % 
degradation: 17.6% /hr 
"secretion": 27. 6 % /hr 
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Figure 4.12 shows the fluorogram of pulse-chase labelling of apolipoprotein A-IV in 
expt. 20 (high fat feeding). 
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Fig. 4.12. Fluorogram showing pulse-chase labelling of apolipoprotein A-IV (MW - 44.5 
kDa) following immuno-precipitation (IP) from enterocytes prepared from a high fat-
fed animal (expt. 20) and incubated with 35s-methionine. 
Key to lanes: 
a = medium (neat) t = 90' 
b = MW standards 
c = O' chase, cells & medium, combined IP with anti-A-IV 
antiserum 
d = 30' chase, cells & medium, combined IP with anti-A-IV 
antiserum 
e = 60' chase, cells & medium, combined IP with anti-A-IV 
antiserum 
f = 90' chase, cells & medium, combined IP with anti-A-IV 
antiserum 
g = O' cells, anti-A-IV IP 
h = O' medium, " " " 
i = 60' cells, " " " 
j = 60' medium, " " " 
(k = anti-A-I IP) 
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Expt. Twenty-one 
Mass of animal: 197 g 
Length of small bowel: 45.5 cm 
Length of proximal jejunum chosen for enterocyte 
preparation: 11.5 cm 
Mass of bowel chosen: 0. 787 g 
Average quantity of cell protein incubated: 97 µ.g 
Average cellular TAG content, per incubation flask: 98 µ.g 
Cell TAG/protein ratio: 1.00 
Plasma TAG concentration: 241 
General rate ~f protein synthesis (T=O' chase): 3876 dpm/ µ.g 
cell protein 
"High Methionine" incubation (20' pulse-labelling): 47 dpm/ µ.g 
cell protein 
Total protein degradation/hr (0' -60' chase): 13 .1 % /hr 




synthesis (as % total protein synthesis at 
T=O' chase): 0.6% 
degradation (0'-60' chase): 17.6% 
"secretion" (0'-60' chase): 41.2% 
synthesis: 4.1 % 
degradation: 74% /hr 
"secretion": 3 8 % /hr 
Mass of animal: 218 g 
Length of small bowel: 44.5 cm 
Length of proximal jejunum chosen for enterocyte 
preparation: 18 cm 
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Mass of bowel chosen: 1.310 g 
Average quantity of cell protein incubated: 921 µg 
Average cellular TAG content, per incubation flask: 1608 µg 
Cell TAG/protein ratio: 1.75 
Plasma TAG concentration: 942 mg/dl 
General rate of protein synthesis (T=O' chase): 3923 dpm/ µg 
cell protein 
"High Methionine" incubation (20' pulse-labelling): 44 dpm/ µg 
cell protein 
Total protein degradation/hr (0'-60' chase): 1.5% /hr 
Total protein "secreted" /hr: 5 .1 % /hr 
Apo B-48 
Apo A-IV 
synthesis (as % total protein synthesis at 
T=O' chase): 1.3% 
degradation (0'-60' chase): 7.4% /hr 
"secretion" (0'-60' chase): 28% /hr 
synthesis: 1.9% 
degradation: 14% nett synthesis observed 
"secretion": 32% /hr 
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Figure 4.13 shows the fluorogram of both apo B-48 and apo A-IV pulse-chase labelling 
in expt. 22. 







Fig. 4 . 13. Fluorogram showing pulse-chase labelling of apolipoproteins B-48 and A-IV 
(MW - 200 & 45 kDa, respectively) following IP from enterocytes prepared from a 
high fat-fed animal (expt. 22) and incubated with 35s-methionine. The IPs have been 
combined on the same gel lane. 
Key to lanes 
a= MW stds. 
b = cell IP, B-48 & A-IV, t = O' chase 
c = medium IP, 11 
d = cell IP, 11 
e = medium IP, 11 
II 
II ti II 
t = 60' chase 




In expt. 15 (low fat-fed animal), there was no measurable protein degradation with 
respect to general proteins (an apparent nett 2.9% synthesis during the "chase" period 
was obtained), yet 65% of the Apo B-48 synthesized during the pulse-labelling was 
degraded in the first hour of the chase. Thus apo B-48 did not behave as an "average" 
cell protein: its turnover rate was much greater. The fluorograms confirmed the 
specificity of the immuno-precipitation with a single protein of the expected MW for the 
given apolipoprotein being precipitated on each occasion. 
In expt. 16 (low fat-fed animal), once again the general protein degradation in the system 
was not measurable (an apparent nett synthesis of 4.9% was recorded in the 1 hr chase 
period) yet the degradation of apolipoprotein B-48 was measured at 55 % per hour of 
chase incubation time. A similar result ( 4. 3 % general protein degradation compared 
with 81 % of apo B-48 degradation per hour) was obtained in expt. 17. 
It is noteworthy that expt. 18 produced a result rather different from those of the other 3 
low fat-fed animal experiments in that apo B-48 was not degraded at all in the chase 
period (0% degraded/hr) (a nett synthesis of 13.2 % was obtained for general proteins 
during the 1 hr chase period). Also, unlike the preceding 3 low fat-fed expts., secretion 
of apolipoprotein B-48 (13 %/h) was observed in expt. 18. No apo B-48 had been 
detected in the medium of the first 3 low fat-fed experiments. 
The results obtained with apolipoprotein A-IV were more varied with respect to the 
degradation rates of this protein in the 4 low fat-fed expts. In expt. 15 a 60% nett 
synthesis was observed, in expt. 16 a 70% nett degradation; a similar nett degradation 
of 78% was obtained in expt. 17, while a nett synthesis of apolipoprotein A-IV of 9% 
was obtained in expt. 18. Unlike the first 3 expts., in which apo A-IV was not detected 
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in the incubation medium after a 60' chase period (i.e. secretion = 0%/hr), in the case 
of expt. 18, 20% of the apo A-IV previously in the cell at the start of the chase period, 
was secreted into the incubation medium after a 60' chase time. Expt. 18 therefore 
appeared inconsistent with the three other low fat-fed expts., and, in fact, more closely 
resembled the results obtained with the high fat-fed expts. 
In all 4 high fat-fed expts. the degradation rates of apolipoprotein B-48 were lower than 
those obtained in 3 out of the 4 low fat-fed expts.: expt. 19 (B-48 degradation = 3.5%; 
general protein degradation = 13.2 % ); expt. 20 (apo B-48, 34.6% degraded/hr; general 
proteins: 13.7% per hour); expt. 21 (apo B-48, 17.6% degraded/hr; general proteins, 
13.1 % per hr), and expt. 22 (apo B-48, 7.4% degraded/hr compared with 1.6% 
degradation per hr in the case of general cell proteins). In all the high fat-fed animal 
expts., apo B-48 secretion into the chase incubation medium was observed: 29%, 26%, 
41 % and 28% secreted/hr in expts. 19 to 22, respectively: all these values were above 
the "general" protein secretion observed in each experiment. 
The degradation rates for apolipoprotein A-IV in the case of the high fat-fed experiments 
were 35.1 %, 17.6%, 74% and 14% nett synthesis, for expts. 19 to 22, respectively. 
The results for apo A-IV degradation are therefore less consistent and more varied. 
However, apo A-IV was consistently found to be secreted in the case of the 4 high fat-
fed expts. (secretion rates of 17, 27.6, 38 and 32% secretion per 60' chase incubation 
time, respectively, for the 4 high fat-fed expts.). 
The TAG content of the cells (expressed as a ratio relative to the cell protein content) 
was generally higher in the high fat-fed (HFF) compared with the low fat-fed (LFF) 
expts. LFF: ratios of 0.41, 0.16, 0.11 and 0.16 compared with HFF ratios of 0.34, 
1.23, 1.00 and 1.75 respectively, indicating higher mucosal TAG content and, therefore, 
mucosal TAG flux in the HFF expts. (except for expt. 19). The plasma TAG 
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concentrations of the HFF animals were all greater than those of the LFF animals (327, 
274, 241 and 942 mg/dl, HFF, versus 107, 127, 76 and 128 mg/dl for the LFF 
animals). 
A review of the 22 experiments presented in this chapter shows: 
(i) 7 experiments involving animals fed the same low fat (rice only) diet for 20 
hours (expts. 1, 2, 9, 10, 15-17); 
(ii) 8 experiments in which all the animnals were fed a high unsaturated fat diet 
(rice:oil, 80:20 w/w) for 20 hours (expts. 7, 8, 11, 12, 19-22). 
Within these 2 groups of experiments, the dietary regimes followed were exactly the 
same. 
In all the experiments the % protein synthesis for each apolipoprotein studied was 
expressed in the same way viz. as that proportion of radioactive TCA-precipitated 
material present in the specifically immuno-precipitated apolipoprotein relative to the 
total TCA-precipitated material, following a twenty minute radio-labelling period. The 
only difference between expts. 1, 2, 7, 8, 9, 10, 11, 12 and expts. 15-22 was that in the 
former group the incorporation of radio-labelled amino acid into protein was stopped by 
transferring the incubation flask from a 37°C orbital shaker/waterbath onto ice; in the 
latter group it was abolished by the addition of excess "cold" amino acid (2 mM 
methionine, final concentration) i.e. to effect the "chase", with a ten minute equilibration 
period. 
The "percentage synthesis" r~sults of these experiments are therefore directly 
comparable, and a statistical review of the results is presented in Tables 4.4 (A)-(C). 
Degradation and secretion studies could only be studied using the pulse-chase method 
employed in expts. 15-22. Because of the atypical nature of expt. 18 (apolipoprotein 
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secretion despite the enterocytes being derived from an apparently low fat-fed animal), I 
have regarded it as an outlier and have excluded it from the statistical analyses. 
The rates of synthesis of the apolipoproteins showed considerable variation even amongst 
animals within the high or low fat-fed groups, but the overall result indicated that there 
were no significant differences in the synthesis rates of apolipoprotein B-48 or A-IV 
between the 2 dietary groups. This finding is consistent with other studies in the 
literature of apo B-48, but it contradicts previous findings of increased apo A-IV 
synthesis seen with acute (or chronic) dietary lipid feeding (e.g. Apfelbaum et al. 1987). 
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4.8 ANIMAL-TO-ANIMAL EXPERIMENT VARIATION: POSSIBLE 
EXPLANATIONS 
A pervasive problem in these animal experiments has been the variation in the results 
from animal to animal (or from one enterocyte preparation to the next). Observe, for 
example, the large variations in many of the synthesis, secretion and degradation results 
presented. Standardization of results was attempted as far as possible (e.g. by use of the 
"high methionine" system to correct for possible variations in the intracellular 
methionine pools from one animal's enterocytes to the next; also, the expression of 
results relative to the cell protein content, thus correcting for variations in the cell yield 
for the different intestinal segments and for varying quantities of cells incubated). 
Despite these measures, however, animal to animal variation (within a given dietary 
group) remained an unsolved problem. 
Some of these difficulties encountered may be explained by the peculiarities of the 
hamster digestive tract (see chapt.2.1). An important question in all dietary experiments 
is the timing of the killing of the animal following the dietary perturbation. This is 
especially important in the acutely fat-fed animals (bolus lipid administration); it is 
probably less important in the animals fed for 20 hrs on a given diet and is unlikely to be 
a significant factor in the chronic adaptation diets of six weeks duration. Ideally one 
would wish to obtain the enterocytes from the proximal jejunum during the period of 
maximal transmucosal TAG flux. In my experiments a 2 hr period of food deprivation 
was used following the last observed meal to allow for gastric emptying into the 
proximal small bowel. However, the hamster has a forestomach (see Fig. 2.1) in which 
food may be stored for anything from 10 minutes to an hour or even longer (Borer, 
1985) and this could unpredictably delay gastric emptying. 
The problem is further complicated by the hamsters' internal cheek pouches which they 
use to store and transport (non-liquid) food. In my experiments the animals were 
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initially maintained on a standard laboratory "chow" ("Epol" pellets) which contained 
approximately 4% of mainly polyunsaturated fat, w/w. At the onset of the 20 hr feeding 
regimes they were transferred to new sawdust-free cages containing only the new 
experimental dietary food. Their cheek pouches were inspected (as far as could be done) 
for any pellets but it is conceivable that some hoarding may have been missed. It is 
feasible that the tiny quantity of fat present in a stray pellet may contribute to alterations 
in apolipoprotein synthesis and degradation (see later, for a discussion of a model for 
apolipoprotein B-48 fluxes in the enterocyte). 
Returning to the hamster forestomach, it is known that this organ is capable of 
fermenting cellulose to produce fatty acids (Borer, 1985). Thus even sawdust may 
contribute additional fatty acids and it is conceivable that the odd "low fat" experiment 
(see experiment 18, for example) may have contained more fat or fatty acids from pellet 
hoarding or forestomach fermentation than one might have believed at the time. 
Whole animal experiments are generally known to produce wide variations in results 
(see, for example, the studies of Davidson et al. (1985, 1986) on rat intestinal 
apolipoprotein biosynthesis). Nevertheless, despite the variation, a picture - at least of 
apolipoprotein B-48 fluxes in the intestine - does appear to emerge from my 
experiments, and is supported by previously published data especially concerning 
degradation studies of apolipoprotein B in liver cell cultures. 
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4.9 A MODEL FOR INTESTINAL APOLIPOPROTEIN FLUXES? 
The rates of apolipoprotein B-48 synthesis were unaltered by dietary lipid ( compared 
with the low fat fed controls), yet the secretion of this protein increased, as one might 
have expected with increased chylomicron packaging and "export" from the cells. In 3 
of the 4 low fat-fed animal experiments, the rates of apolipoprotein B-48 degradation 
were significantly higher compared to the high fat-fed state. These findings support a 
model for apolipoprotein B-48 fluxes previously discussed in section l.8(i) in which the 
rate of protein synthesis is constant and unaltered by dietary lipid flux (acute or chronic) 
and in which the rate of protein synthesis is probably always maximally "up-regulated"; 
this produces a large intracellular pool of pre-formed apolipoprotein B-48 which is 
always available in the cell should a high lipid load arrive. During periods of low lipid 
flux a significant proportion of the apolipoprotein B-48 intracellular pool (not utilized in 
lipoprotein packaging) is degraded intracellularly; with the advent of a large dietary 
lipid flux, the synthesis rate remains unchanged but the degradation rate of 
apolipoprotein B-48 is significantly reduced, so that the size of the intracellular pool is 
perhaps momentarily increased to accommodate the need for increased lipoprotein 
packaging. With increased utilization of the apolipoproteins for lipoprotein assembly 
and packaging, the pool is reduced again to its previous size. Hypothetical figures for 
rates of apolipoprotein B-48 synthesis, degradation and secretion are used to illustrate the 
model diagrarnatically (fig. 4.14). 
Most of my experiments (excepting for expt. 18) lend support to this model. It is further 
supported by evidence from the Glickman group who showed no increase in 
apolipoprotein B-48 synthesis with acute or chronic dietary lipid flux (Davidson et al. 
1986 and 1987) and who also measured the distribution of apolipoprotein B-48 in 2 
intracellular pools or compartments viz. the predominantly membrane-associated, non 
lipoprotein-bound intracellular pool, and a lipoprotein-associated pool. They found that 
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Fig. 4.14. Schematic representation of a model for apolipoprotein B-48 dynamics under 
conditions of (A) low, & (B), high fat-feeding. 
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feeding, a small shift occurred from the membrane-associated to the lipoprotein-
associated pool, but most of the intracellular apolipoprotein B remained in the 
membrane-bound pool. The constant presence of this large pool inside the cell meant 
that apolipoprotein synthesis was not the rate-limiting step in lipoprotein assembly or 
secretion (Magun et al., 1988). 
Measurements of apolipoprotein B-48 degradation in the small intestine have not 
previously been described in the literature. However, hepatocyte studies of apo B by 
Borchardt & Davis (1987), Dixon & Ginsberg (1991 and 1993) and White et al. (1992) 
have supported the idea of enhanced apolipoprotein B degradation in the absence of 
exogenous (medium) fatty acid. With the addition of the fatty acid oleate to hepatocytes 
of the hepatoma cell line, Hep G2, the synthesis of apoB was unaltered but the secretion 
of apo B-containing lipoproteins was enhanced by reducing the pre-secretory degradation 
of the protein. Fatty acids therefore appear to protect nascent apo B from rapid 
intracellular degradation and a similar mechanism is likely to operate in the enterocyte. 
In three of my experiments performed under conditions of dietary lipid depletion, there 
was no detectable secretion of the apolipoproteins (including B-48) and this coincided 
with a high rate of B-48 degradation intracellularly. (The enterocytes of the fourth "low 
fat-fed" hamster - expt. 18 - behaved in a manner that strongly suggested the presence of 
some lipid in the diet - apo B-48 was secreted into the medium and there was no 
measurable intracellular degradation of the protein during the chase period). 
The Hep G2 studies of Dixon & . Ginsberg and White have confirmed that under lipid-
poor conditions only a small fraction of newly synthesized apolipoprotein B is actually 
secreted; most of the molecules are rapidly degraded inside the cells. 
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In a recent study by Sakata et al. (1993), the calpain inhibitor I, N-acetyl-leucyl-leucyl-
norleucinal (ALLN) was used to study the possible mechanisms underlying these 
processes in Hep G2 cells. They showed that ALLN protected apo B from rapid 
intracellular degradation, thus increasing the intracellular apo B pool (and, therefore, its 
potential to be secreted), but did not actually accelerate its secretion; oleate, on the other 
hand, promoted the secretion of the protein from the cells, while the combined effects of 
oleate and ALLN were additive, resulting in an acceleration and increase in the total apo 
B secretion. 
A possible model proposed by the authors to explain this finding was that oleate 
facilitated the transport of apo B out of a protease-containing compartment associated 
with the endoplasmic reticulum (the protease being sensitive to ALLN). By perhaps 
associating with intracellular lipid, the apo B molecules were rapidly translocated beyond 
the protease-containing compartment and along the secretory pathway. A direct 
inhibitory effect of oleate on the proteolysis of apo B could not, however, be excluded 
by their results (Sakata et al. 1993). 
In my experiments the fatty acids were supplied by the previous dietary treatments rather 
than by the in vitro introduction of exogenous fatty acids to the medium of the incubated 
enterocytes i.e. the in vitro incubation served only as an assay for radio-labelled 
apolipoprotein synthesis, degradation and secretion and was not experimentally modified 
(except during initial optimization expts - see chapt. 2). Pulse-chase studies of 
apolipoprotein degradation are not feasible in in vivo experiments. 
Although data for apo A-I degradation are lacking in my experiments (due to a lack of 
antiserum for immuno-precipitation), the model for apo A-I may be presumed to be 
similar to that of apo B-48 (see discussion 1.8 (ii)). The experimental work of Magun et 
al. (1988) supports this idea. 
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A model for apolipoprotein A-IV is more problematic. Previous workers have 
consistently shown that the synthesis of apolipoprotein A-IV is enhanced by dietary lipid. 
The mRNA for this protein, the radio-labelled amino acid incorporation into Apo A-IV, 
the total intracellular apo A-IV content of the cells, the lymphatic content of apo A-IV 
and even the postprandial plasma concentrations of apo A-IV have all been shown to 
increase after lipid feeding (see review 1.8 (iii)). The regulation of this protein has 
therefore generally been accepted to operate at a pre-translational level. 
In my experiments, however, despite a quantitative immuno-precipiation of apo A-IV, its 
rate of synthesis remained unaltered by lipid feeding (although, once again, there was 
considerable animal to animal variation in the results); its secretion, however, increased 
with high fat feeding and its degradation was similar in both low and high fat-fed animal 
enterocytes. If these results are to be believed, the intracellular pool of apolipoprotein 
A-IV should have fallen significantly following lipid feeding, given increased secretion 
yet similar rates of synthesis and degradation. 
An attempt was made to measure the size of the intracellular apolipoprotein A-IV pool. 
In the absence of a suitable radio-immunoassay for the purpose, an experiment was 
devised in which serial immuno-precipitations using a constant quantity of radio-labelled 
cell lysate from an incubation experiment of a fat-fed and a non fat-fed animal were 
performed. The amount of antiserum used was progressively increased (1 , 2, 5, 10 etc. 
µl of antiserum). The radio-labelled immuno-precipitable protein products were run on 
an SDS-polyacrylamide gel, and a fluorogram obtained. The quantity of radio-labelled 
protein immuno-precipitated by the differing amounts of antiserum were measured by 
densitometric scanning of the fluorographic bands. The density of the individual bands 
was expressed relative to the density of the largest band (obtained when the standard 25 
µl of antiserum was used). A graph was then plotted of the log I/antiserum versus the 
% density of the resultant band for both the non-fat and the fat-fed preparations. Both 
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graphs yielded very similar gradients (-70 and -73, respectively) indicating no significant 
differences in the intracellular apo A-IV pool sizes between the LFF and HFF 
preparations. A coherent model for apo A-IV fluxes in the small intestine based on my 
experiment results was therefore not possible, since synthesis, degradation and pool size 
all appeared to remain constant, despite an increase in apo A-IV secretion from the cells. 
In 1990 Hayashi et al. showed, usmg the inhibitor of chylomicron assembly and 
secretion, Pluronic L-81, that the stimulus for increased apo A-IV synthesis was not the 
actual absorption of MAG & FF A into the cell or its re-synthesis into lipid; rather it 
was the events of chylomicron assembly and secretion that stimulated apo A-IV 
synthesis. Perhaps a relative secretion block existed in my in vitro system in which 
chylomicron secretion did occur but not to the extent that it would in vivo; perhaps this 
reduced secretion (due to a lack of calcium intracellularly, say, or to the lack of external 
stimuli that depended on normal intestinal cellular architecture or an intact systemic 
blood supply) resulted in a reduced stimulus to apolipoprotein synthesis and a consequent 
failure to make more apo A-IV in the cell. This would not have been observed in the 
case of apo B since its regulation was, in any case, not controlled at a pre-translational 
level and the protective effect of the fatty acids on early apo B degradation may still have 
been operating even in a collection of enterocyte sheets with a defective lipoprotein 
secretory mechanism. I shall return to the question of the "validity" of my enterocyte 
system i.e. how closely it resembles the physiological processes of the cell in vivo, in the 
concluding chapter (chapt. 7). 
Finally, I was unable to perform ·any measurements of the relative mRNA abundance of 
the apolipoproteins under the various dietary conditions owing to a lack of a suitable 
probe for the hamster mRNA. Attempts using a rat cDNA probe for the hamster apo B 
mRNA were unsuccessful. 
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5.1 INTRODUCTION: N-LINKED GLYCOSYLATION 
The polypeptide backbone of human apolipoprotein B undergoes a variety of co-or post-
translational modifications. There are 25 cysteine residues in apolipoprotein B-100, 12 
of which occur in the first 500 amino acids. 6 out of every 7 of the cysteine residues are 
involved in intra-molecular disulphide bonds and the amino terminus of the molecule is 
especially highly cross-linked (Knott et al. 1986, Yang et al. 1986). N-linked 
glycosylation has been demonstrated and there is some indirect evidence suggesting the 
presence of 0-linked sugars as well. Palmitate and stearate fatty acylation via covalent 
thio-ester linkages at cysteine residues has been demonstrated in apo B-100 from the 
hepatoma-derived cell line, HepG2 (Hoeg et al. 1988). Apolipoprotein B-100 also 
displays 2 intra-molecular thio-ester linkages (between cysteine 51 and glutamine 54, and 
cysteine 3734 and aspartate 3737, respectively). 
From the amino acid sequence of apolipoprotein B-100, 19 potential glycosylation sites 
for N-linked oligosaccharides have been found (sequence Asn-X-Thr/Ser). Of these 16 
have been shown to be glycosylated. Since apolipoprotein B-48 comprises the first 2152 
amino acid residues of the N-terminal portion of B-100, there are six putative sites for 
N-linked oligosaccharides, of which 5 are likely to be glycosylated. (The first potential 
site at asparagine residue 7 has been shown not to be glycosylated in B-100 and B-48). 
Studies of hepatic B-100 from plasma LDL have revealed that 37% of the 
oligosaccharide structures consist of the high-mannose type with the rest being mainly bi-
antennary complex oligosaccharides (Scott 1989 & 1990). A study of the 
oligosaccharide chains of human small intestinal apo B-48 by Sasak, Lown and Colburn 
(1991) showed that 16% of the oligosaccharides were of the high-mannose type, with 
78% bi-antennary complex oligosaccharide structures and the remaining 6% consisting of 
higher-branched oligosaccharides. Of the bi-antennary complex sugars, half were 
sialylated, with a ratio of mono- to di-sialylation of 1:2. Knowing the mono-saccharide 
composition and the proportion of different types of N-linked oligosaccharides, it has 
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been calculated that human intestinal apo B-48 has, on average, one high-mannose type 
and 4 complex-type oligosaccharide chains. 
There is thus a difference in the glycosylation pattern of B-100 and B-48. This may be 
organ-specific (liver versus small intestine) but the role of the carbohydrate modification 
is unknown. Some postulated functions have included protection against proteolysis (and 
hence increased molecular stability) and roles in affecting the insertion of the protein into 
membranes or the phospholipid layer of lipoproteins, intra-cellular migration and sorting 
as well as secretion. However, a study by Siuta-Mangano et al. in 1982 showed that N-
linked glycosylation was not required for the secretion of apolipoprotein B from chicken 
or rat liver. In the condition of chylomicron retention disease, where malabsorption of 
fat occurs with low concentrations of plasma lipids and cholesterol and the absence of 
chylomicrons in the plasma, lipid droplets together with apolipoprotein B-48 accumulate 
in the small intestinal cells of these patients (Roy et al. 1987). When compared with 
normal subjects the incorporation of mannose into intracellular chylomicrons was 
reduced by 80% (Levy et al. 1987). Since apo B-48 is the only apolipoprotein present in 
chylomicrons that is known to contain N-linked oligosaccharides, it has been suggested 
that a specific apo B-48 glycolsylation deficiency occurs in this condition. 
Tunicamycin is a compound which inhibits the enzyme catalyzing the addition of N-
acetylglucosamine to dolichol phosphate, the first step in the biosynthesis of an 
oligosaccharide-pyrophosphoryl-dolichol complex (Murray 1988). Normally, following 
completion of the primary oligosaccharide chain, it is transferred en bloc from the 
dolichol pyrophosphoryl backbone to form an N-glycosidic bond with one or more 
specific asparagine residues on the protein during its synthesis on membrane-bound 
polyribosomes. The modification is therefore co-translational. Subsequent processing or 
trimming of the oligosaccharide chain on the protein to form either high-mannose or 
complex-type sugars takes place at first on the nascent peptide attached to endoplasmic 
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reticulum-bound polyribosomes, and later, on the cis, medial and trans cistemae of the 
Golgi apparatus. 
5.2 AN EXPERIMENT USING TUNICAMYCIN 
This experiment has previously been described in Chapter 3.10 (ii). 
5.3 RESULTS AND DISCUSSION 
The fluorogram (Fig. 5 .1) showed a decrease from approximate! y 185 to 173 kilodaltons 
in the molecular weight of apolipoprotein B-48 in the tunicamycin-treated system after 
60 minutes chase time compared with the system in which Tunicamycin was absent. 
This decrease was observed in both cell lysate immuno-precipitations and media samples. 
Furthermore, when quantified by densitometric scanning relative to the apo A-I or apo 
A-IV bonds of the same sample or lane (which were unaltered by tunicamycin 
treatment), the quantities of radio-labelled apolipoprotein B-48 were similar, with or 
without tunicamycin treatment. (The apparently denser B-48 bands in the tunicamycin-
treated samples reflected differences in the total quantity of cell protein incubated in the 
2 systems). 
Thus, hamster small intestinal apo B-48 possesses N-linked oligosaccharide chains. This 
carbohydrate modification does not appear to affect its secretion or degradation in an in 
vitro pulse-chase incubation experiment of enterocyte sheets from a fat-fed animal. This 
finding is supported by work in rat and chicken hepatocytes which also showed no 
interference with apo B secretion by tunicamycin treatment (Siuta-Mangano et al. 1982; 
Forte & Nordhausen 1984). 
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Fig. 5. 1. Pulse-chase experiment in the presence or absence of tunicamycin. Enterocytes 
from a fat-fed hamster were incubated with 35s-methi .onine in the presence or 
absence of tunicamycin (10 µg/ml final concentration). After a 20' pulse, cold 
methionine was added and a subsequent 60' "chase" period followed. The cell lysates 
and media samples were immuno-precipitated using "Rabbit 5" antiserum. 
Key to lanes: 
a = medium following chase period, without tunicamycin + R5 IP 
b = medium following chase period in presence of tunicamycin 
c = cell lysate, IP with R5 antiserum, without Tunicamycin 
d = cell lysate, IP with R5 antiserum, in presence of tunicamycin. 
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5.4 PHOSPHORYLATION 
The covalent modification of proteins and enzymes by reversible phosphorylation and 
dephosphorylation is an important mechanism by which intracellular events are regulated 
in mammalian tissue. A number of studies have demonstrated phosphorylation of 
apolipoprotein B (Davis et al. 1984 & 1986; Sparks et al. 1988 & Jackson et al. 1990). 
Experiments were attempted to demonstrate phosphorylation of apo B-48 using [32p] 
orthophosphate in the enterocyte sheet incubation system, but due to technical difficulties 
they were unsuccessful and inconclusive. 
5.5 CONCLUSION 
Hamster intestinal apolipoprotein B-48 undergoes N-linked glycosylation. Neither the 
secretion nor the degradation of the protein was affected when N-linked glycosylation 




APOLIPROTEIN BIOSYNTHESIS AND TURNOVER IN MAMMALIAN SMALL 
INTESTINAL EPITHELIUM 
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In order to study the dynamics of apolipoprotein biosynthesis and turnover in the 
mammalian small intestine, a system was established whereby intestinal epithelial cell 
(enterocyte) sheets could be freshly isolated from the hamster jejunum and incubated in 
vitro in a supportive medium. (The hamster was chosen as the best available small animal-
model of human lipoprotein metabolism). The dietary treatments being tested were 
performed on the intact animals prior to killing and cell preparation on the assumption that 
metabolic activities would be maintained during the preparation and incubation of the cell 
sheets. The methods of cell preparation and incubation were based on a description by 
Towler et al. (1978) but were modified and optimized for the present purposes. The 
majority of the cells remained intact and viable during the incubation period and were 
capable of synthesizing and secreting apolipoproteins. The three principal intestinal 
apolipoproteins, B-48, A-IV and A-I, were identified by specific immuno-precipitation, and 
the method of pulse-chase labelling enabled measurements of apolipoprotein synthesis, 
secretion and degradation to be performed. 
Previous systems devised to study the regulation of intestinal apolipoprotein synthesis (for 
example, the Glickman model of pulse labelling in situ in anaesthetized rats) precluded 
studies of protein degradation; there are, in fact, no reports in the literature to date on 
turnover studies of apolipoproteins in the intestinal epithelium. Studies have, however, 
been performed in rat hepatocytes in primary culture and in the hepatoma cell line, HepG2 
(Borchardt & Davis 1987; Dixon et al. 1991; Dixon & Ginsberg 1993; White et al. 
1992). A potential cell culture model for the human small intestinal epithelium, the human 
colonic carcinoma-derived CaC0-2 cell line, has been used to study lipid and 
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apolipoprotein synthesis and secretion (Hughes et al. 1987 and 1988) but many features of 
this cell line (e.g. the secretion of lipoproteins of unusual density, the predominance of apo 
' 
B-100 secretion over apo B-48) have called into question the reliability of this model in 
reflecting normal small intestinal epithelium. In any event, no studies of apolipoprotein 
degradation have been reported in CaC0-2 cells. 
In the past, the use of freshly isolated intestinal epithelial cells has generally been limited to 
studies of amino acid and sugar transport across the epithelial cell (Wilson & Vincent 1955; 
Alvarado, 1968; Bihler & Crane 1962; Kimmich (review), 1975). A paper by Yousef and 
Kuksis (1972) reported the in vitro release of chylomicrons from isolated cells of the rat 
intestine that had been "pre-loaded" in vivo by dietary-derived lipid. The group of Sviridov 
et al. (1986 and 1990) have used freshly isolated epithelial cells of the human small 
intestine to study their ~interactions with high density lipoproteins. 
Isolated epithelial cells have a (theoretical) advantage over whole bowel or intact animal 
studies in allowing the study of the "genuine" newly secreted intestinal lipoproteins and 
apolipoproteins, free from the subsequent interactions and exchanges of material with other 
circulating lipoproteins that are thought to occur soon after the nascent particles are released 
from the cells. In order to produce sufficient quantities of material for subsequent 
compositional analysis, however, large preparations of cells are needed. The quantities 
available in this study for column chromatography and SDS-polyacrylamide gel analysis 
were unfortunately too small. (A study by Mahley et al. in 1971 analyzing the nascent 
VLDL particles associated with the Golgi apparatus of the rat small intestine required 
pooling of enterocyte preparations from 12 animals - this would probably be equivalent to 
36 hamsters). Nevertheless, such "scaled-up" versions of the kinds of experiments reported 
in this project would provide additional information especially with regard to the protein 
and lipid composition of nascent intestinal lipoprotein particles. 
. ,. 
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An important concern in the use of isolated epithelial cells is the exposure of the basolateral 
surface of the cells to the potentially harmful effects of residual luminal bile acids. This 
' 
could, in theory, result in dissolution of the basolateral membrane and cell lysis. In my 
experiments, however, the cells were washed twice prior to re-suspension in the incubation 
medium - this should have cleared away most or all the luminal contents that would have 
contaminated the initial cell preparation. Secondly, no significant lysis was ever 
demonstrated during a five hour incubation period (the pulse-chase labelling experiments 
involved a maximum incubation time of only two hours). Finally, morphological 
appearances of the released epithelial ct?lls on light microscopy suggested that the cells were 
rel~ in large groups or sheets from the villi tips, still attached to the basement 
membrane (which detached with the cells) and therefore still maintaining cell-to-cell contact 
(see fig. 4.2). 
An important disadvantage of the use of epithelial cells or sheets of cells isolated from the 
bowel wall relates to the process of isolation itself which, however mild, must by its very 
definition result in cells that are somehow different from those in the intact bowel. This 
kind of alteration or damage is an escapable and inevitable consequence of the method - the 
real question is, by how much does the behaviour of these cells in vitro differ from that in 
the intact bowel? Do they synthesize and secrete proteins at rates similar to those achieved 
in vivo? Do the degradation rates measured in vitro bear any resemblance to those 
occurring in vivo? Do the isolated cells suffer from an artefactual secretion block? Are 
they deprived of hormones or nervous influences normally carried to the intestine from the 
systemic circulation that critically influence the processes of synthesis, secretion and 
degradation? Are they missing necessary local gut hormones? Are they adversely affected 
by a lack of normal cell-to-cell contact? 
In one sense, the answer is simple - of course, by the very definition of being isolated, they 
must be lacking the normal systemic neural and endocrine influences. The isolated cell 
system cannot be the answer to all the questions of intestinal lipoprotein metabolism. 
. " 
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Nevertheless, when figures for intestinal apolipoprotein biosynthesis ( expressed as a 
percentage of total radio-labelled protein synthesis) are compared between my system and 
' 
the in vivo labelling system of Glickman et al., the results are of a similar order of 
magnitude: Apo B-48, 2% in my system compared with 0.8% (Davidson et al. 1986), apo 
A-I (1.9% versus 1.8% (Davidson et al. 1985), and apo A-N 3% versus 2% (non fat-fed, 
Apfelbaum et al. 1987). Some of the differences may be explained by the cross-species 
comparison (hamsters versus rats). When comparing degradation figures in hepatocytes 
with those in the isolated intestinal cell incubations, similar figures are seen. In my non 
fat-fed system, the average degradation rate for apolipoprotein B-48 was about 60% (of the 
previ~usly pulse-labelled apolipoprotein) degraded in 1 hr; for the fat-fed system, the 
average figure was 15 % • In Hep 02 cells in the absence of oleate in the medium, the 
degradation was 58% in 20 mins of :"chase" incubation; in the presence of oleate, it was 
29% (Dixon et al., 1991). Borchardt and Davis (1987) could only account for 36% of apo ,,. 
B-100 and 60% of apo B-48, previously synthesized intracellularly, appearing in the 
medium of rat hepatocytes in primary culture. The general principle seems to apply 
throughout: increased lipoprotein (including apolipoprotein B) secretion is associated with 
reduced rates of intracellular degradation and, conversely, degradation is high when the 
transmucosal lipid flux is low (or oleate is absent from the culture medium). The 
concordance with other systems of study adds credibility to the system itself. 
There is a difficulty in the case of the results obtained for apolipoprotein A-N secretion by 
the intestinal cells in this system (see discussion, chapt. 4.8). Perhaps lipoprotein assembly 
and secretion operated below normal and the normal pre-translationally controlled 
mechanism(s) for increasing the synthesis of apolipoprotein A-N is lacking in the isolated 
epithelial cells. Or perhaps apo A-N regulation in the hamster is controlled differently 
than it is in the more commonly studied laboratory rat? In any case, the isolated cells do 
secrete apolipoproteins into the medium, even if they do so at apparently lower rates than 
occur physiologically. 
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No attempts were made in my experiments to modify the lipid content of th~ incubation 
medium during an experiment. Such experiments may in the future provide useful insights 
into the precise mechanisms involved in regulating rates of apolipoprotein synthesis, 
secretion or degradation. For example, it would be useful to know whether the rate of 
apolipoprotein B-48 degradation can be reduced, in vitro, when oleate is added to an 
incubation of jejunal enterocytes from a low fat-fed hamster. 
Measurements of apolipoprotein messenger RNA abundance and radio-immunoassays of the 
intracellular apolipoprotein pool sizes would also contribute potentially useful information 
in helping to formulate a model for the regulation of intestinal apolipoprotein fluxes but 
these were not possible in this study (except for a crude assay of the apo A-IV content - see 
chapt. 4.9). 
Unanswered questions with respect to the regulation of apolipoprotein biosynthesis and 
turnover in the various intestinal segments could also, in the future, be addressed in the 
isolated enterocyte system. The proximal jejunum was used in all my experiments because 
it is known to be the most important site for the absorption of dietary lipid but other 
segments of the small bowel including the ileum may also be involved (Hoving & V alkema, 
1969); preliminary work by Davidson et al (1985 and 1986) suggests that fundamental 
differences exist in the regulation of apo B-48 and apo A-I synthesis in ileal compared with 
jejunal enterocytes of the rat (for example, biliary lipid appears to be an important factor in 
regulating ileal but not jejunal apolipoprotein A-I synthesis). 
Another unexplored avenue concerns variation along the villus-crypt axis. The cell 
preparation technique involved pooling the cell "effluents" from a series of "tapping" 
procedures designed to gently free the epithelial cells from the lamina propria. Initial cell 
collections would contain the terminally differentiated epithelial cells of the villus tip, 
. ,. 
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subsequent (more vigorous) tappings would be expected to free additional epithelial cells in 
the upper, middle and later, even lower, villus regions (see Weiser et al. 1973 and 1978). 
Thus, by collecting the sequential cell harvests separately, a differentiation of cells along 
the villus-crypt axis could be obtained and studied independently with regards 
apolipoprotein biosynthesis, etc. J.M. Dietschy and co-workers have previously 
demonstrated variations in cholesterol synthesis and LDL uptake along the villus-crypt axis 
(Stange & Dietschy review, 1985); it is likely that variations in apolipoprotein turnover 
also occur along this axis - the more differentiated cells of the upper villus are likely to be 
more active in apolipoprotein synthesis since they are most actively involved in the 
absorption of the luminal digestive products. 
The question of intracellular processing and co- and post-translational modification of 
apolipoproteins has been briefly addressed (chapt. 5). A study using tunicamycin indicated 
that intestinal apolipoprotein B-48 was co- or post-translationally modified by N-linked 
glycosylation but this carbohydrate modification or lack of it did not appear to affect the 
secretion or susceptibility to degradation of the protein. With larger scale cell preparations, 
better subcellular fractionation techniques (see chapt. 3.8), and the use of a wider range of 
inhibitors of post-translational carbohydrate modifications, a more comprehensive picture of 
the intracellular processing of the apolipoproteins may emerge. Many other proteins 
thought to be synthesized by enterocytes with functions closely related to lipoprotein 
metabolism e.g. acylation stimulating protein (ASP), fatty acid binding proteins (FABP) g 
and h and the low density lipoprotein receptor (LDL-receptor) were not successfully 
identified in this project while the mystery of protein X (chapt. 3) remained unsolved. 
With improved antibodies and immuno-identification techniques these proteins may be 
identified and, like the apolipoproteins, may be subjected to similar studies of synthesis, 
secretion and degradation rates under various dietary treatments. Indeed, many other 
enterocyte proteins not necessarily related to lipoprotein metabolism e.g. the various 
digestive enzymes, intestinal transferrin, etc. may all be amenable to study following 
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dietary or experimental manipulations in the intact animals. 
Finally, it should be remembered that the impetus for scientific inquiry into lipoprotein 
metabolism in general and intestinal lipoprotein metabolism in particular has been the 
association of dietary fat intake and hypercholesterolaemia with atherogenesis and 
cardiovascular disease. While this study has focused particularly on intestinal 
apolipoprotein dynamics, a fundamental long-term question remains - how do these changes 
induced by various diets affect overall lipid metabolism? Only by studying the subsequent 
metabolism of the intestinal lipoproteins and their component protein and lipid constituents 
can a more comprehensive picture emerge of the role or contribution of the small intestine 
to overall, whole-body lipid dynamics. 
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